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Patients of Alzheimer’s Disease (AD) showed reduced levels of the actin-binding protein Drebrin in their 
neurons. The here presented work was set out to analyse the interaction between Drebrin and the 
disease-associated peptide Amyloid-β. 
To analyse the interaction in vivo two novel models were designed, employing the nematode C. elegans. 
The Amyloid-β pathology was modelled by overexpressing the disease causing peptide pan-neuronally 
and employing a genetic sub-stoichiometric labelling method to be able to follow the aggregation in vivo 
and in situ in a non-invasive manner. A second model, expressing human Drebrin pan-neuronally was 
generated to analyse Drebrin stability, localization and phosphorylation as well as analysing the effect 
of Drebrin overexpression on the nematodes’ vitality and fitness. The third project combined both 
generated models to obtain a genetic cross expressing Aβ1-42 and Drebrin simultaneously. This model 
was sought to study the interaction between Aβ1-42 and Drebrin. 
I could show, that Aβ1-42 aggregates with the progression of ageing and exhibits multiple disease 
phenotypes that can be correlated to observations obtained in murine neurons as well as observations 
of AD patients’ brain tissues. Furthermore, I observed, that a distinct subset of head neurons of the 
anterior ganglion, the IL2 neurons, exhibits the first aggregates and that a cell-type specific suppression 
of Aβ1-42 in IL2 neurons could delay the disease onset. 
Drebrin was observed to be regulated by phosphorylation at Serine-647 by Ataxia telangiectasia 
mutated kinase and render nematodes more resistant towards chronic oxidative stress. 
The genetic cross of Aβ1-42 and Drebrin unravelled that overexpression of Drebrin can ameliorate Aβ1-42 









Patienten, die an der Alzheimer’schen Krankheit leiden, weisen reduzierte Mengen des 
Aktinbindeproteins Drebrin in ihren Nervenzellen auf. Ziel der vorliegenden Arbeit war es, die Interaktion 
zwischen Drebrin und dem krankheitsassoziierten Peptid Amyloid-β zu untersuchen. 
Für eine in vivo Analyse wurden zwei neue Modellsysteme im Fadenwurm C. elegans entwickelt. Die 
Amyloid-β-pathologie wurde durch panneuronale Überexpression des krankheitsinduzierenden Peptids 
nachgestellt. Zusätzlich wurde ein sub-stöchiometrischer Teil der Peptide genetisch markiert, um eine 
in vivo und in situ Nachverfolgung der Aggregation zu ermöglichen. Als zweites Modell wurde ein 
Stamm generiert, der humanes Drebrin panneuronal überexprimiert, um Drebrin-stabiliät, -lokalisation 
und -phosphorylierung, sowie den Einfluss auf die Vitalität und Fitness der Nematoden zu analysieren. 
Das dritte Projekt sollte die beiden zuvor generierten Modelle kombinieren. Eine genetische Kreuzung, 
die Drebrin und Aβ1-42 simultan exprimiert, wurde generiert, um die Interaktion zwischen den beiden 
Proteinen zu analysieren. Ich konnte zeigen, dass Aβ1-42-Aggregation mit fortschreitendem Altern der 
Nematoden einherging und verschiedene Krankheitsbilder damit korrelierten, welche in Experimenten 
mit murinen Neuronen, als auch in Experimenten an Gehirngewebsproben aus menschlichen 
Alzheimerpatienten nachgewiesen werden konnten. Darüber hinaus konnte ich zeigen, dass die ersten 
Aggregate in einer Subpopulation Kopfneurone des anterioren Ganglions, den IL2-Neuronen, auftreten, 
sowie, dass eine zellspezifische Inhibition der Aβ1-42-expression in jenen IL2-Neuronen genügt, um die 
Aggregation in anderen Neuronen zu verzögern. 
Es konnte gezeigt werden, dass Drebrin-Degradierung durch Phosphorylierung des Serin-647 durch 
die Ataxia telangiectasia mutated Kinase (ATM) reguliert wird und dass diese Phosphorylierung mit einer 
erhöhten Resistenz der Nematoden gegenüber chronischem oxidativen Stress einhergeht. 
Die Kreuzung von Aβ1-42 und Drebrin konnte schließlich zeigen, dass sowohl Aβ1-42-Aggregation als auch 
Toxizität durch Drebrin-Überexpression abgeschwächt werden und dass dieser Effekt abhängig von 
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Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that was first described more 
than one hundred years ago by Aloïs Alzheimer 1. Despite the discovery of neurofibrillary tangles, 
amyloid plaques, astrogliosis and neuronal dystrophy as hallmarks of the disease we still do not fully 
understand the mechanisms leading to AD. 
Currently, about 50 million people worldwide are suffering from dementia, including AD as the most 
common cause accounting for up to 70% of the cases 2–4. Although, about 50 % of the AD patients 
display not only hallmarks of AD pathology but a mix with pathologies of other forms of dementia (e.g. 
synucleinopathies, fronto-temporalopathies) 5. Together, they exhibit an enormous socio-economic 
burden for our society, bearing in mind the increasing amount of elderly people 6. While coronary and 
heart diseases decrease, AD pathogenesis is accounted as the leading cause of death with an average 
survival time of eight years for those diagnosed at the age of 65 7.  
AD can be distinguished in a familial early-onset and a sporadic late-onset disease. Whereas, the 
familial early-onset AD represents less than 1% of all AD cases 8. The familial AD is a result of a rare 
inherited autosomal dominant mutation, predominantly found in the genes for the amyloid-precursor 
protein (APP), Presenilin-1 and Presenilin-2 8,9. Such pathology driving mutations increase the 
production of the pathological amyloid-beta peptide (Aβ) or increase the fraction of the most toxic Aβ 
variant, the 42 amino acids long Aβ1-42 10–12. The vast majority (> 95%) of AD cases are sporadic late-
onset variants 8. While genetic 13 and environmental factors contribute to increase the prevalence to 
develop AD, the most pronounced risk factor is ageing 14. 
The first hallmarks of AD develop years before the first mild cognition defects manifest. The severity of 
the disease is then gradually increasing, impairing memory and cognitive capacity further and leading 
ultimately to neuronal lesions, neuron atrophy and death. These three phases can be considered a (1) 




The biochemical phase 
 
The “biochemical phase” is characterized by the abnormal procession of the amyloid-precursor protein 
(APP), aggregation and oligomer formation of amyloid-beta peptides (Aβ), hyperphosphorylation and 
aggregation of tau protein, as well as spreading and seeding of aggregation. Protein misfolding and 
aggregation are hallmarks of AD as they are for most neurodegenerative diseases 16–19.  
The aggregation prone Aβ peptides are released as by-products of an abnormal degradation of APP by 
the membrane-bound β- and "-secretases (Fig.1.1) 20. The most abundant forms are the less 
aggregation prone, 40 amino acids long, Aβ1-40 and the more aggregation prone, more toxic, 42 amino 
acids long, Aβ1-42. Shorter peptides are described, but because senile plaque are mostly composed of 
Aβ1-42 they are thought to be more important for the disease phenotype 21–23. APP can be cleaved by an ⍺-secretase in a non-amyloidogenic pathway that competes with the abnormal processing, producing 
a neurotrophic and neuroprotective cleavage product (sAβPP⍺) 24,25. Finally, healthy brains produce 
Aβ1-42 in low picomolar concentrations, which are thought to affect synaptic plasticity and memory 
formation positively 26–28. 
 
Figure 1.1: Schema of APP processing 
The amyloid precursor protein is processed by the combination of ⍺-secretase and "-secretase to 
retrieve non-amyloidogenic cleavage products or by β-secretase and "-secretase to yield an 
amyloidogenic Aβ of 39 to 43 amino acids length. The cleavage-sites of the ⍺-secretase (green), 
β-secretase (orange) and "-secretase (violet) are indicated. The C’-terminal domain is located inside the 
cytoplasm, while the C’ terminal part of the Aβ stretch is located inside the plasma membrane. Adapted 
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The rate limiting step for the amyloidogenic pathway is considered to be the cleavage by the 
β-secretase 30,31. This first step occurs in multiple intracellular sites such as the Golgi, the endoplasmic 
reticulum (ER) or other endosomal compartments 32–35. The second step, the cleavage by the "-secretase complex, can occur throughout the whole protein trafficking as it is localized on the plasma 
membrane 36, the ER 37, the Golgi 38 and endosomes 36. There is indirect evidence, that Aβ is also 
localized in the cytoplasm as it inhibits proteasomes that are cytoplasmic residents in vivo and 
in vitro 39–41.  
This increase of pathogenic Aβ leads to the formation of oligomeric Aβ species followed by further 
progression of aggregation to form insoluble amyloid deposits. These large insoluble aggregates can 
be found in post mortem brain samples of AD patients and are termed amyloid plaques. This process 
of aggregation was correlated to toxicity and termed as “amyloid cascade hypothesis” 42,43. Today, this 
hypothesis is more controversial than ever, as a multitude of other hypothesis have been proposed 
regarding the mechanism of toxicity in AD (see Fig.1.2). 
The amyloid cascade hypothesis can be regarded as the most popular theory for the toxicity in AD and 
many other theories can be referred to as extensions of it (e.g. calcium-influx hypothesis 44,45). Yet, it’s 
most critical assumption, that the formation of large amyloid deposits / amyloid plaques leads to a 
series of toxic events in AD, has to be to questioned as clinical trials aiming to reduce the amyloid 
burden of AD patients did not yield success 46,47. 
Today, it is believed that oligomeric Aβ species (AβO) are the most toxic agent in AD and inflicting the 
most damage ultimately leading to neuron death. The size of AβOs can vary and consist of three up to 
thirty or more monomers and there is no defined quaternary structure described 48–51. There is evidence 
that Aβ plaques are not the major toxic species in AD. Synaptic loss was observed in APP transgenic 
mice models of AD while no plaque formation was observed 52, as well as intracellular Aβ could be 
correlated with cognitive dysfunction in several AD models in the absence of amyloid plaques 53,54. Yet, 
it was shown that they could cause several aberrations: Amyloids can sequester other metastable 
proteins, induce protein misfolding thereby and give rise to potential toxic gain-of-function as well as 
loss-of-function by depletion of physiologically important proteins 17,55–58. Furthermore, amyloid fibrils 
can cover plasma membrane surfaces and disrupt them mechanically 59,60. Also, Aβ can complex and 
reduce metal-ions leading to increased formation of reactive oxygen species (ROS) 61–63. Most 
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importantly, Aβ amyloids can induce secondary nucleation of Aβ monomers and therefore increase the 
amount of AβO formation and further aggregation in a feedforward loop manner 64–66. Studies reasoning 
that AβO evoke the major toxic effects have gathered some strong evidence. Case studies have found 
that AβO abundance in AD patients correlated with the severity of cognitive impairment and neuronal 
lesion 48,67,68. Furthermore, antibodies against AβOs were efficiently reversing cognition deficits in mouse 
models of AD 69,70.  
 
 
Figure 1.2: The Amyloid Cascade Hypothesis 
Schema containing the ‘Amyloid Cascade Hypothesis’, extended by features of the ‘toxic-oligomer 
hypothesis’, the ‘Ca2+ influx hypothesis’ and the ‘cellular phase hypothesis’. Depicted is the progression 
of amyloid formation starting with unfolded (red stripe) or misfolded monomeric Aβ1-42 (red forward arrow 
linked to light-red reversed arrow), that continue to condense to larger structures. Listed below are 
observed effects that are correlated to the indicated Aβ-species. 
 
monomers oligomeres proto fibrils mature amyloids
•  direct binding to receptors
•  indirect interference with receptor binding
•  membrane disruption by incorporation into
    the lipid-bilayer
•  membrane damage by pore formation
•  dysregulation of Ca2+ homeostasis
•  inhibiting proteasomal degradation
•  inhibiting autophagy
•  protein sequestration
•  inducing protein misfolding 
•  membrane disruption by adsorption onto
    the lipid-bilayer
•  complexation of metal ions
•  seeding secondary nucleation
•  produce reactive oxygen species
•  induce tau protein hyper-phosphorylation
•  chronic activation of microglia leading to inflammation
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The spectra of observed perturbations by AβOs range from direct receptor binding, to membrane 
integrity perturbation and perturbation of intraneuronal proteostasis. Among the interaction with 
receptors, the most interesting ones are the activities on N-methyl-D-aspartate (NMDA) receptors and  
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors that are decreasing long 
term potentiation (LTP) and enhancing long term depression (LTD), thereby interfering with memory 
formation and consolidation 71. The binding of AβOs to the Insulin-like growth factor-1 receptor and the 
Insulin receptor is described to compromise signalling and therefore enhance neurodegeneration in AD 
72. Monomeric and small oligomeric Aβ can be incorporated into plasma membranes and affect 
membrane fluidity and lipid composition 73 by which mechanism also raft domains containing ⍺7nACh 
receptors are perturbed. The lipid microenvironment is particularly important for the proper function of ⍺7nACh receptors even though it is not known, if membrane fluidity or the lipid identity is responsible 
for the functionality 74,75. The perturbation of this particular microenvironment by Aβ may pose a major 
perturbance for ⍺7nACh receptor activity 76,77.  
The incorporation of Aβ into plasma membranes can also induce Aβ pore formation or ion-channel 
formation 78. Ca2+ entry through such channels perturbs ion homeostasis generally and poses a problem 
for maintaining neuronal membrane potential 44. Secondly, such pores are hypothesized to be 
foundations for further fibril growth and subsequent lipid clustering around the growing aggregate, 
leading to major damage at the affected membrane 79–81. 
As already mentioned, Aβ species can also enter the cytoplasm and provoke perturbation of the 
proteostasis machinery, by sequestering chaperones 82–84, inhibiting proteasomes 39,41 and by perturbing 
autophagy 85–87. 
 
The second signature of the proteotoxic phenotype is the hyperphosphorylation and aggregation of the 
microtubule-associated protein tau (Tau) into amyloids termed ‘neuro fibrillar tangles’ (NFT) 88. NFTs 
were found to correlate with AD severity 89–91 and their composition included a high ratio of 
hyperphosphorylated Tau compared to not phosphorylated Tau 92–94. Tau-pathology and Aβ-pathology 
are tightly connected, as was shown by studies that observed that Aβ presence would increase the 
pathologic relevant hyperphosphorylation of Tau 95,96. Studies have been conducted to identify kinases 
evoking Tau hyperphosphorylation and found CDK5 and GSK3β as strong candidates 97–99. Those 
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kinases are regulated by Calpain, a Ca2+-dependent cysteine protease 100,101. Taken together, this is an 
interesting correlation to the Aβ-pathology that disturbs Ca2+ homeostasis by ion channel formation and 
previous studies observed an induction of Tau hyperphosphorylation by Aβ1-42 102,103. 
While most of the described perturbations affect neurons at a single cell level primarily, some are 
thought to promote the disease to progress to a “cellular phase”, impairing multiple cell-types and 
tissues alike. One of these effects is the increased production of reactive oxygen species in AD brains. 
Previous studies observed, that Aβ1-42 not only elicits proteotoxic stress, but also oxidative stress by 
the direct production of ROS as well as by interfering with mitochondria’s functional integrity 104–106. 
Furthermore, Aβ induces microglia activation and inflammation 107. 
 
The cellular phase  
The cellular phase of AD is characterized by the progression of perturbations, not only in neurons but 
in all adjacent cell types, resulting in a catastrophic accumulation of damage that ultimately leads to the 
disorchestration of neuronal signal processing.  
Microglia are the phagocytic cells of the central nervous system and comprise 5 to 12 % of the cells in 
adult murine brains 108. Previous studies observed a tight association between senile plaques and 
microglia 109. As mentioned above, Aβ can activate microglia and induce inflammation 107. Tasks of 
microglia cells include the detection and removal of cellular debris and extracellular protein aggregates, 
the removal of supernumerary neurons during normal brain development and synaptic pruning, the 
constant and iterative inspection of synapses to remove dysfunctional or unnecessary synapses 110–112. 
Two studies found rare mutations in receptors expressed in microglia, that are correlated with an up to 
fivefold increased risk of late-onset AD 113,114. Together, this highlights that microglial cells are affected 
from AD and may contribute to the disease phenotype.  
Another cell type, that is particularly important for the function of the nervous system are the 
oligodendrocytes. This cell type synthesizes myelin to cover axons and therefore facilitates neuronal 
signal transduction as saltatory action potentials. Their breakdown is a hallmark of multiple sclerosis, 
an autoimmune-mediated neurodegenerative disorder 115. Yet, also for AD patients demyelination was 
described, as well as a link between Aβ aggregates and local demyelination 116,117. 
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The third class of glia cells in the brain that plays a crucial role in fine tuning neurotransmission are the 
astrocytes. They are required for multiple different supportive activities (e.g. maintaining the blood-
brain-barrier together with endothelial cells, feeding the neurons, buffering of pH and ion 
concentrations, etc.) 118. Furthermore, they facilitate synapse formation, maintenance and even 
influence neurotransmission by secretion of gliotransmitters like ATP, glutamate or D-serine 119. 
Therefore, they can be regarded as an integrative part for the computing function of the brain 119,120. 
In experiments with AD mice, no significant reduction of astrocytes could be detected nor were such 
reductions detected in ageing human brains or AD brains 121,122. Thus, the situation is much more 
complex and the role astrocytes play in AD neurodegeneration remains enigmatic. One possible 
synaptotoxic mechanism is the upregulation of NF&B by Aβ that induces the release of the complement 
C3 protein, that leads to alterations of dendritic morphology and can possibly trigger synapse 
pruning 123. Another key feature of astrocytes is the removal and recycling of otherwise excitotoxic 
neurotransmitters from the synapses 124. Impairment of this function swiftly translates into 
neurodegeneration. In late stages of AD, reactive astrocytes can form glial scar-like barriers around 
amyloid plaques and by this disrupt the specific architecture of non-reactive astrocytes in the 
neocortex 125.  
At this stage, multiple malfunctions accumulate and lead to the characteristic AD symptoms of 
dementia, progressing from mild to severe. This may be referred to as “clinical phase”. 
  
The clinical phase 
The “clinical phase” of AD is characterized by the onset of mild dementia. Cellular mechanisms are no 
longer able to maintain homeostasis and compensatory mechanisms 126,127 that were maintaining 
neuronal plasticity or were providing a “cognitive reserve”, start failing. Recent studies suggest that the 
asymptomatic phase of AD may proceed the onset of mild cognitive impairment by up to 20 years 128. 
Synaptic loss correlates with cognitive decline in many vulnerable regions (e.g. hippocampus, dentate 
gyrus, etc.), but not with all affected areas 129. Indeed, decrease in synaptic density is more highly 
correlated to the AD pathology and cognitive impairment than amyloid burden or NFTs 129–131. 
Synapse function and integrity is closely linked to the morphology of dendritic spines and hence to the 
underlying structure and organization of the filamentous actin cytoskeleton (F-actin) 132. An intact actin 
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cytoskeleton is vital for activity-dependent modulation, long-term changes and memory consolidation 
of the nervous system 133. On the other hand, cytoskeletal defects appear to underlie cognitive deficits 
associated with ageing and dementia 134,135. Candidate regulators of F-actin stability involved in 
cognitive decline and synaptic loss have been identified 129–132,136, among them the 
developmentally-regulated brain protein (Drebrin). 
 
The actin-binding protein Drebrin 
Drebrin is a highly conserved actin-binding protein regulating actin filament organization, F-actin 
stability and turn-over. In particular, it is involved during the formation of neurites and protrusion of 
motile cells 137–139. Therefore, it exists in two major isoforms, an embryonic isoform (Drebrin E) and an 
adult isoform (Drebrin A) (Fig. 1.3), that are produced by alternative splicing 140,141. While Drebrin E exists 
in multiple types of motile cells, as well as in growing neurons 137–139, a precise switch to Drebrin A is 
described in neurons upon synapse formation 142, suggesting an important contribution of Drebrin A in 
orchestrating a necessary reorganization of the actin cytoskeleton at synapses. Drebrin A is enriched 
in dendritic spines, protrusions on the neuronal surface that receive most excitatory input, forming the 
post synaptic sites of synapses 143,144.  
 
Figure 1.3: Domain organization of Drebrin 
Schema of Drebrin protein adult isoform domain organization consisting of an actin depolymerizing 
factor (ADF/Cofilin) homology domain, a coiled-coil domain followed by a helical domain and a proline-
rich stretch. The actin-binding domain is indicated (amino acid 232 – 301). The adult specific insert of 
44 amino acids (amino acid position 320 – 365) is characteristic for the ‘adult isoform’. Four putative 
phosphorylation sites are indicated. pS647 (bold) is located in a putative unstructured domain and 
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As already mentioned in the previous chapter, Drebrin is linked to both mild cognitive decline upon 
ageing as well as pathological decline in AD and Down’s Syndrome (DS) 134,145. In post mortem stainings 
of AD patient‘s brains a major loss of Drebrin was observed 145,146. A reduction of Drebrin levels precedes 
pre-synaptic Synaptophysin loss in a mouse model of AD 147. Further experiments with mouse models 
of AD could show, that a down-regulation of Drebrin aggravates AD toxicity 148, while overexpression of 
Drebrin alleviates the AD pathology 149. A first mechanistic relationship between Drebrin degradation 
and concomitant loss of F-actin mediated by AD induced Calpain overactivation was shown by Chimura 
et al. 150.  
Proper synaptic function relies on the highly regulated shape of dendritic spines, which in turn are 
dependent on continuous changes of the F-actin cytoskeleton. Drebrin A can bind up to two F-actin 
strands with its coiled-coil domain and adjacent helical domain (see Fig.1.3) 138,151. Upon Drebrin 
decoration, the helical pitch of F-actin changes from 36 nm to 40 nm 152 and propagates this alteration 
also to undecorated F-actin parts. The Drebrin binding decreases F-actin depolymerisation rate and 
increases F-actin stability 153. Furthermore, the two actin binding sites may bind two independent 
F-actin strands, enabling the formation of large bundles of F-actin by bridging Drebrin 139. Experiments 
overexpressing Drebrin A in neuronal cell culture led to abnormally extended dendritic spines154, while 
depletion of Drebrin was found to reduce the overall number of synapses drastically 155,156. 
Beside its functional stabilization and bundling of F-actin, Drebrin A further contributes to synapse 
maturation by providing a diverse binding platform for different indispensable proteins that form the 
post synaptic density (e.g. Spikar directly accumulates by binding to Drebrin 157, PSD-95 likely 
accumulates via Drebrin interaction with Homer and Shank 158).  
Drebrin is not accumulated in all dendritic spines, but about 20% do not contain detectable amounts 
of Drebrin in vivo 159. Yet, it was found, that Drebrin exits dendritic spines by a neuronal stimulus initiated 
process (see Fig. 1.4). NMDAR antagonists prevent the Drebrin exodus and it was thought that NMDAR 
activity is crucial for Drebrin translocation 160. The artificial induction of chemical long term potentiation 
(cLTP) induces a transient Drebrin exodus comparable to the in vivo exodus 161. NMDAR mediated Ca2+ 
influx into the post synapse activates Myosin II ATPase, thus resulting in the destabilization of Drebrin-
F-actin complexes that promotes the Drebrin exodus 162,163. After reduction of the stable F-actin pool, 
globular Actin (G-actin) can enter the spine by diffusion from the dendrite and facilitate F-actin 
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polymerization 164,165, therefore expanding the dendritic spine head size and enhancing the post synaptic 
density 166,167. Finally, Drebrin re-enters the dendritic spines and stabilizes F-actin and therefore 




Figure 1.4: Drebrin exodus hypothesis 
Depicted is a schema of the Drebrin exodus hypothesis. Dendritic spines contain two pools of differently 
behaving F-actins, a dynamic pool (     , blue circles) that undergoes swift treadmilling and is defining the 
spine shape, whilst a second pool is the Drebrin-bound stabilized pool  (      , magenta circles). Upon 
iterative neuronal inputs resting state spines can undergo synaptic strengthening leading to long term 
potentiation, enlarging the post synaptic density (      , orange oval). Drebrin (    , green hexagons) 
detaches from F-actin and evades from the spine head (exodus). Monomeric G-actin enters the spine 
and polymerizes to F-actin, bloating the spine head (promotion of nucleation) and enlarging the post 
synaptic density. Finally, Drebrin re-enters the spine and promotes F-actin bundling, stabilizing the 
dendritic spine. Adapted from Shirao et al. (2017) 169. 
 
Drebrin is phosphorylated at multiple sites to fine tune actin binding activity, spine shape remodelling 
activity and protein stability. A number of phosphorylation sites has been identified by mass 
spectrometry of brain material and different cell lines 170–176, yet, only one site has been linked to a 
specific kinase 151,177 at the beginning of the thesis project. 
While the phosphorylation sites from the ADF/Cofilin domain to the proline-rich domain are thought to 
influence actin-binding and spine remodelling, the focus was on the phosphorylation site pS647 as it is 
localized in a putative native disordered domain. Kreis et al. could show, that Phosphatase and Tensin 
homolog (PTEN) can dephosphorylate pS647, while neuronal activity leads to phosphorylation of 
Drebrin at S647 178. To this extent, one of the main findings of this cooperation project together with the 
resting state
neuronal activity
Drebrin exodus promotion of actin nucleation reconstruction of stable actin
neuronal activity
synapse strengthening / long term potentiation
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Eickholt Lab was, that S647 can be phosphorylated by the kinase Ataxia-telangiectasia mutated (ATM), 
a stress-induced kinase that activates DNA repair mechanisms upon DNA damage and that such 
phosphorylation of Serine-647 regulates Drebrin stability and turn-over 179–181. 
 
Even though, reduced Drebrin levels correlate with decreased synapse count and mild cognitive 
impairment, Drebrin knockout brains have been observed to be healthy. It is a paradox that spine shape 
and synaptic function are not impaired 182, imposing that more factors contribute to mental deterioration. 
 
Hence, to analyse multiple parameters that may cause Drebrin reduction as well as the complex effects 
induced by Drebrin reduction a model organism of fast ageing was sought that offers the possibility to 
analyse the Drebrin AD relationship in a quick and simple manner. 
 
The nematode C. elegans 
Caenorhabditis elegans (C. elegans) is a small, soil lived nematode whose suitability to become a model 
system for molecular biology, developmental biology, neuroscience, molecular ageing and many more 
fields was realized by Sidney Brenner nearly half a century ago 183. 
Among all its benefits it is one simple, yet most important trait of C. elegans that it constitutes a whole 
organism, harbouring different tissues and cell types that cooperate and communicate in a complexly 
orchestrated way (Fig.1.5). C. elegans offers the benefit of being a complete animal that can be cultured 
in large quantities on the scale of tissue culture experiments 184. 
 
C. elegans, a simple, yet powerful model system 
C. elegans is a non-parasitic organism that feeds on bacteria and occurs in two sexes, hermaphrodites 
(being the majority with about 99.9 % abundance) and males, making it easy to culture genetically 
stable strains at low costs 183,185. Furthermore, the nematodes are transparent, rendering them the ideal 
candidates for fluorescence microscopy studies. The complete genome was sequenced in 1998 and 
many genetic tools and models are available 186,187. 
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C. elegans has a generation cycle of 3.5 days (at 20°C), as it takes 3.5 days for a single nematode from 
hatching to grow into an egg-laying adult. One wild type hermaphrodite can have up to 300 progeny 
and live for up to four weeks.  
Since the nematodes age, they are suitable models to analyse ageing related processes and the 
molecular mechanisms of ageing themselves 188–190. Furthermore, the nematode’s proteome contains 
approximately 80% human ortholog proteins and most of the signalling cascades are highly conserved 
between nematode and human (e.g. insulin / insulin-like pathway) 190–192. 
 
 
Figure 1.5: Anatomy of the nematode C. elegans 
The left image is a differential interference contrast (DIC) microscopy picture of an adult nematode 
exhibiting tail (1), vulva (2) and head (3). Scale bar is 100 µm. The right schema shows different tissue 
types, starting with the reproductive system and the pharynx on the top, followed by an outline of the 
body wall muscle cells (red) and the indicated nervous system (blue) on the bottom. 
 
For my aims to study processes in neurons and the nervous system, another feature of the nematode 
is very useful: adult nematodes have a defined number of cells (959 in hermaphrodites and 1031 in 
males). Along with this, an adult hermaphrodite has exactly 302 neurons with specialist tasks, 
capabilities and fixed positions 193, a number high enough to enable complex interconnections and 













C. elegans as a model for neurodegenerative diseases 
Modelling neurodegenerative diseases in C. elegans has a long and successful history. Malfunctional 
protein aggregation and subsequent neurodegeneration are hallmarks of most neurodegenerative 
diseases 19,194 and the expression of such proteotoxic proteins was conducted for many diseases and 
their disease-related proteins (e.g. overexpression of alpha-synuclein in dopaminergic neurons as a 
model of Parkinson’s Disease 195; overexpression of SOD1 196,197, TDP-43 198–200 or FUS 200,201 as models 
of amyotrophic lateral sclerosis; overexpression of poly-Q or Htt-Exon1 as models for Huntington’s 
Disease 202,203).  
Also, disease models of AD were constructed in C. elegans by overexpressing Tau protein 204,205 or Aβ 
(see Table 1.1 ). This led to the identification of gene expression changes in the Aβ-pathology, such as 
increased levels of the small heat shock proteins Hsp-16.2 and Hsp-16.41 206,207. Screenings have been 
conducted to identify beneficial chemical compounds, as well as tests of known compounds for 
alleviation of the Aβ toxicity (e.g. ginkgolide, resveratrol) 208–210. Despite those discoveries, the employed 
models were far from being flawless. Some of the most widespread models used to study AD in 
C. elegans express a truncated version of Aβ, one that consists of the amino acids 3 – 42, that was 
found to be less toxic than full length Aβ1-42 211. Besides that, none of the available models that exhibited 
a disease phenotype was fluorescently tagged 212. For localization studies or the in situ assessment of 
amyloid burden a fluorescence tag is indispensable. The first model that expressed an Aβ tagged with 
green fluorescent protein (GFP) was found to be aggregation-impaired, forming only oligomers in vitro 












Table 1.1: C. elegans amyloid-beta models 
List of Aβ variants expressing model strains. Some assays were not conducted or information is not available 
(n/a).  
 
Strain Aβ Expression Systemic Defects Neurodegeneration Aggregation 

























GMC101 1-42 body wall muscles paralysis n/a yes 
GRU102 1-42 pan-neuronal 




UA116 3-42 glutamatergic neurons n/a yes n/a 
pbLH98 n/a cholinergic neurons n/a n/a no 
FDX25 3-42 ASE neurons n/a yes n/a 






(1) The generation of a novel model of Alzheimer’s Disease in C. elegans 
 
How can one trace amyloid formation in vivo in a non-invasive manner? 
As stated before, so far, no C. elegans Aβ model was fluorescently tagged and detection of amyloids 
required fixation, permeabilization and staining, disabling an in vivo and in situ analysis of fibril 
formation. All models so far allowed only taking snap shots of the aggregation state and ignored that 
amyloids are highly dynamic structures that undergo changes with time. To analyse Aβ aggregation 
in vivo and in situ in a non-invasive manner I aimed to generate a novel model strain, that is fluorescently 
tagged and exhibits characteristic AD pathology. 
 
How is ageing affecting amyloid formation? 
Aβ1-42 is generated in low amounts already at young ages in human, yet cognitive decline and Aβ1-42 
aggregation are associated with elderly people (age 65+). This gave rise to the question, if Aβ1-42 
aggregation tendency and disease related toxicity would increase upon ageing in C. elegans.  
To analyse this question, nematodes were analysed at different ages: day 3 as last day of larval stage 
(L4-stage), day 4 as first day of their fecund period (adult stage), day 7 near the end of the fertile period 
and day 10 for old nematodes in their post-fertile age. 
 
What perturbations can be found in the novel AD model strain? 
I was wondering to which extent C. elegans is impaired by the expression of Aβ1-42 and what phenotypes 
one would be able to observe. Therefore, the models’ general vitality, neurodegeneration and Aβ 
aggregation has been analysed. 
 
How is the nervous system impaired? 
Some features of direct neurodegeneration or perturbation of neuronal function were found in the 
previously established C. elegans models of AD. Hence, the focus was on the nature of 
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neurodegeneration and impairment of nervous systems functions 212,214. The expression profiles of 
different neuron types differ significantly from each other and every neuron has an unique proteome to 
fulfil its functions 215,216. Yet, this offers the possibility to detect differences in the vulnerability against 
Aβ and to uncover the molecular traits that lead to such increased susceptibility.  
 
 
(2) A model system to analyse Drebrin regulation in vivo 
 
What are the functions of C. elegans dbn-1? 
The nematode C. elegans has a homolog of human Drebrin, Drebrin-like protein 1 (DBN-1, 
corresponding gene: dbn-1). Both proteins share a 54% sequence homology in the N’-terminal and a 
53% sequence homology in the C’-terminal part. Previous studies observed actin-binding activity of 
DBN-1 in body wall muscle cells and intestinal cells 217,218. Yet, I was interested how DBN-1 depletion 
would affect the nematode systemically and neuronally. 
 
How is Drebrin regulated in C. elegans? 
Human Drebrin can be phosphorylated at multiple sites modifying its binding to F-actin, its actin 
bundling activity and its stability. Since a majority of signalling pathways is highly conserved between 
human and nematode I wanted to analyse if nematode proteins can interact with human Drebrin in a 
cooperative manner and regulate Drebrin activity and turn-over. I was most interested in the 
phosphorylation of Serine-647 to corroborate results from our cooperation partners of the Eickholt lab 









(3) The interaction of Aβ and Drebrin in vivo  
 
Is Aβ aggregation affecting Drebrin abundance and localization? 
Kaminski et al. showed that fluorescently labelled proteins, forming amyloid structures, exhibit a shifted 
fluorescence lifetime compared to monomeric species 219,220. I wanted to employ fluorescence lifetime 
imaging (FLIM) to analyse Aβ1-42 fibrilization and correlate Drebrin abundance/localisation using a 
genetically tagged version of Drebrin, a fusion with yellow fluorescent protein (YFP). Furthermore, I 
aimed to analyse lifespan and brood size as markers for systemic vitality. 
 
Are Drebrin and Aβ directly interacting and co-aggregating? 
I wanted to employ fluorescent tags on Drebrin and Aβ to analyse subcellular colocalization. A FLIM 
approach was thought to analyse the aggregation state of Drebrin and Aβ. 
 
Can Drebrin overexpression attenuate Aβ fibrilization and phenotype? 
Mouse models of AD showed, that Aβ toxicity is exacerbated upon Drebrin depletion, while 
overexpression of Drebrin attenuates the toxic phenotype 148,149. I was wondering, if this phenotype 








Generation of a novel Alzheimer’s Disease model 
To analyse the sub-cellular localization and the progression of aggregation of Aβ1-42 in vivo and in situ a 
novel model system was designed. Since the labelling of Aβ with GFP prevented Aβ from aggregation 
due to steric hindrances a model of sub-stoichiometric labelling was employed. 
A bi-cistronic operon was designed under the control of either the pan neuronal rgef-1 promoter or the 
body wall muscle promoter of myo-3 (Fig. 2.1 A).  
 
Figure 2.1: Operon for Aβ expression 
(A) Schema of the organization of the bi-cistronic ‘Scabeta’ operon to drive overexpression of human 
Aβ1-42 and sub-stoichiometric expression of wrmScarlet-Aβ1-42. (B) Confocal images (DIC + mScarlet 
fluorescence) of a JKM2 nematode expressing ‘Scabeta’ under control of the pan neuronal promoter 
rgef-1 (100-fold magnification). Scale bar is 50 µm. Insets 1 – 3 show the respective close-ups of the 
head region (1), the mid body (2) and the tail (3) (630-fold magnification). Scale bar is 20 µm. 
(C) Representative western blot of total lysate of a non-synchronized population of JKM2 nematodes 
(yet, not older than day 5 of life). Detection with Mouse-anti-Aβ (6E10) and anti-Mouse-HRP. The 
migration of wrmScarlet-Aβ1-42 and untagged Aβ1-42 is indicated on the right. Kindly provided by Manuel 
Iburg. 
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The operon is transcribed into one mRNA that is differently translated: the 5’ ‘signal peptide-Aβ1-42’ 
sequence by highly efficient cap-dependent translation, while the translation of the following 
3’ ‘wrmScarlet-Aβ1-42’ is driven by an internal ribosome entry site (IRES) that is less efficient. The signal 
peptide gets cleaved and the Aβ1-42 peptide gets retro-translocated to the cytosol 208,221. This results in 
a defined ratio of an excess of untagged Aβ that facilitates near-native fibril growth while sub-
stoichiometric amounts of tagged wrmScarlet-Aβ are stochastically incorporated into the aggregates 
labelling them fluorescently. The efficient pan neuronal expression of the red fluorescent wrmScarlet-Aβ 
in the new strain JKM2 (nAβ) can be seen in the confocal image (Fig. 2.1 B). To ensure both variants, 
tagged and untagged Aβ are expressed, a western blot was performed (immunodetection with an anti-
Aβ (6E10)) (Fig. 2.1 C). Two signals appeared, one band below the 10 kDa molecular weight marker 
corresponding to the untagged Aβ and a second band appeared at approx. 35 kDa, corresponding to 
wrmScarlet-Aβ. The net protein yield of the transgene in neurons is low as one can see in the 
fluorescence intensity (Fig. 2.1 B) as well as in the respective signal intensity in the western blot 
(Fig. 2.1 C).  
To obtain a model that is suitable for biochemical analysis of protein-protein interactions, proteome 
changes or for the analysis of the cellular ultrastructure, a second model strain was generated, 
expressing the ‘Scabeta’ operon under the control of the body wall muscle promoter myo-3p (strain 
JKM7 (mAβ)) (Fig. 2.2). The expression in the body wall muscles yields a higher amount of transgenic 
protein than the pan neuronal expression. Therefore, the signals on the western blot of mAβ show both 
Aβ variants and are stronger than on the western blot of nAβ (compare Fig. 2.1 C and Fig. 2.2 B). The 
blot of mAβ also exhibits the intended difference in abundance of Aβ1-42 (3 – 5 fold excess) and 
wrmScarlet-Aβ1-42. To show that Aβ1-42 and wrmScarlet-Aβ1-42 interact with each other, an 
immunoprecipitation with an antibody against GFP was performed (Fig. 2.2 B right lane). Equal amounts 
of total protein were loaded in both lanes of the blot, yet an enrichment of wrmScarlet-Aβ and Aβ was 
observed. Most importantly, wrmScarlet-Aβ and Aβ co-precipitated upon pulldown with anti-GFP 
antibodies. I conclude, that both variants are interacting with each other, possibly forming amyloid fibrils 
together. For further validation of the model, the intracellular colocalization of Aβ1-42 and mScarlet-Aβ1-
42 was analysed by immunohistochemistry. JKM2 (nAβ) and JKM7 (mAβ) nematodes were fixed and 




Figure 2.2: Expression of 'Scabeta' in body wall muscles 
(A) Confocal images (DIC + mScarlet fluorescence) of a JKM7 nematode expressing ‘Scabeta’ under 
control of the body wall muscle specific promoter myo-3p (100-fold magnification). Scale bar is 50 µm. 
Insets 1 – 3 show the respective close-ups of the head region (1), the mid body (2) and the tail region (3) 
(630-fold magnification). Scale bar is 20 µm. (B) Representative western blot of crude lysate (left lane) of 
a non-synchronized population of JKM7 nematodes (yet, not older than day 5 of life) and blot of 
immunoprecipitated material (with anti-GFP) (right lane). Detection with Mouse-anti-Aβ (6E10) and anti-
Mouse-HRP. The migration of wrmScarlet-Aβ1-42 and untagged Aβ1-42 is indicated on the right. Kindly 
provided by Manuel Iburg. 
 
 
Aβ1-42 and mScarlet-Aβ1-42 exhibited a strong colocalization (JKM2s Pearson’s correlation coefficient = 
0.64 ± 0.12, JKM7s Pearson’s correlation coefficient = 0.77 ± 0.11) indicating that they interact in vivo. 
Most importantly, there are no foci composed of Aβ1-42 alone that are devoid of mScarlet-Aβ1-42. 
This leads to the conclusion that mScarlet-Aβ1-42 is not excluded from aggregation and fibril formation. 
Yet, I can confirm observations by Link et al. that Aβ1-42 is localized intracellularly and cannot be found 
extracellularly by employing a protocol of fixation and staining as was described previously 221,222 and 
as was performed here. This observation does not negate that Aβ could spread outside of the 
expressing tissue, but rather that the detection method might simply be not sensitive enough. 
To test if the novel model strains JKM2 and JKM7 exhibit amyloid formation, a staining with the amyloid-
sensitive dye ‘Thioflavin T’ (ThT) was employed (Fig. 2.3 B and Supplemental Fig. 7.1 B). Upon binding 


























a factor of » 500 223. Yet, ThT staining of nematodes remains of poor quality and a strong 
autofluorescence was observed. Despite this obstacle, aggregates were detected exhibiting a strong 
fluorescence that clearly distinguishes from the autofluorescence (see white arrows in Fig. 2.3 B and 
Supplemental Fig. 7.1 B). Still, the staining efficacy varies among the nematodes of one batch stained 
with ThT. This makes ThT detection of aggregates erratic and unreliable for the attempt to quantify for 
aggregation. To overcome this issue, fluorescence lifetime microscopy was employed to assess and 
quantify the aggregation of Aβ1-42 together with wrmScarlet-Aβ1-42.  
 
 
Figure 2.3: Aβ1-42 and wrmScarlet-Aβ1-42 are forming amyloids  
(A) Representative image of nAβ fixed with PFA and stained with anti-Aβ (6E10) + anti-mouse-IR680. 
Scale bar represents 20 µm. Colocalization of mScarlet fluorescence and IR680 fluorescence was 
analysed and Pearson’s correlation coefficient was determined for all acquired images (n = 16), noted 
as mean ± SD. (B) Representative image of nAβ, fixed and stained with ThT. ThT-positive foci are marked 
with white arrows. Scale bar is 20 µm. 
 
  
A mScarlet-Aβ1-42 anti-Aβ (4G8) bright field merged
mScarlet-Aβ1-42 Thioflavin T bright field merged
B
Pearson‘s correlation = 0.64 ± 0.12
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Aggregation of Aβ can be followed in vivo and in situ with the progression of ageing 
Time-correlated single photon counting fluorescence lifetime microscopy (TCSPC-FLIM) was employed 
to measure the aggregation of Aβ in JKM2 and JKM7 nematodes in vivo and in situ. In theory, 
aggregation and incorporation of mScarlet-Aβ1-42 into a growing amyloid fibril will lead to a quenching 
of the fluorophore that in turn reduces the apparent fluorescence lifetime 220. The amyloid fibril serves 
as an acceptor for radiation free energy transfer, therefore long-lived photons have a high chance to be 
transferred instead of being emitted. The degree of short-lived photons that get emitted increases in 
relation to the long-lived photons, reducing the apparent fluorescent lifetime (t). Thus, the reduction of 
the lifetime can be used as a proxy for the aggregation of Aβ1-42 (Fig. 2.4). FLIM analyses are also 
independent of the expression level of the fluorophore 224, which is crucial when analyzing living animals 
that often exhibit reduced expression or stability of the transgenic protein with ageing. 
 
 
Figure 2.4: Schema of apparent fluorescence lifetime shift upon aggregation of Aβ1-42 
Upon amyloid formation mScarlet-Aβ fluorophores get trapped into the growing amyloid fibrils and the 
apparent fluorescence lifetime (t) is decreased. 
 
The fluorescence lifetime is an intrinsic property of fluorophores and only dependent on the fluorophore 
and its microenvironment. Purified mScarlet exhibits a fluorescence lifetime of approx. 3.9 ns 225. The 
fluorescence lifetime observed in young nematodes is already altered by the microenvironment of the 
cell, reducing the fluorescence lifetime of non-aggregated mScarlet in neurons to 2.9 ns and to 3.1 ns 
in muscle cells (Fig. 2.5). Only slight, yet not significant changes were observed in the progress of 














Figure 2.5: mScarlet does not aggregate upon ageing 
Representative TCPSC-FLIM images of neuronal/muscle mScarlet control (JKM3 and JKM8) on day 4, 
7 and 10 alive. Fluorescence lifetime is false-coloured (from blue = low fluorescence lifetime to red = 
high fluorescence lifetime) and merged with the measured fluorescence intensity. Magnification was set 
to 630x and two to three cohorts of 10 to 15 nematodes per age were acquired. The average 
fluorescence lifetime of all recorded images per age is given as mean ± SD ('). Scale bar represents 
20 µm. 
 
In the disease model strains JKM2 and JKM7 on the other hand, a progressive increase of aggregation 
was observed in an age dependent manner (Fig. 2.6). At day three of life, in the L4 stage, no foci 
formation nor reduced fluorescent lifetime pixels were visible and the histogram of the pixels exhibiting 
a certain fluorescence lifetime of JKM2 (nAβ; Fig. 2.6 A) overlapped to a great extent with the histogram 
of the control (JKM3, expression of mScarlet alone; black dashed line). On day four, the first foci 
appeared that show a decreased fluorescence lifetime (to about 2.0 to 2.4 ns), that can be referred to 
as aggregates (see white arrows in Fig. 2.6 A). The corresponding histogram for day four shows a clear 
shift to shortened fluorescence lifetimes. Previous studies have reported that on day four of life the 
proteostasis capacity of C. elegans starts to decline 19,226,227. Interestingly, the first aggregates appeared 
reliably (in more than 90% of the observed JKM2 nematodes) in four to six head neurons of the anterior 
head ganglion around day 4 (Fig. 2.6 A, white arrows). 
Day 4
neuronal mScarlet (strain JKM3)
τ ≈ 2.85 ± 0.08 ns τ ≈ 2.76 ± 0.17 ns τ ≈ 2.71 ± 0.14 ns 
Day 7 Day 10
Day 4
muscular mScarlet (strain JKM8)
τ ≈ 3.12 ± 0.12 ns τ ≈ 3.00 ± 0.11 ns τ ≈ 3.05 ± 0.10 ns 







Figure 2.6: Direct detection of the progression of aggregation of Aβ in neurons and body wall muscles 
using FLIM 
(A) Representative confocal TCSPC images of neuronal Aβ at different ages (day 3, 4, 7 and 10). 
Fluorescence lifetime is false-colored (from blue = low fluorescence lifetime to red = high fluorescence 
lifetime) and merged with the measured fluorescence intensity. 945-fold magnification, scale bar is 
20 µm. The respective histograms depicted underneath each representative image of that particular age 
show the average occurrence of pixels exhibiting a certain fluorescence lifetime. ℕ = 3 (cohorts), 
n = 10 - 15 (individual nematodes) per condition. Dashed black lines are outlining the shape of the 
histograms of control nematodes expressing only mScarlet in the neurons. (B) Representative confocal 
TCSPC images of muscle Aβ at different ages (day 3, 4, 7 and 10). Fluorescence lifetime is false-colored 
(from blue = low fluorescence lifetime to red = high fluorescence lifetime) and merged with the measured 
fluorescence intensity. 630-fold magnification, scale bar is 25 µm. The respective histograms depicted 































underneath each representative image of that particular age show the average occurrence of pixels 
exhibiting a certain fluorescence lifetime. ℕ = 3 (cohorts), n = 10 (individual nematodes) per condition. 
Dashed black lines are outlining the shape of the histograms of control nematodes expressing only 
mScarlet in the muscle cells. 
 
At advanced age (day 7 – 10) more numerous and also smaller aggregates appeared that formed visible 
foci with a reduced fluorescence lifetime (1.8 ns to 2.4 ns; see blue arrows in Fig. 2.6 A). This trend 
continues on day 10 of life. The overall fluorescence intensity was decreased in the fraction that was 
not localized in foci, indicating a further decrease of soluble Aβ species, resembling in a strong shift of 
the '-distribution in the corresponding day 10 histogram. 
I observed a comparable, yet not identical behaviour in a model expressing Aβ1-42 in the body wall 
muscle cells (JKM7, mAβ). I detected foci formation already from early larval stages on including L4 
stage at day three (Fig. 2.6 B). Though, most of these foci did not display a reduced fluorescence 
lifetime. Such foci need to be regarded as “accumulates” rather than aggregates, as they are composed 
of non-aggregated, non-amyloidogenic material. The first shift towards reduced fluorescence lifetime 
was observed on day four but is less pronounced than the day 4 shift in nAβ. From day seven onwards, 
aggregation increases progressively. In contrast to the fluorescence intensity reduction observed in nAβ 
at day 10, no such decrease was found.  
For quantification, the average fluorescence lifetime for all recorded images was plotted (Figure 2.7). 
 
Figure 2.7: Scatter dot plot of the progression of aggregation in JKM2 and JKM7 
The average fluorescence lifetime of nAβ (red) and mAβ (violet) at different ages in comparison to their 
corresponding control expressing only mScarlet in neurons (yellow) or muscle cells (light-blue). Two 
populations exhibiting different life times (t) were marked with dashed, grey circles. Every dot represents 
the mean fluorescence lifetime of a single image. Bars depict mean ± SD. 





















































While only a minor, not significant decrease of the controls could be observed, the progressive nature 
of age dependent Aβ aggregation in both neuronal or muscular expression is clearly recognizable. 
Notably, despite the clear trend of the analysed cohorts, single animals exhibited differences in the 
mean fluorescence lifetime. This suggests that the observed variance is dependent on the individual 
fitness of every nematode analysed. Furthermore, this can also lead to the clustering of nematodes into 
sub-populations exhibiting different degrees of aggregate burden at the same day (see grey circle in 
Figure 2.7).  
To test the hypothesis, that untagged Aβ1-42 is necessary for aggregation in the generated model 
systems, a control strain that expresses mScarlet-Aβ1-42 but no untagged Aβ1-42 was generated (StopAβ, 
JKM5; see Supplemental Figure 7.2 A). Analysing the aggregation by FLIM revealed, that the 
fluorescence lifetime is, due to the microenvironment, already reduced on day four of life, but no further 
decrease in the progression of ageing was observed (Figure 2.8). Additionally, no characteristic foci 
formation was observed, suggesting that the untagged Aβ1-42 is, indeed, required for native amyloid fibril 
formation. Using the amyloid specific dye ThT, no aggregation could be detected either (Supplemental 
Figure 7.2 B). Observations on C. elegans models that used only fluorescently labelled Aβ failed to 
detect fibrilization and thus further corroborate the conclusion that a moiety of untagged (naive) Aβ1-42 
is necessary to facilitate the aggregation of mScarlet-Aβ1-42. 
 
 
Figure 2.8: mScarlet-Aβ alone does not aggregate 
Representative TCSPC-FLIM images of StopAβ (JKM5) on day 4 and day 7 alive. Three cohorts of 10   
15 nematodes each were analysed. Scale bar represents 20 µm. Scatter dot plot depicts mean  SD, 
single dots represent the average fluorescence lifetime of one FLIM-image. JKM3 data, neuronal 
mScarlet control, was provided as reference. 
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The ultrastructure of Aβ aggregates is distorted 
To analyse the ultrastructure and shape of amyloid fibrils in vivo would help to understand if and how 
amyloid spreading could work and if mechanic stress evokes toxicity. In vitro experiments with purified 
Aβ1-40 or Aβ1-42 showed a polar mode of fibril growth, and possible fibril lengths of several microns 228. 
Stimulated emission depletion confocal microscopy (STED), transmission electron microscopy (TEM) 
and correlative light electron microscopy (CLEM) were employed to understand the shape of amyloids 
in the generated AD models in vivo. 
STED extends the resolution of confocal microscopy beyond the diffraction barrier up to 40 nm. Fibrils 
of several microns could therefore be visible. Yet, no clearly distinguishable fibrils were observed (Figure 
2.9). Most foci appeared thinner on STED images compared to the corresponding standard confocal 
images. Furthermore, foci that appeared as large, blurred spot in standard confocal microscopy were 
observed to be composed of several smaller foci that accumulated into one site (see Figure 2.9 close-
up, green scales indicate size of apparent sub-foci). While detection of Aβ1-42 fibrils in axial direction 
would be possible in theory, to discriminate between multiple axially aligned fibrils is not possible using 
STED. Furthermore, it is questionable if Aβ1-42 fibrils would grow in a straight direction when they are 
affected from molecular crowding or if they would rather form tangles in vivo as surrounding proteins 
and structures could limit the straight growth and dictate fibril growth in the limited space available.  
 
Figure 2.9: Confocal images of Aβ1-42 foci do not reveal their underlying ultrastructure 
Representative stimulation emission depletion confocal image from a JKM2 nematode showing two 
neuron bodies from the retro-vesicular ganglion at 6000-fold magnification. Resolution-limited confocal 
image (cLSM) exhibits strong fluorescent, blurry foci. Scale bar represents 5 µm. STED image resolves 






Also, in vivo sheering forces and other perturbations due to cellular activities could shatter fibrils 
prematurely. Such shattered amyloids could induce secondary nucleation processes and increase 
aggregation and toxicity further. Yet, such disease relevant processes would not be detectable in vitro 
as only the unperturbed fibril growth is analysed. 
 
Figure 2.10: wrmScarlet-positive foci are composed of electron non-dense material 
(A) Correlative light-electron microscopy image of a JKM7 nematode embedded in HM20. wrmScarlet 
fluorescence (red) overlaps with material exhibiting altered electron density compared to the surrounding 
cytoplasm (see close-up, dashed white line). Kindly provided by Diogo Feleciano.  
(B) Transmission electron microscopy of a JKM7 nematode embedded in Epoxy resin. The left image 
displays an intracellular region of a muscle cell, exhibiting an actin-myosin-fibre (f), mitochondria (m), a 
nucleus (n) and electron density altered material (black dashed line, a) at 30000-fold magnification. Scale 
bar is 1 µm. Right image displays extracellular space (ex) filled with some electron dense material (a). 
The cell membranes of the neighbouring cells are marked with a dashed, orange line. Image recorded 
at 20000-fold magnification. Scale bar represents 2 µm.   










A technique with a higher resolution was employed: transmission electron microscopy (TEM). To detect 
aggregates, an approach combining light and electron microscopy was employed, correlated light 
electron microscopy (CLEM). DNA was stained with DAPI and used to align confocal and TEM images. 
Fluorescence of wrmScarlet-Aβ1-42 was detected to colocalize with material that was slightly more 
electron dense than the surrounding cytoplasm (Figure 2.10 A). However, the quality of the TEM was 
too low, making it impossible to analyse the underlying ultrastructure. A second attempt of TEM was 
performed, using epoxy embedding that preserves the ultrastructure more reliably. 
A cytosolic area containing presumably protein rich material, free from surrounding ribosomes and not 
delimited by a membrane was observed (Figure 2.10 B, left image, dashed black line, a). No halo around 
mitochondria and crisp cristae were detected as a sign for high quality freezing and fixation. The 
presumably protein rich material exhibited no striking underlying structures, yet the observed pattern 
was unique to Aβ1-42 expressing nematodes. In wild type control nematodes, no such deposits could 
be found. Most interestingly, some deposits were detected in the pseudocoelom outside of the body 
wall muscle cells in mAβ but not in wild type nematodes (Figure 2.10 B, right image, a). This deposited 
material could be aggregated Aβ as well as endogenous aggregation prone material that got deposited 
upon increased proteotoxic stress elicited by Aβ1-42 overexpression. Several proteins have been 
reported to aggregate in ageing nematodes 229,230, yet decreased proteoprotective capacity upon 
induced proteopathies (such as overexpression of Aβ1-42) could accelerate these naturally occurring 
processes in a feedforward loop manner. 
 
After amyloid formation and aggregate ultrastructure was observed and correlated to the progression 




Aggregation of Aβ elicits systemic defects 
To characterize how the expression of Aβ1-42 impairs the nematodes and to find possible read-outs for 
further hypothesis-driven experiments, several assays analysing the potentially systemic proteotoxicity 
have been conducted.  
First, the lifespan of both nAβ and mAβ was analysed. nAβ nematodes exhibit a reduction of the median 
lifespan by 40% to 8.8 days and a decrease of the maximum life expectancy to 22 days (21% reduction) 
compared to wild type nematodes (Figure 2.11 left). The muscle expression strain mAβ exhibited a 
median lifespan reduction of 25% to 11 days and a decreased maximum life expectancy of 22 days 
(reduction of 21%) compared to wild type nematodes (Figure 2.11 right). The control strains expressing 
only wrmScarlet did not show any impairment of lifespan. Furthermore, the strain StopAβ (JKM5) did 
not show any lifespan reduction either (Supplemental Figure 7.2 C), correlating the observed toxicity in 
JKM2 and JKM7 to a progressive aggregation of Aβ1-42. These data show, that Aβ1-42 severely affects 
the lifespan, which is in contrast to previous studies where only moderate effects were reported 212,231. 
 
Figure 2.11: Aβ1-42 expression reduces the nematodes lifespan 
Lifespan analysis of nAβ vs. N2 (wild type) vs. control (expression of mScarlet in neurons) and lifespan 
analysis of mAβ vs. N2 (wild type) vs. control (mScarlet expression in muscle). Shown is the mean 
cumulative survival probability versus age (days alive). Three cohorts of each 100 – 150 nematodes have 
been tested for nAβ, neuronal control and N2. One cohort of 120 nematodes has been tested for muscle 
Aβ and muscle control. A log-rank test was performed to test for significance (∗∗∗  =  p < 10-6). The 
median and maximum lifespans for each strain are listed in the table below the graphs in days. 
wild type neuronal A 1- 42 neuronal control muscle A 1- 42 muscle control
16.1 ± 1.7 8.8 ± 1.1 17.9 ± 1.8 11.3 ± 1.2 17.2 ± 1.1median
max 30 21 26 22 29




































An additional read-out for organismal fitness is fecundity, which was measured by counting the viable 
offspring of Aβ1-42 expressing nematodes (Figure 2.12 A). Both, nAβ and mAβ exhibited reduced brood 
sizes, while the wrmScarlet expressing controls did not show a reduction. 
 
Figure 2.12: Aβ1-42 expression impairs neuro muscular function 
(A) Scatter dot plot of a progeny assay for nAβ + control (JKM3), mAβ + control (JKM8) and wild type. 
Shown is the average number of viable offspring per nematode as mean ± SD. Three cohorts of 10 – 15 
nematodes have been tested for N2 and nAβ. One cohort of 10 – 15 nematodes has been tested for 
neuronal control, muscle control and mAβ. Significance was assessed by one-way ANOVA + Bonferroni 
post hoc test (∗∗∗  =  p < 0.001) between the different strains and their respective controls. (B) Scatter 
dot plot of the pharynx pumping activity of nAβ (red) + control (yellow; JKM3) and mAβ (violet) + control 
(light-blue; JKM8) at day 4 and day 10 of life. Shown is the average pharyngeal activity as mean ± SD. 
In total, 20 to 60 nematodes have been tested per strain and day in cohorts of 10 – 15. Significance was 
tested with one-way ANOVA + Bonferroni post hoc test (∗∗∗  =  p < 0.001) between the different strains 
and their respective controls or between different ages of one strain. (C) Scatter dot plot of the thrashing 
capability of the same nematode lines as (B) swimming in M9 solution on day 4 and day 7 of life, 
respectively. Shown is mean ± SD. Three cohorts of 20 nematodes were recorded three times for 20 
seconds as technical replicates. Significance was tested with two-way ANOVA + Bonferroni post hoc 
test (∗  =  p < 0.033 ; ∗∗∗  =  p < 0.001) between the different strains and their respective controls.            
(D) Scatter dot plot of the ability of the same nematode lines as (B) to swim in M9 solution for a period 
of 30 minutes. Paralyzed nematodes were counted and their fraction was plotted as mean ± SD from 
three cohorts of 20 – 30 nematodes per strain and day. The average of each cohort is represented by a 


































































































































The aggregation-impaired strain JKM5 did not exhibit a reduction in fertility, too, exemplifying the 
necessity of “Aβ1-42 native” aggregation to exert toxicity (Supplemental Figure 7.2 D).  
Next, the coordinated activity of neurons and muscles was tested by analyzing motility of the new 
disease model strains. Pharyngeal pumping was analyzed and found to be impaired compared to their 
respective controls and further aggravated upon ageing of the strains nAβ and mAβ (Figure 2.12 B). 
To further test muscle activity, the swimming / thrashing of the nematodes in M9 medium was analyzed 
(Figure 2.12 C) and a strong reduction was observed for mAβ (» 60%), while a less pronounced, yet still 
significant, reduction was observed for nAβ (» 15%). Counterintuitively, the disease models performed 
better at older age. This is probably because of a survivorship bias: the most afflicted nematodes that 
perform poorly on day 4 die prematurely and are missing in the assay on day 7. This variance in 
population and the survivor effect was especially pronounced for mAβ as one could deduce from the 
observed phenotype and from the observed aggregation in the FLIM measurements (compare grey 
circles in Figure 2.7). To close the general characterization, a paralysis assay was performed, testing 
the swimming endurance in liquid medium. After 30 min swimming about 43% of the nAβ nematodes 
were not moving anymore nor reacting to prodding with an eye leash. Upon ageing this fraction 
increased to about 71%. mAβ was less affected, suggesting that neuronal activity is the limiting factor 
in this assay (Figure 2.12 D). 
 
Aβ disturbs subcellular organelle organization and proteostasis  
As JKM2 and JKM7 displayed severe systemic impairments, an analysis of subcellular and molecular 
perturbations was intended. Therefore, TEM images of Aβ1-42 expressing nematodes were analyzed 
regarding subcellular organization and integrity (Figure 2.13). Major aberrations were found in both 
strains nAβ and mAβ body wall muscle cells, yet the exact occurrence differed. mAβ body wall muscle 
cells exhibited unnatural accumulations of probably defective endosomal, lysosomal and 
autophagosomal vesicles. These organelles were unfinished as their membranes were not closed, 
pointing towards defective membrane closure mechanisms (see red arrows in Figure 2.13 A). Yet, in the 
obtained images, all recorded muscle cells displayed accumulations of defective vesicles that engulfed 
each other in a matryoshka-like fashion, termed amphisomes. Since the neuronal Aβ1-42 animals are 
also impaired in their motility I extended the EM analysis to Aβ1-42 nematodes to see if this effect is 
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exclusively because of damaged motor neurons or if muscle cells themselves are damaged. Despite 
Aβ1-42 was expressed in neurons, the adjacent muscle cells exhibited several abberations that were 
slightly different from those in mAβ nematodes. The endoplasmic reticulum (ER) was swollen (see green 
arrows in Figure 2.13 A). Amphisomes were detected, but they were not as abundant as in mAβ animals. 
The abundance of these perturbed structures was assessed by analysing the corresponding volume 
fraction as area of organelles vs. total cellular area (Figure 2.13 B). Amphisomes were enriched in mAβ, 
raising the hypothesis that these nematodes exhibit a strong perturbation of autophagy and possibly 
endo-lysosomal trafficking. The ER was significantly enlarged in nAβ compared to wild type, indicating 
defects in protein sorting. 
Furthermore, ribosomes were observed to be reduced in mAβ and nearly completely depleted in nAβ 
(Figure 2.14). This matches previous findings, showing that both, the total amount of ribosomes as well 
as polysomes, are reduced in Aβ expressing nematodes 232. This indicates defects in protein synthesis 
and evokes the hypothesis if other mechanisms maintaining proteostasis might by compromised, too. 
 
Figure 2.13: Cellular ultrastructure is damaged from Aβ1-42 overexpression 
(A) Transmission electron microscopy (TEM) of epoxy embedded mAβ (JKM7) and nAβ (JKM2). Left, 
20.000-fold magnification showing a close-up of a muscle cell. Red arrows show incomplete membranes 
from amphisome clusters (defective endosomal, lysosomal and/or autophagosomal structures). Right, 
7000-fold magnification from nAβ displaying swollen ER (green arrows). (B) Scatter dot plot of total 
volume fractions of different organelles extracted from TEM images. mAβ (violet), nAβ (red) and wild type 
control (black) were plotted. 20 - 25 muscle cells from 5 - 6 nematodes were analysed. Significance was 
tested with two-way ANOVA + Bonferroni post hoc test (∗∗∗  =  p < 0.001). 
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Figure 2.14: Ribosomes are depleted in Aβ1-42 expressing nematodes 
Representative TEM images of wild type (wt, 12000-fold magnification), mAβ (12000-fold magnification) 
and nAβ (20000-fold magnification) nematodes with muscle cells displaying depletion of ribosomes. 
Scale bars represent 1 µm. Close-up images of indicated regions (dashed white box) displaying 
cytosol/ER with ribosomes (not indicated for wt, as there are too many; white arrows mark ribosomes in 
mAβ and nAβ). 
 
Protein degradation is impaired in a model of AD 
After observation of defects in membrane closure and amphisome enrichment, it was assumed that the 
endo-lysosomal / vesicular pathway could be impaired. Therefore, the protein degradation by 
autophagy as well as by the ubiquitin proteasome system (UPS) was assessed in Aβ1-42 expressing 
nematodes. Day four old nAβ and mAβ nematodes were subjected to western blot analysis and SQST-1 
(homolog of human p62) and LGG-1 (homolog of human LC-3) protein levels were assessed to analyse 
the autophagic flux (Figure 2.15 A). The levels of the adaptor and substrate protein SQST-1 were not 
affected by the Aβ1-42 expression, suggesting that there is no turnover of SQST-1/p62. Yet, reduced 
levels of LGG-1 in mAβ animals were observed. LGG-1 is required to initiate phagophore construction 
and autophagosome maturation, rendering it an indispensable player for autophagy. Together with the 
TEM images that depict incomplete or disrupted membranous structures, this led to the conclusion that 
the autophagic flux is compromised in Aβ1-42 animals. 
The second major degradation pathway in eukaryotes, the UPS, is tightly connected with the regulation 
of autophagy and could be compromised in Aβ1-42 expressing nematodes as previous studies 







chains and get subsequently processed by proteasomes. Proteasomes harbour three catalytic subunits 
that perform the proteolytic step. The most active of these catalytic sites has a chymotrypsin-like activity 
that can be tested in an in vitro assay using nematode lysates. The proteasomal activity of nAβ and 
control nematodes was tested regarding the progression of ageing (Figure 2.15 B). nAβ exhibited 
impaired proteasomal activity at advanced age (day 8) but not before. Thus, both major degradation 
pathways are compromised in Aβ1-42 expressing nematodes. 
 
Figure 2.15: Autophagy and Proteasomes are inhibited 
(A) Quantification of the abundance of SQST-1 / p62 proteins in nAβ (red), neuronal control (yellow), mAβ 
(violet) or muscle control (light-blue) by western blot. Shown is mean intensity  SD. Four cohorts were 
analysed. Significance was tested with one-way ANOVA + Bonferroni post hoc test. Image below is a 
representative western blot using anti-SQST-1 antibodies. Equal loading was checked by detection of ⍺-Tubulin. Kindly provided by Manuel Iburg. (B) Quantification of the abundance of LGG-1 / LC3 proteins 
in nAβ (red), neuronal control (yellow), mAβ (violet) or muscle control (light-blue) by western blot. Shown 
is mean intensity  SD. Three cohorts were analysed. Significance was tested with one-way ANOVA + 
Bonferroni post hoc test (∗  =  p < 0.033). Image below is a representative western blot using anti-LGG-1 
antibodies. Equal loading was checked by detection of ⍺-Tubulin. Kindly provided by Manuel Iburg.       
(C) Scatter dot plot of proteasome activity test of nAβ vs. neuron control (JKM3). Three independent, 
age synchronized cohorts were harvested at the indicated age of 1, 4, 6 or 8 days and lysed. The 
proteasomal activity was measured in triplicates for each condition. Plotted is mean ± SD. Significance 

















































































































Aβ1-42 spreads to distant tissues 
Since systemic toxicity and perturbed protein trafficking, synthesis and degradation were observed, I 
assumed a cell non-autonomous mechanism of pathogenicity, possibly involving spreading of Aβ1-42 
moieties. To analyse if Aβ1-42 expressed in nAβ and mAβ can spread to distant tissues, a set of 
experiments was designed to address this major question. It was first tested, if Aβ1-42 could be released 
from their expressing cells and migrate to the pseudocoelom, the central body cavity. Three pairs of 
coelomocytes are residing in the pseudocoelom and constantly filtering their surrounding medium. Yet, 
it was suggested that they serve immune, scavenging and hepatic functions 233. In nAβ, red fluorescent 
wrmScarlet-Aβ1-42 was found enriched in coelomocytes (Figure 2.16). Corresponding analysis of 
wrmScarlet control expression revealed only a small fraction of nematodes to exhibit enrichment of red 
fluorescent material in coelomocytes. While the fraction of nematodes exhibiting red fluorescence in 
the vacuoles of coelomocytes in control animals increased upon ageing slightly, there was no change 
observed for nAβ, yet a further increase seems to be hardly possible as already on day four 95% of the 
nematodes exhibited red fluorescent material in the coelomocytes. Hence, wrmScarlet-Aβ1-42 seems to 
facilitate its release from neuronal cells and subsequently accumulate in the pseudocoelom and the 
coelomocytes. This may be an indication, that the deposited material found outside of cells in the TEM 
images could truly be Aβ1-42.  
 
Figure 2.16: Aβ1-42 accumulates in coelomocytes 
Representative confocal images of JKM2×ZIM1048 and JKM3×ZIM1048. Coelomocytes are labelled 
with GFP (unc-122p::GFP). wrmScarlet-Aβ1-42 was found inside vacuoles of coelomocytes. Scale bars 
are 10 µm. Scatter dot plot to the right displays the fraction of nematodes exhibiting red fluorescence in 
coelomocytes at day 4 and 7 of life. Depicted is mean ± SD. Significance was tested with two-way 



















































To test if Aβ1-42 could be detected outside of cells, but not localized in coelomocytes, a second approach 
was employed by crossing JKM2 and JKM7 nematodes with nematodes expressing a pan neuronal 
YFP or body wall muscle GFP respectively. For both, nAβ and mAβ day 7 old nematodes wrmScarlet-
Aβ1-42 was observed outside of their respective expressing tissue (Figure 2.17 A, white arrows). No 
extrusion of wrmScarlet could be observed for the control nematodes JKM3 and JKM8 (crossed with 
nQ0 or mQ0 respectively Figure 2.17 B). This indicates that Aβ1-42 is spreading. It was unclear if Aβ1-42 
was outside of cells at all or if it was able to invade other cell types and form deposits within them.  
To test Aβ’s ability to invade other cells, spreading was tested exemplarily to hypodermis. The 
hypodermis has a large surface and shares a close proximity to both, neurons and muscle cells. A 
hypodermally expressed GFP was employed to track wrmScarlet-Aβ1-42 that was translocated into 
hypodermis (Figure 2.18 A). Indeed, colocalization of wrmScarlet-Aβ1-42 derived fluorescence and 
hypodermal marker fluorescence was observed, both for neuronal and muscle cell origin (see blue 
arrows in Figure 2.18 A, Supplemental Figure 7.3). This clearly shows, that Aβ1-42 is able to passage to 
other tissues, while wrmScarlet control is not able to intrude into the hypodermis. 
 
 
Figure 2.17: Aβ1-42 escapes the expressing tissues 
(A) Representative confocal images of day 7 old JKM2×nYFP and JKM7×mGFP. Neurons or muscle 
cells are labelled with green fluorescence (respective YFP or GFP). Colocalization with red fluorescent 
wrmScarlet or wrmScarlet-Aβ1-42 was analysed and non-colocalizing spots were marked with white 
arrows. (B) Representative confocal images of day 7 old JKM3×nYFP on the left side; and JKM8×mGFP 
on the right side. Scale bars are 20 µm. 
mAβ / mScarletmuscle cells merged
mAβ












Figure 2.18: Hypodermal permeation by Aβ1-42 
(A) Representative confocal images of nAβ×CS628 and JKM3×CS628 (expressing a hypodermal GFP 
marker). Scale bar represents 20 µm. Close-up (zoom) image of the indicated region exhibits wrmScarlet-
Aβ1-42 foci in hypodermis (blue arrows), as well as red fluorescence in neurons (white arrows). Position of 
neurons is indicated by dashed, white lines. A hypodermal nucleus is labelled (n). (B) Representative 
images of nAβ×BIJ34, mAβ×BIJ34, JKM3×BIJ34 and JKM8×BIJ34 exhibit green fluorescence from 
hypodermal LGALS3-sfGFP. Upon Ca2+ influx LGALS3 oligomerizes and forms visible foci (white arrows). 
Three independent cohorts, each of 10 – 20 nematodes were analysed in triplicates and the nematode 
fractions displaying certain number of foci are shown as bar plot (right). To test significance a two-way 







































Although the mechanism that facilitates direct cell to cell transfer of Aβ is not known yet, an active 
transport and excretion/uptake mechanism could be involved in Aβ1-42 spreading. Another possible 
mechanism could be passive transmission by disturbing membrane integrity. 
To test this hypothesis, plasma membrane integrity was assessed indirectly, using a reporter strain 
expressing human Galectin-3::superfolderGFP (GAL3-sfGFP) in hypodermal cells. Galectin-3 
oligomerizes upon binding to Ca2+, indicating a leakage of Ca2+ into to cytoplasm and therefore 
compromised membrane integrity (Figure 2.18). 
An abundant foci formation was observed in nAβ and mAβ (crossed with the Galectin reporter strain 
BIJ34) already in day four old nematodes. Nematodes expressing only the Galectin reporter or a 
combination with muscle / neuronal wrmScarlet did not show accumulation of GAL3-foci. This is a 
strong indication that membranes are permeated in Aβ1-42 expressing nematodes resulting in Ca2+ influx 
from either the extracellular matrix or leakage from compromised endo-lysosomal compartment, or 
both. Yet, this observation substantiates the hypothesis of a potential passive spreading by direct 
membrane permeation. 
 
Identification of a subset of aggregation prone neurons 
Since strong indications of spreading behaviour of Aβ1-42 were observed in the previously presented 
experiments, I assumed, that aggregation could occur unevenly distributed between different cell-types 
and spreading could induce seeding in distant, less-affected cell types. The aggregation propensity of 
Aβ1-42 as well as other amyloidogenic proteins depends on a multitude of parameters whose 
identification and quantification are subject to current research. Yet, most factors remain elusive and 
both intrinsic (e.g. genetic predisposition) and extrinsic (e.g. environmental cues) ones can contribute 
to facilitate aggregation. Strikingly, nAβ nematodes exhibited the first aggregates consistently in a 
distinct subset of four to six head neurons of the anterior ganglion (approx. 90% of all analysed day 
four old nAβ nematodes were affected) (Figure 2.19 A, white arrows). The total amyloid burden remained 
low on day four of life and started to manifest in the complete nervous system more than one day later 
(Figure 2.6). The early aggregates were found in the neuronal soma. To identify these neurons, a 
confocal Z-stack (Figure 2.19 B) was recorded and I found that the cell bodies are located in the anterior 
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ganglion in close proximity to the metacorpus. They exhibited dendrites reaching to the tip of the nose, 
ending in potential sensory arrays and an axon directed into the central nerve ring. To identify the 
neurons, genetic crossings with animals expressing multiple neuronal markers were conducted.  
First, the neurotransmitter identity was assessed by crossing nAβ nematodes with dopaminergic GFP 
expression marker (BZ555), glutamatergic GFP expression marker (OH10972) or cholinergic GFP 
expression marker (LX929) (Figure 2.19 C, Figure 2.20). The early aggregates occurred in cholinergic 
neurons. The relative position of individual neurons can vary between nematodes up to several lengths 
of one neuron body 193,234. Together, shape, position and neurotransmitter identity led to the conclusion 
that the neurons exhibiting the first aggregates were either IL2 or URA neurons.  
 
 
Figure 2.19: IL2 neurons exhibit the first aggregates 
(A) Representative FLIM image of a day four old nAβ nematode, exhibiting first aggregates in IL2 neurons 
(white arrows). Image is false-coloured to indicate fluorescence lifetime (from blue = low fluorescence 
lifetime to red = high fluorescence lifetime). Outline of the nematode is indicated by a dashed, white line. 
Scale bar is 20 µm. (B) Collapsed confocal Z-Stack (in 1 µm steps through the whole nematode head, 
» 40 µm) of a representative day four old nAβ nematode. IL2 neurons are indicated (red arrows). 
Nematode is outlined by a dashed, white line. Scale bar is 20 µm. (C) Schema of relative position of the 
neuron bodies of head neurons of the anterior ganglion (left side). Relative position of the neurons 
exhibiting the first aggregates is indicated (black arrow). Neurons are coloured depending on 































To identify the neurons, two additional markers were employed. First, the expression of flp-22p::GFP 235, 
localized in a subset of approx. 34 neurons, with the most anterior expression in URA neurons           
(Figure 2.20, blue arrows) was observed to display no colocalization with the early aggregating Aβ1-42. 
Second, a marker expressed in IL2 neurons (klp-6p::GFP 236) was employed that exhibited colocalization 
with the early aggregation (Figure 2.20, last panel). To exclude that the early onset of aggregation in IL2 
neurons is only dose-dependent, FLIM images were analysed again regarding coincidence of intense 
fluorescence and aggregation (low fluorescence lifetime) (Supplemental Figure 7.4). Aggregation in IL2 
was observed to be independent from expression levels, as no aggregates were detected in other 
neurons that exhibited an equivalent or even higher fluorescence intensity. Only a low amount of 
randomly occurring aggregates (regarding count and distribution) were found that were not localized in 
IL2 neurons (Supplemental Figure 7.4, yellow dashed arrows). This is in stark contrast to the aggregates 






Figure 2.20: Identification of the 
neurons exhibiting the first 
aggregate as IL2 neurons 
 
Representative confocal images of 
crosses of the indicated strains 
were performed to assess 
neurotransmitter identity of the 
neurons exhibiting the first 
aggregates (cross with strains 
BZ555, OH10972 and LX929). 
Fluorescence of GFP markers and 
wrmScarlet-Aβ1-42 was measured 
and analysed for colocalization.  
Crosses with strains expressing 
flp-22p::GFP (expression in a 
subset of » 34 neurons) or 
klp-6p::GFP (hermaphrodite 
expression in IL2 neurons only) 
were performed to exactly identify 
IL2 neurons as the neurons 
exhibiting the first aggregates.  
Nematodes are outlined with 
dashed, white lines. Scale bars are 
20 µm. White arrows point to the 
neurons with the first aggregates / 
IL2 neurons; blue arrows point to 
URA neurons. 
klp-6p::GFP × JKM2 cross and 






























flp-22 expression:  AIM, AIZ, ASG, AVA, AVG, AVL, CEP, CP neuron, PVD, PVW,











Aβ1-42 aggregation causes neurodegeneration and impairs neuronal function 
Based on the observed systemic toxicity of neuronal Aβ1-42 expression it was hypothesised that nAβ 
could exhibit visible neurodegeneration. Thus, the integrity of neurons was analysed using a fluorescent 
marker in a subset of neurons (under control of tol-1 promoter). tol-1p expression is mainly found in the 
four URY neurons (ventral-left/right and dorsal-left/right) that belong to the anterior ganglion and are in 
close vicinity of the IL2 neurons. Z-stack images of nAβ × tol-1p::GFP nematodes were recorded on 
day 4, day 7 and day 10 of life. The fractions of nematodes displaying damaged neurites vs. intact 
neurites were quantified (Figure 2.21). On day seven of life 67% of the analysed nAβ nematodes showed 
damaged URY neurons compared to 35% of control nematodes. Upon ageing (day 10) this phenotype 
became more severe: 78% of the Aβ1-42 expressing nematodes displayed damaged URY neurons, while 
still only 35% of the wild type animals displayed damage. 
To complement this observation, the functionality of the URY neurons in nAβ was evaluated: their ability 
to sense certain pathogenic bacteria and provoke an avoidance behaviour. 
 
 
Figure 2.21: URY neurons suffer from progressive deterioration in nAβ 
Collapsed confocal Z-Stack of nAβ × tol-1p::GFP nematodes representative for healthy (1) or afflicted 
state (2) are shown. Nematodes were counted as damaged if they exhibited five or more blebs (blue 
arrow), two or more spheres or outgrowing branches (white arrow), and/or complete ablation / necrosis 
of URY neurons (dashed red line). Nematodes are outlined (dashed, white line). Scale bar represents 
20 µm. The scatter dot plot to the right shows the quantification nAβ vs. wild type control animals as 
mean ± SD. Three to four individual cohorts of 8 - 16 nematodes each were analysed. Significance was 













































A previously established pathogen avoidance assay was adapted 237, employing E. coli OP50 (common 
food source) as control and Serratia marcescens Db11 (pathogenic bacterial strain), as well as 
S. marcescens Db1140 (attenuated strain) to test avoidance. Wild type nematodes evade pathogenic 
Db11 bacteria. The tol-1 receptor gene is particularly important for this reaction and a tol-1 mutant 
strain (IG10) does not exhibit pathogen avoidance towards Db11. All analysed nematode strains dwell 
on non-pathogenic OP50 bacteria, but display a differentiated behaviour towards pathogenic Db11 
bacteria. Wild type nematodes avoided Db11, while tol-1 mutant nematodes did not avoid Db11. 
Notably, nAβ nematodes did not show any avoidance behaviour, compared to control nematodes JKM3 
(neuronal wrmScarlet) and JKM5 (StopAβ, aggregation impaired) (Figure 2.22 A, Supplemental        
Figure 7.2 E). 
  
 
Figure 2.22: nAβ exhibits impaired pathogen avoidance and chemotaxis 
(A) Scatter dot plot of a pathogen avoidance assay showing nematodes’ reaction to different bacteria. 
Non-pathogenic E. coli strain OP50 was used to show nematodes’ lawn dwelling. Pathogenic Serratia 
marcescens strain Db11 and attenuated S. marcescens strain Db1140 were employed to test avoidance 
reactions. Wild type (N2; black) served as positive control for avoidance reaction and tol-1 mutant strain 
(IG10; green) served as negative control. nAβ animals are represented by red dots and neuronal control 
animals by yellow dots. Three independent experiments consisting of 3 - 5 cohorts of 10 - 15 nematodes 
were measured four times in 5 min intervals for their behaviour after being exposed to the respective 
bacteria for 48 h. (B) Scatter dot plot of a chemotaxis assay. Three independent experiments with each 
2 - 4 cohorts of 50 - 100 nematodes (day 4/5 adults) were analysed regarding the distribution of 
nematodes between test and control quadrants, exposing them to odorants or solvent controls. 
Chemotaxis-Index was calculated. Significance was tested with two-way ANOVA + Bonferroni post hoc 




























































The analysis of avoidance was performed from day four to day six of life. Hence, neuronal impairment 
occurs before macroscopic aberrations of neuronal structures become visible (compare starting 
degeneration from day 7 onwards, Figure 2.21). 
To further investigate neuronal function that relies on the activity of other neurons, a chemotaxis assay 
was employed to analyse the nematodes’ behaviour to volatile odorants. Diluted benzaldehyde (1% v/v) 
was tested for the induction of attraction behaviour. In wild type nematodes diluted benzaldehyde is 
sensed by AWC neurons, a class of chemotactic neurons located in the lateral ganglion and induces an 
attraction behaviour 238. As expected, wild type nematodes are attracted towards 1% benzaldehyde. 
nAβ nematodes on the other hand are not attracted, therefore seem to be chemotactically impaired in 
either detecting the odorant or reacting to it. Both nematode strains are, on the other hand, repelled by 




Suppression of Aβ1-42 aggregation in IL2 neurons can delay amyloid pathology 
systemically  
After I observed that Aβ1-42 was indeed eliciting neurodegeneration I was wondering if spreading would 
play a role in this process and if prevention of spreading could alleviate neurodegeneration. Yet, the 
major question was if IL2 neurons, that exhibited the first aggregates, were especially vulnerable or 
unprotected towards Aβ1-42 aggregation. This also offers the possibility that an inhibition of Aβ 
aggregation specifically in IL2 neurons could delay the aggregation systemically and lead to an 
alleviation of the AD phenotype.  
To address this question, a cell-type specific knockdown by expressing a short hairpin construct site-
specifically in IL2 neurons was employed (Figure 2.23 A). As a control, the same construct was 
expressed in a subset of other neurons with the major expression in URY neurons (driven by tol-1p). 
These constructs were crossed with nAβ animals (Figure 2.23 B) and tested for aggregation and 
systemic impairment. First, the specificity of the hairpin construct was evaluated by testing a specific 
phenotype in nAβ + shRNAURY: pathogen avoidance (Supplemental Figure 7.5). Avoidance from 
  
56 
pathogenic S. marcescens Db11 bacteria was rescued partially by the expression of the short-hairpin 
construct in URY neurons, while the chemotaxis towards diluted benzaldehyde, that requires AWC 
neuron activity, remained impaired. I conclude that the designed short-hairpin expression system 
induces indeed cell-type specific RNAi. To assess the impact on the Aβ1-42 aggregation, fluorescence 
lifetime measurements were conducted on nAβ with or without the co-expression of the short-hairpin 
constructs in IL2 neurons or URY neurons (Figure 2.24 A). Indeed, a systemic reduction of aggregation 
was observed for day four old nematodes upon Aβ1-42 knockdown in IL2 neurons, yet not for a 
knockdown specifically in URY neurons (Figure 2.24 A, C). Also, a reduction of IL2 neurons harbouring 
aggregates was observed upon IL2-specific knockdown underlining the specificity of the employed 
site-specific knockdown approach (Figure 2.24 B). Given that a reduction of amyloid burden in IL2 
neurons reduced neuronal Aβ1-42 aggregation systemically, it was hypothesised that it may also alleviate 
toxicity in the nervous system and even on an organismal level. 
 
 
Figure 2.23: Expression of a short-hairpin construct for Aβ1-42-knockdown 
(A) Schema depicting the strategy for cell type specific knockdown in neurons of the anterior ganglion. 
A short-hairpin construct against Aβ1-42 is expressed in either IL2 neurons (using klp-6 promoter 
sequence) or URY neurons (using tol-1 promoter sequence). View on the left side of the head, affected 
IL2 and URY neurons on the right side of the head are light coloured and have dashed lines. Unaffected 
neurons for orientation are shown for the left side only and are grey coloured. (B) Agarose gel 
electrophoresis of a genotyping PCR for the short-hairpin construct (400 bp band) in transgenic 
nematode strains. One isolate was tested as triplicate for nAβ + shRNAURY, three isolates were tested for 
nAβ + shRNAIL2 in duplicates. The vector used for transgenesis was used as positive control (+) and wild 
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To this end, the general vitality of these nematodes was assayed by lifespan, swimming and paralysis 
assays. nAβ, +shRNAIL2, +shRNAURY and wild type nematodes were incubated in M9 medium swimming 
for 30 min and the fraction of paralyzed nematodes was assessed afterwards (Figure 2.25 A).  
The co-expression of the hairpin construct in IL2 neurons reduced the fraction of paralyzed day 4 old 
nematodes compared to nAβ (+shRNAIL2: 18% vs. nAβ: 43%) or the control, expressing the hairpin 
construct in URY neurons, significantly (+shRNAIL2: 18% vs. +shRNAURY: 57 %).  
 
Figure 2.24: Knockdown of Aβ1-42 in IL2 reduces amyloid burden 
(A) Shown are representative TCSPC-FLIM images of nAβ, +shRNAURY, +shRNAIL2 in false-colours (from 
blue = low fluorescence lifetime to red = high fluorescence lifetime). Nematodes are outlined with dashed 
white lines. Scale bar represents 20 µm. (B) Scatter dot plot of the fraction of IL2 neurons displaying 
aggregates in nAβ, +shRNAURY, +shRNAIL2 on day four of life. Aggregate evaluation was performed on 
FLIM images. Four cohorts of 8 – 12 nematodes each were analysed and mean ± SD is displayed. 
Significance was tested with one-way ANOVA + Bonferroni post hoc test (∗  =  p < 0.033). (C) Scatter 
dot plot of the mean fluorescence lifetime of nAβ, +shRNAURY, +shRNAIL2 on day four of life. Four cohorts 
of 8 – 12 nematodes each were analysed and mean ± SD is displayed. Significance was tested with one-
way ANOVA + Bonferroni post hoc test (∗∗∗  =  p < 0.001). 
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There was no significant difference between nAβ and nAβ + shRNAURY, as well as there was no 
significant difference between the wild type and the rescue strain nAβ + shRNAIL2. Hence, a reduction 
of nAβ1-42 aggregation in the early onset of aggregation IL2 neurons seemed to reduce overall neuronal 
aggregation and importantly was beneficial for the organismal fitness. To complement this, thrashing 
was analysed and a significant rescue was observed for IL2-specific knockdown, but not for control 
knockdown or an untreated control (Figure 2.25 B). 
To analyse if the knockdown provides a lasting benefit for the AD pathology, lifespan was assessed for 
nAβ and nAβ + shRNAIL2. The knockdown increased the median lifespan by 27% (+shRNAIL2: 9.0 days 
vs. nAβ: 7.1 days), but did not extend the maximum life expectancy (both strains: 18 days, Figure 2.25 
C). This observation suggests that the IL2-specific knockdown delayed the onset of aggregation in 
other neurons, but could not completely suppress the progression of aggregation.  
 
Figure 2.25: Knockdown of Aβ1-42 in IL2 neurons alleviates AD toxicity temporarily 
(A) Scatter dot plot of the ability of nAβ, +shRNAURY, +shRNAIL2 or wild type nematodes (day 4 old) to 
swim for 30 min in M9 medium. Paralyzed nematodes were counted and their fraction plotted as mean 
± SD from six - nine cohorts of 10 – 20 nematodes each per strain. Significance was tested with one-
way ANOVA + Bonferroni post hoc test (∗  =  p < 0.033; ∗∗∗  =  p < 0.001). Data were acquired in 
cooperation with Manuel Iburg. (B) Scatter dot plot of the thrashing activity of nAβ, +shRNAURY, 
+shRNAIL2 or wild type nematodes (day 4 old) swimming in M9 medium. 38 – 40 individual nematodes 
were recorded for 30 sec in triplicates, plotted is mean ± SD. Significance was tested with one-way 
ANOVA + Bonferroni post hoc test (∗∗∗  =  p < 0.001). Kindly provided by Tanmoyita Nayak. (C) Shown 
is the Kaplan-Meier plot of the cumulative survival probability of nAβ, +shRNAIL2. 95 – 105 nematodes 
were analysed. Significance was tested for the indicated ranges with a log-rank test (∗  =  p < 0.01). The 
inset table displays the median survival ± SD from three cohorts of 30 - 35 nematodes each per strain. 
Significance was tested with Student’s t-test (∗  =  p < 0.033). Kindly provided by Sara Maria Ayala 




















































































Generation and Characterization of a C. elegans model expressing human Drebrin 
 
The actin-binding protein Drebrin was observed to be depleted from AD brains in post mortem analyses 
and depletion experiments in AD mouse models observed increased severity of AD phenotypes. Yet, 
an analysis of human Drebrin in C. elegans as a comprehensive model to analyse multiple parameters 
in a fast manner (e.g. ageing studies, compound testing, etc.) was pursued. 
To analyse human Drebrin in living nematodes, the utilization of a model, lacking the C. elegans 
endogenous ortholog DBN-1, was intended. DBN-1 shares sequence homology to two human proteins, 
Drebrin (DBN1) and Drebrin-like protein (DBNL). To exclude interference of the nematode DBN-1, a 
knockout strain lacking dbn-1 (RB1004) was employed (Figure 2.26).  
 
 
Figure 2.26: Schema of the dbn-1 locus 
The dbn-1 locus (sequence K08E3.4) consists of six exons (cyan) and a 3’UTR (grey) spanning over 2633 
base pairs and is located on the antisense strand of chromosome III. The deletion mutant strain RB1004 
(variation ok925) lacks 1146 base pairs of exons 5 and 6. 
 
First, the general vitality was assayed to find potential impairments due to the knockout of dbn-1. Yet, 
no apparent dysfunction was detected. Brood size and larval development were not impaired            
(Figure 2.27), both being general vitality markers. For the dbn-1 mutant strain 285 ± 39 vivid progenies 
per nematode were counted. This did not differ significantly from the 292 ± 29 progeny per nematode 
that were counted for wild type nematodes. The obtained larvae aged and developed well, reaching L4 
stage within three days at 20°C and reaching young adult stage at day 4, where they started to lay eggs 
on their own. There was no interference observed in the unstressed steady state, invoking the idea, that 
dbn-1 could serve functions in acute stress response.  
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Figure 2.27: dbn-1 deletion does not impair fecundity or larval development 
(A) Scatter dot plot of the vivid offspring per nematode. Three cohorts of 10 – 15 wild type (N2) and 
dbn-1 (RB1004) nematodes each were analysed and mean ± SD plotted. Significance was tested with 
Student’s t-test. (B) Stacked bar plot of the development of an age synchronised cohort after four days. 
Three independent cohorts of 50 – 150 nematodes each were analysed, plotted is mean ± SD. 
Significance was tested by two-way ANOVA + Bonferroni post hoc test. 
  
Analysis of oxidative stress in dbn-1 nematodes 
To test if DBN-1 was involved in stress response, nematodes were challenged with oxidative stress 
using Paraquat. Paraquat can uncouple electrons from mitochondria and transfer them to oxygen 
molecules converting them to superoxide free radicals.  
Lifespan analysis of wild type and dbn-1 nematodes revealed that ageing under unstressed conditions 
is not affected in dbn-1 animals (Figure 2.28). Yet, a significant effect was observed upon challenging 
with oxidative stress. Counterintuitively, wild type nematodes exhibited a stronger lifespan reduction 
(maximum life expectancy N2: 18 days vs. RB1004: 23 days). It was expected, that DBN-1 would be 
beneficial under stress conditions and that a depletion would subsequently aggravate damage under 
such conditions. The found results were an indication that either the hypothesis was wrong or that the 
model system employed was inappropriate.  
Indeed, Butkevich et al. 217 analysed phenotypic traits of DBN-1 to muscle cells and generated an 
antibody against DBN-1. They observed that the ok925 variation in RB1004 leads to an incomplete 
knockout of dbn-1, still producing a truncated variant of DBN-1 of 35 kDa. Hence, this N-terminal 
fragment could exhibit some unregulated functionality as actin-binding and remodelling are mainly 

















































Figure 2.28: dbn-1 mutant nematodes are more resistant to oxidative stress 
Kaplan-Meier plot displaying the cumulative survival probability of wild type (N2) and dbn-1 (RB1004) 
nematodes. One cohort for each strain was challenged with 2 mM Paraquat from L4 stage on (+ Pq / 
dotted line). Each cohort consisted of 100 – 150 nematodes. 
 
Generation of a total knockout of dbn-1 
To avoid interference by a truncated DBN-1, two approaches to overcome this obstacle have been 
tested. First, RNAi was performed with a small interfering RNA (siRNA) against dbn-1 transcript in both, 
wild type and dbn-1 mutant strain and second, a complete knockout strain was generated by 
CRISPR/Cas9 (Figure 2.29). In total, four guide RNAs have been employed, two binding at the beginning 
of dbn-1 exon one and two binding the end of the corresponding exon six. One strain was obtained 
that exhibited the desired deletion in a genotyping PCR (Figure 2.29 B). This strain (experimental name 
“green 7.4”) was sequenced at the dbn-1 locus and a major deletion was observed leaving merely 
83 base pairs from the dbn-1 gene (Figure 2.29 C). The strain was named JKM1 and DBN-1 abundance 
was assessed by western blot. The detection with a DBN-1 specific antibody did neither show the full-
length protein (» 130 kDa) nor a truncated variant of any size (Figure 2.29 D and E). To test, if RNAi 
would be appropriate to reduce DBN-1 levels, a western blot was employed, too. Yet, the truncated 
DBN-1 variant was observed for RB1004 and a clear reduction by approx. 60% was detected upon 
siRNA treatment of the nematodes (Figure 2.29 D). Even though, the knockdown is incomplete, the 
effects on the phenotype can be immense up to the extent, to yield results that are indistinguishable 
from the total knockout. To further validate knockdown and knockout, lifespan and brood size were 
analysed as read-outs for general vitality.      



















Figure 2.29: Knockdown and knockout of dbn-1 
(A) Schema of the dbn-1 locus, deletion variant ok925 of strain RB1004 (red), the position of a used siRNA 
(blue) and the position of four used sgRNAs (green) to generate a total knockout strain are indicated.      
(B) Agarose gel electrophoresis of genotyping of the dbn-1 locus in wild type nematodes exhibiting a 
3.3 kb band and in CRISPR/Cas9 treated strain “green 7.4” (coined JKM1) that exhibits a total dbn-1 
knockout (knockout band of 920 bp). (C) Sequencing of the dbn-1 locus in JKM1, displaying a deletion 
of the major part of exons 1 and 6 and a complete deletion of the exons 2 – 5. The corresponding 
translation is indicated. (D) Western blot of RB1004 and JKM1 treated with an siRNA against dbn-1 (+) or 
control siRNA (  ), exhibiting truncated DBN-1 protein at 35 kDa. DBN-1 antibodies and Tubulin antibodies 
were employed. Knockdown efficacy was calculated after densitometric assessment of DBN-1 bands 
over corresponding Tubulin bands. (E) Western blot of wild type (N2) and dbn-1 total knockout (JKM1) 
nematodes detected with anti-DBN-1. Tubulin was detected as loading control. Two replicates of wild 
type and three replicates of ∆dbn-1 were performed. 
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A small, yet significant reduction of brood size was observed for the total knockout (JKM1) compared 
to wild type (N2) or incomplete knockout (RB1004) (Figure 2.30 A), implicating that the presence of a 
truncated DBN-1 variant in RB1004 was enough to compensate for the observed progeny reduction. 
Furthermore, such progeny reduction could be achieved to the same extent in wild type or partial 
knockout lines by siRNA application. This offers the possibility to exploit knockdown in further 
experiments rather than using the complete knockout.  
The lifespan of the total knockout (JKM1), wild type (N2) and incomplete knockout (RB1004) strain was 
analysed and no significant differences were found under non-stressed conditions. Upon induction of 
oxidative stress, the lifespan of the total knockout was significantly decreased compared to wild type 
(Figure 2.30 B), what is in stark contrast to the previous experiments where the alleged knockout strain 
(RB1004) was found to be more long-lived under oxidative stress compared to wild type.  
 
 
Figure 2.30: Complete dbn-1 deficiency renders nematodes sensitive to oxidative stress 
(A) Scatter dot plot of wild type (N2), dbn-1 partial knockout (RB1004) and ∆dbn-1 total knockout (JKM1) 
shown as mean ± SD. 10 - 30 nematodes have been analysed per strain, indicated strains have been 
treated with siRNA against dbn-1 (kd: dbn-1). Significance was tested by one-way ANOVA + Bonferroni 
post hoc test (∗∗∗  =  p < 0.001) (B) Kaplan-Meier plot of wild type (N2), dbn-1 partial knockout (RB1004) 
and ∆dbn-1 total knockout (JKM1) nematodes cumulative survival probability was measured. Strain 
RB1004 was treated with siRNA against dbn-1 to deplete also the truncated DBN-1. To test survival 
under oxidative stress, one cohort of each strain of 100 – 150 nematodes was treated with 2 mM 
Paraquat (dashed lines; + Pq) from L4 stage on. Control cohorts of 100 – 150 nematodes were treated 
with solvent control (water) from L4 stage on (continuous lines). Significance was tested with log-rank 
test (∗∗∗  =  p < 10-6). 




























































Upon application of siRNA to RB1004, the lifespan decrease under oxidative stress was observed to 
be similar to JKM1 under oxidative stress. This confirms that the truncated DBN-1 interfered with the 
conducted experiments and that a solid depletion is detrimental to the following experiments that are 
designed to analyse the effects of human Drebrin in C. elegans. 
 
Generation of a humanized C. elegans model expressing human Drebrin 
The endogenous dbn-1 promoter was cloned from genomic DNA together with human Drebrin-YFP to 
analyse the dbn-1 expression pattern in vivo. Confocal fluorescence microscopy revealed, that dbn-1 
was expressed in multiple tissues (Figure 2.31). A strong expression was observed in pharyngeal tissue 
(Figure 2.31, blue arrow head) and in a subset of head neurons. Further expression was observed in 
other neurons (Figure 2.31, white arrows). Previous studies described dbn-1 expression in body wall 
muscle cells, too 217. Yet, this expression pattern could not be confirmed nor rebutted by the generated 
model as the extrachromosomal array expression was too variable. Even though the expression pattern 
remained unclear to a certain extent, the implication for the following experiments was to employ a 
different promoter. To analyse DBN1 activity in neurons, a promoter that drives expression selectively 
pan-neuronally was employed (rgef-1p), thereby circumventing off-target effects from DBN1 expressed 
otherwise in non-neuronal tissue if dbn-1 promoter would have been used. 
 
 
Figure 2.31: Endogenous dbn-1 is expressed in multiple tissues 
Representative confocal images of a nematode expressing DBN1-YFP under control of the endogenous 
dbn-1 promoter (Ex [dbn-1p::DBN1-YFP]). Fluorescence of YFP and differential interference contrast 
(DIC) were recorded. Scale bar represents 50 µm. White arrows point to DBN1-YFP signals in neurons. 





To corroborate results from our cooperation partners of the Eickholt Lab, Drebrin phosphorylation 
variants were cloned to mimic phosphorylation (substitution of selected amino acid by Aspartate) or 
constitutive dephosphorylation (substitution of selected amino acid by Alanine). The Serine-647 that 
was observed to regulate Drebrin turn-over in an ex vivo neuron model 179 was replaced by either 
Aspartate or Alanine to analyse the regulation of Drebrin turn-over in C. elegans neurons and the 
influence of putatively stabilized Drebrin on stress resistance. Drebrin-YFP fusion variants (wt S647, 
S647A and S647D) were expressed in JKM1 or RB1004 nematodes pan-neuronally (Figure 2.32). 
 
Figure 2.32: Neuronal expression of DBN1-YFP variants 
(A) Representative confocal images (merged DIC + YFP fluorescence) of nDBNwt (∆dbn-1[Ex1-Ex6] + 
rgef-1p::DBN1Awt-YFP), nDBNS647A (ok925 + rgef-1p::DBN1AS647A-YFP) and nDBNS647D (ok925 + 
rgef-1p::DBN1AS647D-YFP). Magnification of images is 100x - 200x, scale bars represent 50 µm. Insets at 
630x magnification, corresponding scale bars represent 20 µm. (B) Representative western blot of lysed 
nematodes (see A) detected with DBN1 specific antibody (M2F6) and with a Tubulin specific antibody 
as loading control. Kindly provided by Patricia Kreis (Eickholt lab, Charité Universitätsmedizin Berlin).  
(C) Scatter dot plot displaying the quantification of the fluorescence intensity of the employed nematode 



















































The pan-neuronal expression was verified by confocal microscopy. YFP fluorescence was observed 
throughout the nervous system, including head, mid body and tail neurons (Figure 2.32 A). The 
expression levels after stable integration into genomic DNA were assessed by immunodetection on 
western blots and additionally by fluorometric measurement of total YFP fluorescence (Figure 2.32 B 
and C). Both, western blot and fluorometry exhibited similar abundances. The DBN1 wild type variant 
was most strongly expressed (99 ± 22%) compared to dephospho-mimicry S647A (41 ± 17%) or 
phospho-mimicry S647D (25 ± 12%). This quantification is particularly important for the evaluation of 
the following experiments, to exclude dose-dependent effects by differential expression levels. 
 
 
Figure 2.33: Human Drebrin rescues dbn-1 depletion partially 
(A) Scatter dot plot displaying the progeny per nematode of N2 (wild type), JKM1 (∆dbn-1[Ex1-Ex6]), 
nDBNwt (∆dbn-1[Ex1-Ex6] + rgef-1p::DBN1Awt-Dendra2), nDBNS647A (∆dbn-1[Ex1-Ex6] + 
rgef-1p::DBN1AS647A-Dendra2) and nDBNS647D (∆dbn-1[Ex1-Ex6] + rgef-1p::DBN1AS647D-Dendra2) strains. 
Significance was tested with one-way ANOVA + Bonferroni post hoc test, JKM1 was significantly 
different from all other tested strains (∗∗∗  =  p < 0.001). (B) Kaplan-Meier plots displaying the cumulative 
survival probability of JKM1 (∆dbn-1[Ex1-Ex6]), nDBNwt (∆dbn-1[Ex1-Ex6] + rgef-1p::DBN1Awt-YFP), 
nDBNS647A (ok925 + rgef-1p::DBN1AS647A-YFP) and nDBNS647D (ok925 + rgef-1p::DBN1AS647D-YFP) strains 
under constant knockdown of dbn-1 by siRNA. Upper panel shows additional treatment with 2 mM 
Paraquat from L4 stage on, lower panel untreated control. Three independent cohorts of 100 – 150 
nematodes per strain and condition were recorded and mean value plotted. Significance was tested by 
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The general vitality and the reaction to oxidative stress were assessed by analysing the progeny per 
nematode and the lifespan. While the total deletion, as well as the RNAi induced depletion, led to 
reduced brood sizes compared to wild type (reduction by » 20%) (Figure 2.30 A). The pan neuronal 
expression of DBN1 variants restored full brood size in ∆dbn-1 nematodes (knockout as well as 
knockdown) (Figure 2.33 A). Therefore, human Drebrin exhibits a protective effect in the nematodes in 
a systemic manner. Since the depletion of dbn-1 led to a sensitisation to oxidative stress, resulting in 
lifespan reduction upon Paraquat treatment, I hypothesized that human Drebrin could compensate this 
phenotype. A lifespan assay was performed inducing oxidative stress in nDBN variant strains (under 
depletion of endogenous dbn-1 by knockout and knockdown) (Figure 2.33 B). Without oxidative stress, 
no significant difference was observed between any of the analysed strains. Yet, oxidative stress 
generated by Paraquat led to a decrease in lifespan in all analysed strains with different efficacy. JKM1 
(∆dbn-1 control) exhibited the strongest reduction among the compared strains (by 54% to a maximum 
life expectancy of 13 days, median of 8.3 days). The expression of nDBN variants was beneficial for the 
lifespan under oxidative stress. The dephospho mimicry variant nDBNS647A exhibited to smallest 
improvement (41% reduction to a maximum life expectancy of 16 days, median of 9.7 days). nDBNwt 
and nDBNS647D exhibited similar results and improved lifespan under oxidative stress compared to dbn-1 
knockout (nDBNwt: 29 % reduction to maximum life expectancy of 20 days, median of 11.8 days; 
nDBNS647D: 27% reduction to maximum life expectancy of 19 days, median of 11.8 days). This indicates, 
that human Drebrin was able to exert a protective function in the nematode neurons and thereby 
stabilize the whole nematode’s health under oxidative stress and consequently rescue the lifespan. 
Furthermore, the rescue was dependent on the phosphorylation of Serine-647, as the reduced efficacy 
of the constitutive dephospho variant displayed.  
The regulation of Serine-647 phosphorylation site was subject to further studies to understand how it 
affects Drebrin and subsequently remodels stress resistance. Our cooperation partners of the Eickholt 
lab were addressing this question in cell based models and ex vivo neuronal culture models 179. I set 
out to corroborate their results in the nematode and could demonstrate that the differential regulation 





Influence of ATM-1 on Drebrin phosphorylation 
Previous studies showed that Drebrin gets phosphorylated at Serine-647 by a previously 
uncharacterised kinase in response to neuronal membrane depolarisation following neuronal activity 178. 
The examination of the amino acid sequence of Drebrin revealed a putative consensus motif at 
Serine-647 for the Serine/Threonine kinase Ataxia telangiectasia mutated (ATM) 239. Our cooperation 
partners could show that ATM phosphorylates S647-Drebrin indeed in response to oxidative stress and 
that this may be an adaption to increased ROS levels in neurons due to neuronal activity 179,240.  
To test if ATM is involved in DBN function in nematodes, the impact of ATM inhibition on lifespan using 
the specific ATM inhibitor KU-55933 was analysed. Prior to the analysis, the ability of KU-55933 to 
inhibit C. elegans ATM-1 was validated. Nematodes expressing nDBNwt were treated with KU-55933 
and phosphorylation at Serine-647 was analysed on a western blot by employing a pS647-Drebrin-
specific antibody (Figure 2.34 A). A significant reduction of pS647-Drebrin signal was observed, 
suggesting that KU-55933 is able to inhibit C. elegans ATM-1 indeed.  
 
Figure 2.34: ATM-1 inhibition aggravates lifespan reduction upon oxidative stress 
(A) Representative western blot detecting pS647-DBN1 over Tubulin. Two cohorts of nDBNwt 
(∆dbn-1[Ex1-Ex6] + rgef-1p::DBN1Awt-YFP) nematodes were treated with ATM kinase inhibitor 
KU-55933 (+ KU) or with DMSO solvent control (control). Lysis and blot were performed by Patricia Kreis 
(Eickholt lab). (B) Kaplan-Meier plot showing the cumulative survival probability of nDBNwt (∆dbn-1[Ex1-
Ex6] + rgef-1p::DBN1Awt-YFP) treated with KU-55933 (+ KU) or DMSO solvent control. Additionally, 
cohorts were challenged with 2 mM Paraquat to induce oxidative stress from day 4 of life on (+ PQ). 
Three independent cohorts of 100 – 120 nematodes each per condition were tested and the mean 
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The lifespan reduction of nDBNwt strain was tested upon chronic oxidative stress ± ATM inhibitor. The 
KU-55933 treated cohorts exhibited a significantly decreased lifespan compared to unstressed 
condition (PQ + KU: 38% reduced lifespan, median 9.7 days vs. PQ + ctrl: 29% reduced lifespan, 
median 11.8 days). This suggested that loss of ATM-1 function exacerbated the effect of oxidative 
stress. To prove that this effect is due to altered phosphorylation at Serine-647, lifespan assay and 
KU-55933 treatment were conducted with the phospho and dephospho mimicry variant expressing 
nematodes (nDBNS647D and nDBNS647A). Since both strains are in the ok925 (incomplete dbn-1 deletion) 
background, the nematodes were cultured with constant siRNA treatment to induce an effective 
depletion of dbn-1. There was no significant difference between KU-55933 treated and untreated 
nematodes of the strains nDBNS647A (median lifespan + KU: 13.1 days vs. ctrl: 13.0 days) and nDBNS647D 
(median lifespan + KU: 15.5 days vs. ctrl: 14.0 days) (Figure 2.35 lower panel). Under chronic oxidative 
stress there was no effect of ATM-1 inhibition either (nDBNS647A median lifespan + PQ + KU: 9.6 days 
vs. + PQ + ctrl: 9.7 days; nDBNS647D median lifespan + PQ + KU: 11.7 days vs. + PQ + ctrl: 11.8 days) 
(Figure 2.35 upper panel).  
Figure 2.35: ATM-1 inhibition has no 
influence on DBN de/phospho 
variants lifespan 
 
Kaplan-Meier plots displaying the 
cumulative survival probability of 
three independent cohorts of 100 - 
120 nematodes per strain and 
condition tested as mean. All strains 
were treated with siRNA against 
dbn-1.  
The upper panel shows the strains 
that were treated with 2 mM Paraquat 
from day 4 of life on, the lower panel 
shows the controls without oxidative 
stress. Influence of ATM1 kinase 
inhibitor KU-55933 was tested (+ KU). 
The controls (all other strains) were 
treated with DMSO as solvent 
control. Significance was tested by 
log-rank test. 
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Since both de-/phospho mimicry variants alter lifespan during oxidative stress independent from ATM-1 
function, S647-Drebrin presents an important ATM substrate in this response. Taken together, these 
results demonstrate DBN phosphorylation at Serine-647 as an integral mechanism involved in Drebrin 
mediated stress resistance towards oxidative stress. 
 
As Drebrin was observed to be depleted in Alzheimer’s Disease, the two established models were 







Interaction between human Drebrin and Aβ1-42 in C. elegans 
 
To analyse the interaction between Drebrin and Aβ1-42 in vivo, the Drebrin expressing strains nDBNwt, 
nDBNS647A and nDBNS647D were crossed with nAβ. Crossed strains that were triple homozygous (for the 
Drebrin variant, neuronal Aβ1-42 expression and ∆dbn-1[Exon1-Exon6]) as well as a double homozygous 
nAβ-∆ control strain (nAβ + ∆dbn-1[Exon1-Exon6]; JKM2-∆) were isolated. 
In the following chapter the crossed strains are named: nDBNwt, nDBNS547A, nDBNS547D and 
nAβ-∆ / JKM2-∆, the corresponding genotype is provided in Table 2.1. 
 













rgef-1p::DBN1AS647D-Dendra2 + rgef-1p::SigPep-Aβ1-42::IRES::wrmScarlet-Aβ1-42 + 
∆dbn-1[Exon1-Exon6] III 
JKM2-∆ (nAβ-∆) rgef-1p::SigPep-Aβ1-42::IRES::wrmScarlet-Aβ1-42 + ∆dbn-1[Exon1-Exon6] III 
 
First, the expression levels of both Aβ1-42 and Drebrin variants were analysed by fluorometry to ensure 
equal protein abundance. There was no significant difference of Aβ1-42 expression detected in nDBNwt, 
nDBNS647A, nDBNS647D and JKM2-∆ (Figure 2.36 A). Since Aβ1-42 aggregation propensity is correlated to 
Aβ1-42 abundance among other factors, a dose-dependent effect evoking changes of aggregation 
behaviour and subsequent toxicity can be excluded. All possibly detectable effects should therefore be 
the result of secondary effects that are independent from Aβ1-42 abundance. 
The expression of DBNS647A and DBNS647D did not exhibit a significant difference, yet their expression 
was approximately twice as strong as DBNwt expression (Figure 2.36 B). Since the expression of the 





Figure 2.36: Expression levels of nDBN × nAβ 
(A) Scatter dot plot displaying the quantification of the fluorescence intensity of wrmScarlet-Aβ1-42 in 
nDBN variants crossed with nAβ. Three independent cohorts of 10 - 20 nematodes each were analysed. 
Shown is mean ± SD. Significance was tested with one-way ANOVA + Bonferroni post hoc test.               
(B) Scatter dot plot displaying the quantification of the fluorescence intensity of DBN-Dendra2 in nDBN 
variants crossed with nAβ. Three independent cohorts of 10 - 20 nematodes each were analysed. 
Depicted is mean ± SD. Significance was tested with one-way ANOVA + Bonferroni post hoc test            
(∗∗  =  p < 0.01). 
 
Drebrin and Aβ1-42 can colocalize  
Both, Aβ1-42 and Drebrin are expressed in neurons and localise mainly in the cytosol (Figure 2.37 A). To 
assess if Aβ1-42 and Drebrin interact with each other, fluorescence microscopy studies were conducted. 
Aβ1-42 formed foci in the cytoplasm of neurons and was able to sequester Drebrin, resulting in a 
colocalization (Figure 2.37 A, white arrows). Furthermore, the presence of Aβ1-42 induced Drebrin foci 
formation without direct interaction, resulting in Drebrin foci that were devoid of Aβ1-42 (Figure 2.37 A, 
green arrows). Such foci formation was not observed in nematodes expressing only Drebrin variants 
but no Aβ1-42. Also, Aβ1-42 foci appeared that were devoid of Drebrin, a phenomenon commonly observed 
in JKM2 nematodes. Hence, Aβ1-42 could sequester Drebrin into foci and even induce Drebrin foci 
formation by secondary effects (e.g. reduced proteostatic capacity). Still, the majority of Drebrin 

































































Figure 2.37: Drebrin and Aβ1-42 colocalize foci-wise 
(A) Representative confocal images of nDBNwt×JKM2-∆ display fluorescence of DBN1-Dendra2 and 
fluorescence of wrmScarlet-Aβ1-42. Magnification was successively increased from 300x (scale bar is 
50 µm; merge includes Dendra2 and wrmScarlet fluorescence + DIC) to 600x (scale bar is 20 µm), to 
945x (scale bar is 10 µm) to zoom on the retrovesicular ganglion. White arrows point to foci exhibiting 





































































Dendra2-only foci. (B) Scatter dot plot showing the total foci count of Dendra2 and wrmScarlet positive 
foci as mean ± SD for n = 15 nematodes recorded per strain. To test significance one-way ANOVA + 
Bonferroni post hoc test was employed (∗  =  p < 0.33, ∗∗∗  =  p < 0.001). (C) Scatter dot plot depicting 
the distribution of Dendra and wrmScarlet fluorescent foci and their colocalization as fraction from total. 
Shown is mean ± SD from n = 15 analysed nematodes per strain. Significance was tested by two-way 
ANOVA + Bonferroni post hoc test (∗∗∗  =  p < 0.001). 
 
 
The total foci formation was reduced in nDBNwt and nDBNS647D compared to nDBNS647A. Additionally, all 
Drebrin expressing variants exhibited reduced foci formation compared to nAβ-∆ strain, expressing 
only Aβ1-42 (Figure 2.37 B). This is an indication, that the presence of Drebrin alters Aβ1-42 aggregation 
behaviour in a potentially beneficial way. Yet, foci number should not be directly correlated to aggregate 
burden, as accumulation of material and amyloid formation constitute two different moieties. To further 
evaluate the contribution of DBN-pS647, the number of foci exhibiting colocalization between Aβ1-42 
and the respective Drebrin variant was scored (Figure 2.37 C). There were minor differences in the 
number of colocalizing foci between the analysed strains, yet there was no clear trend observed. 
Individual nematodes exhibited drastic variations in colocalization, giving rise to the hypothesis, that 
Drebrin sequestration by Aβ1-42 may be independent of pSerine-647. 
 
Drebrin does not aggregate despite foci formation 
To analyse if Drebrin, that was trapped in Aβ1-42 foci, was co-aggregated, DBN-Dendra2 aggregation 
was assessed by fluorescence lifetime microscopy of the crossed strains. The strain nDBNS647A was 
employed as it exhibited the highest foci count of the crossed Drebrin variants. 
Previous studies have described a fluorescence lifetime of 3.3 ns for Dendra2 (in its non-converted 
state) 241. Nevertheless, expressed in C. elegans neurons and fused to Drebrin, a fluorescence lifetime 
of 3.0 to 3.1 ns was measured. nDBNS647A nematodes exhibited an even distribution of Dendra2 
fluorescence as well as an even fluorescence lifetime distribution (Figure 2.38 A, FLIM: Dendra2). Foci 
of Drebrin-Dendra2 as well as foci of colocalized Aβ1-42 and Drebrin-Dendra2 did not exhibit a decreased 





Figure 2.38: DBN-Dendra2 does not show fluorescence lifetime reduction in the presence of Aβ1-42 
(A) Both left panels display representative confocal images of day 4/5 old nDBNS647A nematodes. Dendra2 
and wrmScarlet fluorescence are merged and the scale bar represents 20 µm. On the right, the 
corresponding FLIM images are shown of either Dendra2 or wrmScarlet fluorescence. White arrows 
point to Drebrin-Dendra2 positive foci. (B) Histogram showing the average fluorescence lifetime 






























The corresponding histogram displaying the abundance of certain fluorescence lifetime pixels, 
exhibited a bell-shaped curve with its peak at approx. 3.1 ns, accounting for a single species of 
probably monomeric Drebrin-Dendra2 (Figure 2.38 B). 
wrmScarlet-Aβ1-42 foci on the other hand exhibited reduced fluorescence lifetime, accounting for 
aggregated material (Figure 2.38 A, FLIM: wrmScarlet). Interestingly, the majority of observed foci that 
were colocalized with Drebrin, exhibited aggregated Aβ1-42. In FLIM experiments with JKM2 nematodes, 
foci formation was observed to be independent from aggregation – not all observed foci exhibited a 
reduced fluorescence lifetime. Yet, it seems that DBNS647A drives Aβ1-42 aggregation upon colocalization. 
Since a quantification was not performed, I cannot reject nor verify this hypothesis at the moment.  
 
Drebrin overexpression ameliorates Aβ1-42 aggregation 
To analyse the influence of Drebrin overexpression on Aβ1-42 aggregation and to evaluate the impact of 
pSerine-647, FLIM analyses of nDBNwt, nDBNS647A, nDBNS647D and JKM2-∆ have been performed on 
days 3, 4, 7 and 10 of life. Thus, the change of aggregation over time could be resolved starting with a 
young animal in L4 larval stage (day 3) to an old animal after its fecund period (day 10) (Figure 2.39 and 
Figure 2.40).  
No differences were observed for day 3 old nematodes. Nearly all Aβ1-42 was evenly distributed 
throughout the cytosol of the analysed neurons, not forming foci nor exhibiting aggregates (Figure 2.39). 
The average fluorescence lifetime was equal for all analysed strains at approx. 2.7 ns (Figure 2.40). No 
change of fluorescence lifetime was detected compared to day 4, yet IL2 neurons exhibited the first 
aggregates in more than 85% of the analysed nDBNS647A and JKM2-∆ nematodes, whilst less than 70% 
of the analysed nDBNS647D and nDBNwt nematodes exhibited the early aggregates in IL2 neurons (see 
white arrows and indicated fraction of IL2 neurons bearing aggregates in Figure 2.39). 
A significant increase of aggregation was observed in nDBNwt, nDBNS647A and JKM-∆ on day 7 of life 
(Figure 2.40). Only in nDBNS647D, the Serine-647 phospho mimicry variant, the aggregation was 
significantly ameliorated. There was no change from day 4 to day 7 detected in nDBNS647D. Nevertheless, 
on day 10 of life all nematodes regenerated apparently. I assume that a major survivorship bias occurred 
skewing the day 10 data towards lower aggregate burden.  
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Therefore, day 10 data were omitted from further contemplation. Considering the reduced early-onset 
aggregation on day 4 of life and the overall reduced amyloid burden in nDBNS647D nematodes at day 7 




Figure 2.39: Drebrin overexpression ameliorates Aβ1-42 aggregation 
Representative FLIM images of nDBN variants crossed with nAβ were recorded on days 3, 4, 7 and 10 
of life. White arrows point to IL2 neurons exhibiting the first aggregates on day 4 of life. Fraction of 
nematodes exhibiting first aggregates is provided as rounded values (IL2 aggregation). One to three 

















Figure 2.40: Aβ1-42 aggregation is modulated by Drebrin 
Scatter dot plot displaying the fluorescence lifetime of wrmScarlet-Aβ1-42 in JKM2-∆ (red), nDBNwt (green), 
nDBNS647A (blue) and nDBNS647D (orange) on days 3, 4, 7 and 10 of life. One - three individual cohorts of 
10 - 15 nematodes each were recorded. Mean ± SD is displayed. Significance was tested with two-way 
ANOVA + Bonferroni post hoc test (∗∗∗  =  p < 0.001). 
 
Alleviation of Aβ1-42 toxicity is regulated by DBN-pS647 
After the evaluation of aggregation in the Drebrin variant strains crossed with nAβ, a characterization of 
systemic impairments and neurological defects was intended to correlate the progression of 
aggregation and toxicity. As read-out for general organismal fitness the brood size as well as the 
lifespan of nDBNwt, nDBNS647A, nDBNS647D and JKM2-∆ have been analysed.  
Previous experiments have shown that neuronal expression of Aβ1-42 reduces the number of vivid 
progeny per nematode significantly (Figure 2.12 A; nAβ/JKM2: 108 ± 57). A rather moderate, yet 
significant reduction was observed for the depletion of endogenous dbn-1 (Figure 2.30 A; 
∆dbn-1/JKM1: 232 ± 28). The crossing of both strains, JKM2-∆, exhibited a, compared to wild type, 
reduced brood size of 136 ± 46 progeny per nematode (Figure 2.41 A). It appeared that both genotypes 
combined do not work in a synergistic way. Yet it is difficult to evaluate, because the relative reduction 
of brood size of JKM1 is hardly larger than the standard deviation of the corresponding reduction of 
JKM2.  
The expression of wild type Drebrin led to a slight improvement of progeny count, whilst both, phospho 
































two different mechanisms that are maybe loosely, possibly not at all connected: brood size reduction 
due to a still unknown mechanism directly triggered by DBN-1 depletion and brood size reduction due 
to increased proteotoxic / oxidative stress by Aβ1-42 overexpression. The overexpression of human 
Drebrin de/phospho mimicry variants seem to be not able to rescue any of these possible mechanisms 
and therefore, the fecundity remains reduced.  
The lifespan was analysed as a second read-out of organismal fitness (Figure 2.41 B). Yet, depletion of 
DBN-1 did not reduce the lifespan under unstressed conditions in previous experiments (Figure 2.30 B). 
The lifespan of JKM2-∆ (maximum life expectancy: 20 days, median survival: 9.2 days) was significantly 
reduced compared to wild type (maximum life expectancy: 30 days, median survival: 18.2 days). The 
expression of dephospho mimicry Drebrin (nDBNS647A) in nAβ nematodes did only have a subtle, not 
significant effect rescuing lifespan (maximum life expectancy: 22 days, median survival: 9.8 days). 
nDBNwt prolonged maximum life expectancy (25 days) and median survival (12.5 days) significantly 
compared to JKM2-∆. An even stronger increase of lifespan was observed for nDBNS647D (maximum life 
expectancy: 30 days, median survival: 16.7 days). Hence, Drebrin overexpression seems beneficial for 
the nematodes by possibly counteracting proteotoxic and oxidative stress induced by Aβ1-42. I assume, 
that phosphorylation of Serine-647 plays a key role in regulating the stress compensation, as both, wild 
type Drebrin (that can become phosphorylated upon stress) and the phospho mimicry Drebrin, 
significantly alleviate lifespan reduction as well as ameliorate the aggregate burden, as was shown in 
the FLIM experiments (Figure 2.39 and Figure 2.40). Therefore, a direct correlation between amyloid 
burden and lifespan reduction can be concluded that is regulated by Drebrin-S647 phosphorylation. 
To further analyse if Drebrin exerts also benefits towards neuroprotection in vivo, chemotaxis to volatile 
odorants and pathogen avoidance were tested. Avoiding pathogenic S. marcescens is mediated mainly 
by URY neurons and a defective reaction, hence, indicates neuronal defects. nAβ as well as JKM2-∆ 
exhibited impaired pathogen avoidance towards S. marcescens (Figure 2.22 A and Figure 2.42 A). The 
overexpression of Drebrin variants did improve pathogen avoidance slightly, yet a significant benefit 
was only observed for nDBNS647D. The constitutive phosphorylation mimicry was also significantly more 





Figure 2.41: Drebrin overexpression has systemic beneficial effects on Aβ1-42 expressing nematodes 
(A) Scatter dot plot displaying the progeny count per nematode of the indicated strains as mean ± SD. 
15 - 20 nematodes were analysed per strain. Significance was tested by one-way ANOVA + Bonferroni 
post hoc test (∗∗∗  =  p < 0.001). (B) Kaplan-Meier plot of the cumulative survival probability of JKM2-∆ 
(red), nDBNwt (green), nDBNS647A (blue) and nDBNS647D (orange) and wild type (N2; black) nematodes is 
displayed. 95 - 105 nematodes were analysed per strain. Significance was tested by log-rank test          
(∗∗∗  =  p < 10-6). 
 
Detection of volatile odorants such as Benzaldehyde, Diacetyl or diverse alcohols are vital functions for 
free living nematodes to find food, evade toxic environments etc.. Yet, these detections rely on a whole 
array of sensory neurons. Among them, AWC neurons are suitable to detect Benzaldehyde and resolve 
an attraction behaviour response. In previous experiments, overexpression of Aβ1-42 in neurons was 
observed to negate the nematode’s ability to sense diluted Benzaldehyde (Figure 2.22 B).  
The depletion of endogenous DBN-1 did not alter this phenotype, as JKM2-∆ nematodes exhibited no 
attraction behaviour towards diluted Benzaldehyde (Figure 2.42 B). The co-expression of Drebrin 
nevertheless, was able to rescue attraction behaviour to certain extent. nDBNS647A induced a minor 
response that was exceeded by the response observed in nDBNwt and nDBNS647D. Between nDBNwt and 
nDBNS647D there was no significant difference, yet both strains exhibited a solid attraction towards 
diluted Benzaldehyde. All analysed strains reliably avoided pure Benzaldehyde, exhibiting a not 





























































Figure 2.42: Drebrin overexpression improves neuronal function in nAβ 
(A) Scatter dot plot displaying the avoidance reaction index of JKM2-∆ (red), nDBNwt (green), nDBNS647A 
(blue), nDBNS647D (orange), wild type (N2; black) and IG10 (tol-1; dark green) nematodes towards OP50 
or Db11 bacteria. Three independent cohorts with 3 - 5 replicates of 10 - 15 nematodes each were 
analysed per strain and condition. Plotted is mean ± SD. Significance was tested with two-way ANOVA 
+ Bonferroni post hoc test (∗  =  p < 0.334, ∗∗∗  =  p < 0.001). (B) Scatter dot plot displaying the 
chemotaxis index of the indicated strains towards pure Benzaldehyde (100%) or diluted Benzaldehyde 
(1%). Three independent cohorts with 3 - 5 replicates of 50 - 100 nematodes each per strain and 
condition were analysed. Plotted is mean ± SD. Significance was tested with two-way ANOVA + 







































































Drebrin overexpression appeared to be generally beneficial for the preservation of neuronal functions, 
yet the degree of rescue remained different for all analysed functions. Diverse factors that might 
influence the degree of rescue for certain neurons or certain functions remain elusive and need further 
research. Even though the discrepancies between the three employed Drebrin variants (wild type, 
S647A and S647D) was miniscule for some of the analysed phenotypes (e.g. pathogen avoidance 
assay) a general trend was observed, that Serine-647 phosphorylation was a vital part of Drebrin 
regulation and that phosphorylation was associated with an alleviation of AD toxicity in the here 












In the following chapters the three presented projects shall be discussed separately. Yet, I would like 
to emphasize that they are tightly connected to each other. Drebrin plays a vital role in the regulation of 
synapse stability that is compromised in Alzheimer’s Disease. Still, the regulation of Drebrin itself and 
especially the mechanisms leading to its depletion in AD patients’ brains remain enigmatic.  
The Aβ pathology elicits toxicity affecting a myriad of cellular processes that ultimately lead to 
neurodegeneration (Figure 3.1), yet I would like to discuss some of them, involving Drebrin, in the 
following chapters in further detail. 
 
Figure 3.1: AD perturbs multiple layers of cellular integrity 
Schematic overview depicting a selection of dysregulations evoked by Alzheimer’s Disease. The blue 
box contains a proposed mechanism how Aβ1-42 aggregation and Drebrin depletion contribute to 
neurodegeneration. Aβ and reactive oxygen species (ROS) are affecting each other in a feed forward 
loop increasing pathogenicity. Both elicit multiple disturbances (e.g. damaging of membranes, damaging 
of F-actin fibres). Damaged membranes are leaking Ca2+ that in turn induces a Drebrin exodus from 
dendritic spines, followed by a destabilization of F-actin. Yet, Drebrin regulation is more complex than 
indicated here and Ca2+ imbalance is only one factor affecting Drebrin localisation and activity. 
The yellow box contains a list of other dysregulations evoked by AD. The processes in the blue and in 
the yellow box are complexly interlaced which is indicated by overlapping of the boxes. All listed 



















• impaired cell signalling
 
• gene expression deregulation
 





A novel model for studying Alzheimer’s Disease in vivo 
 
The present thesis presents a novel C. elegans model of Alzheimer’s Disease that overcomes several 
obstacles of previous models. The strain JKM2 is the first AD model in C. elegans that exhibits Aβ1-42 
derived toxicity and enables non-invasive, in vivo and in situ analysis of aggregates by employing 
fluorescence microscopy.  
A set of most widespread AD models in C. elegans expresses a truncated version of Aβ of only 40 
amino acids length that is described as being less toxic than full length Aβ1-42 211,222. Furthermore, only 
mild toxicity was observed in those models while JKM2 (neuronal expression of Aβ1-42) and JKM7 (body 
wall muscle expression of Aβ1-42) exhibit a multitude of disease related phenotypes (e.g. median lifespan 
reduction: JKM2 - 51% vs. CL2355 - 20% 231). Yet most importantly, JKM2 and JKM7 are fluorescently 
labelled in a sub-stoichiometric manner that does not perturb native fibril growth while previous models 
that aimed to establish Aβ-GFP fusions were only forming oligomers in vitro and did not form foci in vivo 
at all 213. 
 
“Native” aggregation of fluorescently labelled Aβ1-42 
One of the main questions of this project was how I could trace amyloid formation in vivo in a non-
invasive manner. For this purpose, I have conceived a model of sub-stoichiometric expression, where 
the majority of untagged Aβ1-42 can fibrilize into “native” amyloids unperturbed, while a seamlessly, sub-
stoichiometric incorporation of fluorescently tagged wrmScarlet-Aβ1-42 labels those fibrils. For amyloid 
in vitro studies sub-stoichiometric labelling by employing a defined ratio of fluorescently tagged and 
untagged moieties is a well-accepted method 228,242. To translate this approach in vivo, the less efficient 
translation initiation by an internal ribosome entry site on a bicistronic expression vector was 
exploited 243,244. By expressing wrmScarlet-Aβ1-42 with and without excess Aβ1-42 I could show, that the 
overexpression of an untagged variant is a prerequisite for amyloid formation as well as for Aβ1-42 
derived toxicity in the nematodes. On one hand, this is a confirmation of previous studies 213, on the 




Aβ1-42 aggregation and toxicity aggravate in the progression of ageing 
The second question was how ageing would affect amyloid formation. Yet, I could observe that 
aggregation increased in the progression of ageing forming more and more widespread aggregates.  
Age-dependent decline of proteostasis capacity is regarded as a major driver of cellular dysfunction 
and degeneration 19,245,246. The exact reasons why proteostasis capacity becomes reduced in mammals 
upon ageing remains unknown, yet one assumption is that lack of evolutionary pressure beyond the 
fertile phase gives rise to mutations limiting an organism’s health- and lifespan.  
This is fundamentally different in C. elegans, where a major reorganization of proteostatic capacity 
occurs on day 4 of life, reducing proteostasis in favour of fecundity 226,227. The observation that both 
JKM2 and JKM7 exhibit their first aggregates at day 4 of life confirms previous studies and is also an 
indication, that failing proteostasis is a key mechanism leading to amyloid growth in vivo. 
To further address this, genetic variations of slow or fast ageing (daf-2, age-1, daf-16 etc.) could be 
crossed with the Aβ1-42 expressing strains to further analyse how Aβ1-42 aggregation propensity is altered 
due to the programmed proteostasis collapse. Furthermore, a genetic deletion of the master regulator 
of this programmed decline (cbd-1) can be employed to untangle Aβ1-42 intrinsic aggregation propensity 
and additional aggregation propensity due to reduced proteostasis capacity 247. 
 
Aβ1-42 elicits systemic defects and spreading toxicity 
I hypothesized that progressive aggregation of Aβ1-42 would elicit multiple disease related phenotypes 
that could be observed in the novel nematode model. Previous model strains could only show a subset 
of mild disease phenotypes. 
I observed a multitude of disease related phenotypes in both JKM2 and JKM7 nematodes, ranging from 
systemic defects to neuron-specific impairments as well as perturbations of the cellular ultrastructure 
(see overview Figure 3.2). Despite the mainly intracellular localization of the expressed Aβ1-42, these 
novel models, JKM2 and JKM7, are appropriate to analyse the traits that lead to AD, as well as to 
support studies in finding key players in aggregation regulation etc.. For one, there is evidence that 
Aβ1-42 can be localized in neurons despite its secretion into the intercellular space 32,69,248 and interact 
with the intracellular proteome. Furthermore, Aβ1-42 was observed to inhibit proteasomes in vivo and it 
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was concluded to be localized inside the cytosol 39–41. JKM2 and JKM7 therefore can serve as tools to 
analyse Aβ1-42–protein interactions in the cytosol. 
One AD related phenotype that was observed in both Aβ1-42 expressing model strains, but was most 
prominent in the muscle expression strain, was the accumulation of amphisomes. The ultrastructure of 
neurons of AD patient brain slices were analysed by TEM and immune-gold labelling in previous studies 
and multivesicular bodies were enlarged 85 or found to exhibit striking similarity to pre-lysosomal 
autophagic vacuoles 249. In the present study, I can confirm this phenotype, yet found in muscle cells 
expressing Aβ1-42. I hypothesized that iterative induction of autophagophores and subsequent failing of 
membrane closure could be a reason for the detected dysfunctional autophagy and result in the 
observed matryoshka-like amphisome clusters. It was previously reported that increased autophagy 
induction in CA1 neurons of AD hippocampi overburdens lysosomal degradation machinery 86. Yet, the 
data suggest that the underlying mechanism of Aβ1-42-induced perturbation of autophagy is cell-type 




Figure 3.2: Schema of the observed phenotypes in the novel AD model strains 
Listed phenotypes belong to the indicated categories, some of them are at the conjunction of categories 
to indicate that they are relevant for both. 
age-related
    progressive 







    chemotaxis
neurite deterioration
first aggregates in IL2 neurons




Furthermore, deregulation of the protein degradation machinery together with depletion of protein 
synthesis, poses a major threat for maintaining proteostasis. I assume that chaperones are either target 
for deregulation too or that they are overwhelmed by possible client abundance. Hence, analysis of the 
different chaperone systems (e.g. Hsp-70/J/110, Hsp-90, etc.) pose a promising approach to 
understand the mechanisms underlying the deregulation as well as finding drug target candidates that 
could ameliorate the AD toxicity. 
I could show that Aβ1-42 leaves its tissue of expression and gets excreted into the pseudocoelom by a 
yet unknown mechanism. There, it can travel through the whole nematode and possibly evoke damage 
at distant sites. Also, coelomocytes accumulate Aβ1-42 in phagocytic vacuoles. This active uptake can 
be regarded as a proto clearance mechanism (a primordial clearance system that may have changed 
and improved due to evolution) and could possibly be employed as a model for Aβ1-42 uptake, as was 
observed for glial cells of the human brain. Furthermore, Aβ1-42 was observed to damage membranes 
and compromise membrane integrity by employing a hypodermal Ca2+ leakage marker, corroborating 
results described by Julien et al. who observed that Aβ1-42 is able to incorporate into membranes and 
form pore-like structures that cause a permeation and challenge cellular repair mechanisms 103.  
Furthermore, I could demonstrate that Aβ1-42 can be transmitted to distant tissues (e.g. hypodermis) by 
a yet unknown mechanism. Since membrane damage and crossing over single membranes could be 
observed, I reason that Aβ1-42 transmission works in a cell non-autonomous way. Yet, I cannot exclude 
that besides the passive membrane rupture/crossing mode a second or even further transmission 
modes exist that may require cellular machineries to facilitate transport (e.g. endosomal trafficking, 
endo- and exocytosis). For instance, such transport was described for another proteotoxic protein, 
alpha-synuclein, the pathogenic protein forming ‘Lewy bodies’ termed aggregates in Parkinson’s 
Disease 250.  
Yet, the discovery of Aβ1-42 spreading in a nematode model paves the way for more detailed analysis of 
Aβ1-42 transport and transmission compared to the more static analysis in other model systems that 





Upon analysing the characteristics of the new model systems, an interesting divergence in population 
fitness was observed. I hypothesized that there is a survivorship bias occurring. Nematodes that were 
more strongly affected by Aβ1-42 expression had a high chance to die prematurely (with a median of 8.8 
days, nearly half of the population of JKM2 would have died by day 7 when the assay was performed), 
therefore the apparent mean was increased. I suspect a mechanism of Darwinian selection of the fittest 
to evoke the observed divergence. Nematodes that acquired a mutation lowering the Aβ1-42 expression 
or aggregation propensity would achieve an improved fitness compared to their cohort and would 
subsequently pass these mutations on to the next generation. Such adaptions can arise spontaneously 
with a rate of 2.2 × 10-7 per gene and generation by diverse mechanisms 251–253. Furthermore, 
overexpression of Aβ induces constant oxidative and proteotoxic stress 104–106, that in turn may increase 
mutation rates due to oxidation of nucleobases 254–256. Eventually, mutations can arise that allow 
nematodes to cope with the proteotoxic stress by Aβ1-42.  
Such selection processes can occur in all thinkable nematode models, yet, JKM2 and JKM7 are 
fluroescently tagged, enabling a consequent counterselection approach by selecting only nematodes 
exhibiting a constant level of fluorescence. On the other hand, the fluorescence intensity is a phenotypic 
marker that is easiliy detectable and quantifiable, rendering the model suitable for mutation screening 
approaches to identify new beneficial mutations. 
 
IL2 neurons harbour the first aggregates and could serve as starting point for disease 
spreading 
I was assuming that neurologic impairments would occur in the novel AD model strains, yet it was 
unclear to which extent single neurons would be affected. 
The first Aβ1-42 aggregates that appeared in JKM2 nematodes occurred reliably in a distinct set of head 
neurons of the anterior ganglion, the IL2 neurons. Furthermore, the onset of aggregation in the IL2 
neurons preceded the aggregation in other neurons. 	
Two questions arose from this observation: (1) are those neurons more susceptible to proteotoxic stress 
and harbour therefore the first aggregates and (2) are amyloids spreading from those neurons, triggering 
aggregation at distant sites? I could show that an IL2 specific knockdown of Aβ1-42 led to not only an 
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expected reduction of aggregation inside IL2 neurons themselves, but also decreased aggregation 
systemically. In consequence, this resulted in a temporary alleviation of AD toxicity. Yet, the knockdown 
could not completely prevent disease progression, but delayed the onset systemically. Also, it is not 
clear yet if a direct transmission of Aβ1-42 from IL2 to other neurons was responsible for initiating an 
aggregation cascade or whether a signalling pathway was activated in IL2 neurons that led to 
modulation of aggregation propensity in other neurons. With respect to the observation of Aβ1-42 
spreading to the hypodermis I assume that neuron-neuron spreading might contribute to AD 
progression in the generated model strain JKM2. 
The question remained if IL2 neurons were more susceptible to proteotoxic stress than other neurons 
and if so, what factors contribute to this predisposition. Previous experiments and studies on other 
disease related amyloid proteins (e.g. polyQ, Tau or alpha-synuclein) have led to the identification of 
differently affected tissues and cell types. Alpha-synuclein for instance, was described as mainly 
affecting dopaminergic neurons and causing dopaminergic neuron degeneration, being a hallmark of 
Parkinson’s Disease 195. The aggregation of huntingtin in Huntington’s Disease is affecting multiple 
regions of the brain, ultimately leading to degeneration of the striatum and death by respiratory 
paralysis. A simple model that expressed only the aggregation-prone poly-glutamine stretch of 
huntingtin in different tissues revealed motor neurons as primarily affected from aggregation and 
aggregation-derived toxicity, yet, without further discrimination of distinct neurons 257. The expression 
of FTDP-17 as model for tauopathies led to the discovery of a uniform pan neuronal aggregation in 
C. elegans 204. Thus, the affected cells and brain areas seem to be inherently dependent on the nature 
of the amyloid protein on the one hand. Furthermore, a high enough detection sensitivity and resolution 
is crucial to uncover early onset aggregation, as could be shown for IL2 neurons in JKM2. I assume that 
the early onset of Aβ1-42 aggregation in IL2 neurons reflects a specific pattern of aggregation and 
pathology. 
The IL2 neurons have been described as polymodal/mechano-/chemo-sensory neurons in the dauer 
stage, where they mediate nictation, a dauer-specific dispersal behaviour 258. In adult nematodes their 
function is still unknown 259,260. They belong to the cholinergic neurons, employing acetylcholine as 
neurotransmitter and harbouring a homologous nicotinic acetylcholine receptor as well as 
neuropeptide Y like receptors 261–263. The cholinergic system was described as one of the targets of 
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Alzheimer’s Disease pathology in the human brain, where presynaptic cholinergic markers of the 
cerebral cortex were observed to be depleted 264,265. The nucleus basalis of Maynert in the basal 
forebrain belongs to the major sources of cortical cholinergic innervation and was found to be severely 
affected from neurodegeneration in AD patients 266,267. Further experiments showed, that cholinergic 
agonists (such as acetylcholine esterase inhibitors) were beneficial for patients suffering from AD 
demonstrating a strong correlation between the function of cholinergic innervation and AD induced 
neurodegenerative effects 268,269. 
C. elegans possesses 159 cholinergic neurons (neurons positive for unc-17 cholinergic marker 270) out 
of 302 neurons in total. Yet, I cannot pinpoint what renders IL2 neurons particularly vulnerable for the 
aggregation of Aβ1-42. IL2 neurons are discussed to participate in chemotaxis and olfaction what is an 
interesting parallel to observations of AD patients that suffer from anosmia and mouse experiments that 
analyse chemotactic neurons of the olfactory bulb. A volume reduction of the olfactory bulb was 
demonstrated in AD patients by brain imaging techniques and the loss of olfaction capacity preceded 
clinical AD pathologies 271–273. Recent studies have observed, that Aβ1-42 can be transported 
anterogradely and retrogradely through axons of neurons, corroborating some results described in this 
thesis, that Aβ1-42 can passage across membranes and be transported along dendrites and neurons. In 
mouse experiments it could be shown that Aβ1-42 oligomers that were injected into the olfactory bulb 
were actively taken up by the surrounding neurons and transported alongside the axons to distant brain 
regions, providing an efficient dispersal mechanism 274–276. Hence, such mechanisms could be studied 
employing JKM2 or by refining the expression by limiting it to IL2 neurons and follow Aβ1-42 spreading 





Concluding remarks and limitations 
Taken together, the novel model systems JKM2 and JKM7 provide a platform to analyse key features 
of the Aβ1-42 pathology. Many characteristic aberrations that occur in AD patients or experiments with 
murine tissue were observed and can be correlated to the progressive aggregation of Aβ1-42. 
Furthermore, the ability to track amyloid growth in vivo and in situ was a prerequisite to identify IL2 
neurons as particularly vulnerable to Aβ1-42 aggregation and may further represent an initiation site for 
amyloid spreading or a yet unknown, transcellular signalling, eliciting amyloid formation in distant 
neurons. 
Yet, the generated models focus on the Aβ1-42 pathology and do not reflect on the dynamic nature of 
different Aβ species of different lengths. Previous studies suggested that Aβ1-42 poses the major toxicity 
in the AD pathology and other species, among them Aβ1-40, could be negligible 21–23. Also, the generation 
of different Aβ-species as well as tau pathology were not considered. Yet, this simplifies analysis 
because many cross reactions that would otherwise occur, are excluded. 
Furthermore, reactivity with different cell-types can be analysed, yet the nematode’s nervous system 
architecture differs in multiple ways from the human brain. For instance, glia cells exist and serve certain 
functions (e.g. promotion of directed neurite growth, promotion of synapse formation, modulation of 
synapse activity, etc.) they share with human glia cells, while other functions do not exist in nematodes 
(e.g. myelination of axons, supplying nutrients to neurons).  
Yet, these limitations also offer possibilities to analyse certain interactions in a simple way without 






A humanized model of Drebrin overexpression in C. elegans 
 
The actin-binding protein Drebrin was thought to stabilize F-actin filaments, bundle them and protect 
synapses by this process. Interestingly, Drebrin knockout mice exhibited no physiological changes to 
its neurons, brain or behaviour (personal communication Dr. Till Mack, 2019). Only after induction of a 
further stressor (e.g. oxidative stress) a stronger synapse deterioration could be observed, indicating 
that Drebrin loss sensitized the affected neurons to oxidative stress 179. Multiple layers of regulation are 
influencing Drebrin activity and I was interested, if nematode signalling pathways could regulate Drebrin 
in a similar way. 
C. elegans DBN-1 protein shares structural homology with two human proteins serving different 
functions and occurring in different tissues: Drebrin (DBN1) in neuronal and motile cells and Drebrin-
like protein (DBNL) in immune and other motile cells. It is tempting to speculate if DBN1 and DBNL are 
paralogs that originate from an ancestral gene like C. elegans dbn-1 but diverged in the progression of 
evolution to fulfil different, yet homologous functions. My results amend previous studies observing that 
dbn-1 is expressed in multiple tissues, among them body wall muscle cells, pharyngeal muscle cells 
and neurons (see Figure 2.31) 217,218. Since I was most interested in the effects of Drebrin in neurons, I 
decided to employ the rgef-1 promoter to achieve pan neuronal expression rather than employing the 
endogenous dbn-1 promoter to exclude cross reactivity through Drebrin overexpression in other 
tissues.  
The following part is dedicated as complementation and corroboration of work done by our cooperation 
partners of the Eickholt lab that were analysing Drebrin overexpression in neuronal cell culture. 
 
Drebrin turn-over is regulated by pSerine-647 
Since Drebrin depletion sensitized neurons to oxidative stress and led to reduced number of dendritic 
spines, while overexpression of Drebrin ameliorated oxidative stress and led to an increase in Dendritic 
spines, it was assumed, that Drebrin protein level may play a pivotal role in actin orchestration and 
stabilization to prevent synapse loss in response to oxidative stress. Our cooperation partners of the 
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Eickholt lab observed that phosphorylation of Serine-647 is crucial for the regulation of Drebrin turn-
over by proteasomal degradation 178,179. 
Wild type Drebrin was observed to have a half-life of approximately 3 days (75 ± 8 h) while DBNS647A 
exhibited an increased protein turn-over (39 ± 3 h). DBNS647D exhibited a yet not significant slower turn-
over (97 ± 16 h) 179. I could not corroborate these observations in nematodes. The protein turn-over 
rates vary between individual neurons. Yet a major discrepancy was observed between head and tail 
neurons. Complete degradation of a marked protein pool was observed in head neurons after 24 h, 
while the degradation in tail neurons was much faster, removing the same, marked protein pool in 
merely 3 h (personal communication Dr. Diogo Feleciano, 2018). Due to these obstacles, a 
quantification of Drebrin degradation in vivo would require a focused approach, where only a subset of 
neurons one after the other is analysed to generate a neuronal degradation map of Drebrin. Yet, a faster 
approach would be the expression of Drebrin-Dendra2 limited to neurons that are interesting for the 
study of AD in nematodes (e.g. IL2 neurons + URY neurons for control). 
 
Drebrin-S647 is a target for ATM-1 phosphorylation 
Previous studies observed Drebrin-S647 phosphorylation upon neuronal stimulation 178 and predicted 
a phosphorylation site for ATM kinase 239. Yet, experiments employing activated ATM kinase and 
purified Drebrin could demonstrate an efficient phosphorylation of Drebrin-S647 in vitro, furthermore 
purified Drebrin could be phosphorylated at Serine-647 employing mouse brain extract 179. The 
phosphorylation of Drebrin-S647 could be efficiently blocked in both experiments, in vitro and ex vivo, 
by employing the specific ATM kinase inhibitor KU-55933 277, exemplifying that ATM was the kinase 
phosphorylating Serine-647 as well as, that ATM was present and active in postnatal brain tissue. 
ATM was reported to mediate cellular adaptions in response to DNA double-strand breaks, yet, recent 
studies identified a cytosolic ATM pool regulating redox signalling in response to oxidative stress 278. 
Neurons are highly metabolically active cells that produce reactive oxygen species by their normal 
activity 240. Ex vivo neuronal cell culture experiments employing agents to increase the synaptic activity 
were able to activate ATM as well as to increase the amount of Drebrin-pS647 179.  
To corroborate these results in vivo I employed a humanized nematode model expressing Drebrin pan-
neuronally (nDBNwt). The induction of constitutive oxidative stress by Paraquat application reduced the 
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nematode’s lifespan, yet this reduction was ameliorated by the overexpression of wild type Drebrin. 
Additional application of the specific ATM kinase inhibitor KU-55933 in turn, negated the benefits of 
Drebrin overexpression to rescue lifespan under oxidative stress conditions. Furthermore, western blot 
experiments showed that application of KU-55933 reduced the phosphorylation of Drebrin-S647, 
therefore KU-55933 was able to inhibit ATM-1 (the nematode homolog of ATM) activity at least partially.  
Drebrin-S647 phosphorylation appeared as an integral part of the stress response to ROS in neuronal 
cell culture 179 and the nematode experiments suggest that the basic stress response pathway remained 
conserved between nematode and human.  
Together with the data of de/phospho mimicry variants, this indicates, that the beneficial effect of 
Drebrin under sustained oxidative stress is mediated by Serine-647 phosphorylation. This is in turn 
dependent on ATM-1 kinase activity in nematodes as demonstrated by the inhibition of ATM-1 that did 
reduce Drebrin-pS647 levels and negated lifespan rescue, whilst phospho and dephosphy mimicry 
variants were uncoupled from ATM-1 regulation. Furthermore, ATM-1 inhibition in nematodes did not 
affect other players that would interfere with lifespan reduction under sustained oxidative stress. 
 
Proposed model for Drebrin regulation and its limitations 
Summarizing data from the literature and recent observations presented in this thesis, a model was 
proposed for the sequential mechanism of Drebrin dependent neuroprotection (Figure 3.3). 
Reactive oxygen species induce ATM kinase activation 278 that phosphorylates, among other proteins, 
Drebrin-S647 (Figure 2.34,179). Drebrin turn-over gets reduced and the Drebrin pool stabilized 179, leading 
to stabilization of F-actin filaments 152,153. Finally, this leads to protection of synapses in cell culture 
experiments 155,156,179,279 and exerts in nematodes systemically beneficial effects on lifespan (Figure 2.33). 
Yet, the observed stabilization of Drebrin due to phosphorylation at Serine-647 by ATM kinase poses 
only one layer of controlling Drebrin activity. Levels of Drebrin-pS647 are closely linked to 
dephosphorylation by PTEN 178. Previous studies observed that PTEN gets translocated upon NMDA 
receptor activation into dendritic spines in close association with PSD-95 being a major regulator of 
long-term depression 280. Further studies could show, that inhibition of PTEN in a mouse model of 
Alzheimer’s Disease could rescue normal synaptic function, yet this function was traced back to the 
localization change of PTEN to dendritic spines upon NMDAR activity 281. This is an appealing 
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observation towards Drebrin function and could, together with the results presented in this thesis and 
the corresponding publication by Kreis, Gallrein, Puente et al. 179, be a foundation to further investigate 
the Aβ1-42 - PTEN - Drebrin relationship. 
Besides Drebrin turn-over regulation by Serine-647, several other phosphorylation sites were observed 
by mass spectrometry experiments suggesting functions in regulating F-actin binding properties and 
activities contributing towards dendritic spine remodelling (e.g. Serine-142, a target of CDK-5 kinase, 
regulates F-actin bundling by specific binding of pS142-Drebrin to parallel F-actin filaments 151). 
Hence, several putative upstream signalling processes regulating Drebrin activity and turn-over may 
influence synaptic stabilization and neuronal health also under neurodegenerative conditions. 
On the other hand, the downstream activities evoked by Drebrin contribute to manifold processes, 
among them the regulation of F-actin dynamics that pose a crucial role for neuronal plasticity. 
Furthermore, adaption of cytoskeletal dynamics in stress or disease conditions may be a fundamental 











Figure 3.3: Proposed model of Drebrin activity 
Oxidative stress induces ATM activation 
leading to increased Drebrin-S647 
phosphorylation. The Drebrin pool gets 
stabilised and subsequently stabilises the 
F-actin filament leading to increased resilience 
towards oxidation damage 
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In vivo interaction between Drebrin and Aβ1-42 
 
Drebrin was observed to be depleted from human brains and cell culture experiments analysing both 
mild cognitive dementia and AD 145,146. To this point, a functional relationship between Drebrin and Aβ1-42 
was described for an AD mouse model, where a depletion of Drebrin led to a more severe AD 
phenotype, while an overexpression of Drebrin alleviated AD toxicity 148,149. Still, the description of a 
causal relationship between Drebrin and Aβ1-42 requires more research. Previous experiments observed 
that an increased activity of histone deacetylases induced by Aβ oligomers led to reduced Drebrin levels 
that could be rescued by the application of histone deacetylase inhibitors 285. Another study described 
a correlation between AD severity and decreased Drebrin mRNA expression 286. Yet, a clear link between 
Drebrin and AD or more specific, between Drebrin and Aβ1-42 remains elusive.  
 
Drebrin and Aβ1-42 can form foci 
Since Aβ1-42 can cross membranes and accumulate in the cytosol of neurons 53,54, this opens the 
possibility of a direct protein-protein interaction with Drebrin. In this study, I observed that Drebrin and 
Aβ1-42 could colocalize in micron-sized foci, yet the majority of Drebrin remained soluble and dispersed 
throughout the cytoplasm. Notably, the Aβ1-42-foci formation was reduced upon Drebrin co-expression 
but the amount of foci composed of aggregated Aβ1-42 was increased. Two different mechanism could 
induce such phenotype: (1) Drebrin could actively drive Aβ1-42 aggregation or (2) Drebrin could prevent 
accumulation of Aβ1-42 to a certain degree and therefore reduce the apparent foci load, yet being unable 
to prevent aggregation, leading to a changed ratio between foci consisting of aggregated material and 
foci consisting of non-aggregated material. Further experimentation would be necessary to prove the 
one or the other, yet it is tempting to speculate whether Drebrin could interact with Aβ1-42 monomers or 
oligomers via its natively disordered C-terminal domain and induce or prevent Aβ1-42 aggregation. 
Besides its actin-binding activity Drebrin can bind several other synaptic proteins to orchestrate 
construction of the post synaptic density 157,158 and thereby manipulate the close-by microenvironment. 
Yet, I cannot pinpoint how and by what mechanism Drebrin might alter Aβ1-42 foci formation in neurons 
of C. elegans. It could therefore be of particular interest to set up in vitro experiments to analyse a 
possible Drebrin-Aβ1-42 binding mode. 
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Drebrin overexpression alleviates Aβ1-42 pathology 
Despite the lack of a molecular mechanism, I could show that Drebrin overexpression is generally 
beneficial for Aβ1-42 expressing nematodes (Figure 2.40, Figure 2.41 and Figure 2.42). Both, general 
vitality (analysed by lifespan and progeny count) as well as neurologic integrity (analysed by chemotaxis 
and pathogen avoidance) were alleviated upon Drebrin overexpression.  
The foci formation in IL2 neurons was reduced in Drebrin expressing nematodes, with a stronger 
reduction for wild type and S647D-Drebrin compared to S647A-Drebrin or Aβ-∆ control. For all analysed 
phenotypes but one (brood size) a correlation between phosphorylation at Drebrin-S647 and improved 
behaviour was observed (see Table 3.1 for overview). Hence, regulation of brood size seems to be 
independent from the mechanism that alleviates the other analysed phenotypes. A similarly regulated 
mechanism might evoke the other analysed phenotypes dependent on phosphorylation of Drebrin-
S647. 
 
Table 3.1: Overview of the observed Drebrin-induced Aβ-toxicity alleviations 
Summary of the observed phenotypes of nDBN variant strains crossed with nAβ (∆dbn-1[Ex1-Ex6] background). Arrows 
indicate up and down regulation respectively, bold arrows indicate strong up/down regulation. 
 
 S647A S647 – wild type S647D 
Aggregation - - D 
IL2 foci formation - L D 
Lifespan - K C 
Progeny - K - 
Chemotaxis - K C 
Pathogen avoidance - K C 
 
Drebrin-S647 phosphorylation was observed to regulate Drebrin turn-over in neuronal cell culture 
experiments 179, showing such regulation for nematodes would require further studies. Yet, it would 
pose a plausible mechanism by which Drebrin is regulated and how it positively affects cellular functions 
compromised by Aβ1-42. Ultimately, the stabilization of the actin cytoskeleton could be one of the key 




Aβ1-42 alleviation is regulated by Drebrin-S647 phosphorylation 
The actin cytoskeleton plays a key role in many cellular processes ranging from protein trafficking, cell 
growth, structural organisation to cell motility and synaptic plasticity in neurons (reviewed by Svitkina 287 
and Sekino et al. 288). Modifiers of actin organization, treadmilling and connection are of pivotal 
importance for the regulation of diverse processes, as is Drebrin for organization and maturation of the 
post-synapse 289.  
Drebrin is depleted from neurons in AD patients, yet it is still unknown if aggregation of Aβ1-42 induces 
Drebrin-depletion or if an initial Drebrin-depletion paves the way for extensive Aβ1-42 aggregation. Most 
likely it is a coupled feedforward loop of mutual amplification of Drebrin-loss and AD toxicity.  
Previous studies could show that overexpression of Drebrin in a mouse model of AD led to a rescue of 
cognitive capacity and an alleviation of other disease related disabilities 149. The results presented in 
this thesis are corroborating those previous findings in a much simpler model system. Using the 
nematode certain questions should be easier to answer, for instance how the actin cytoskeleton is 
affected by AD and if Drebrin could be beneficial in this disease context. 
F-actin disassembly was observed as a major phenotype correlated with AD and thought to be crucial 
for synapse deterioration due to Aβ1-42 toxicity 280,281,290,291. Yet, multiple mechanisms are assumed 
involving endocytosis of neurotransmitter receptors, deregulation of actin-binding proteins and direct 
damaging of actin bundles by oxidation (Figure 3.4). Oxidation events at Cys-374 were observed to be 
initiated by NADPH oxidase contribution as a defined regulation of F-actin dynamics, decreasing 
polymerization rates and weakening filaments 292,293. Another regulator of F-actin dynamics exploiting 
oxidation is the [F-actin]-monooxygenase MICAL1. MICAL1 oxidizes Actin-M44 and Actin-M47 and 
thereby reduces polymerization rate and induces F-actin disassembly from both ends 294–296. 
Since the excessive generation of reactive oxygen species is a hallmark of the Aβ1-42 pathology such 
oxidation-dependent regulation mechanisms could turn into weak points paving the way for oxidation 
events evoking critical toxicity.   
F-actin stability regulating proteins can become deregulated in an AD context leading to a severe 
destabilization of filaments (e.g. ADF/Cofilin gets activated in AD in a Calcineurin dependent fashion 
and promotes F-actin destabilization 297–299). Drebrin is one of those proteins that are depleted in AD by 
a yet elusive set of interactions. PTEN phosphatase could be one part of this, getting translocated into 
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dendritic spines in Aβ1-42 treated neurons 280,281, inducing a close proximity to one of its putative targets, 
Drebrin-pS647 178. A Drebrin dephosphorylation at Serine-647 increases its degradation by the 
ubiquitin-proteasome system and thereby destabilizes synapses. 
Drebrin-S647 phosphorylation could be shown to have effects on most observed phenotypes in this 
study (Table 3.1). Hence, the regulation of Serine-647 phosphorylation poses a strong candidate for 
external interference.  
 
 
Figure 3.4: Actin cytoskeleton is crucial for synapse integrity 
F-actin plays a central role in both synapse integrity and synaptic plasticity being regulated by manifold 
players. Reactive oxygen species (ROS) can oxidize exposed residues and induce F-actin 
destabilization, while actin-binding proteins like Drebrin can bind to F-actin filaments and stabilize them. 
Yet such proteins are regulated by upstream factors, as is Drebrin by phosphorylation by Ataxia 
telangiectasia mutated (ATM) and dephosphorylation by Phosphatase and Tensin homolog (PTEN). 
 
 
Targeted activation of ATM or selective inhibition of PTEN could be promising drug targets for treating 
AD. The nematode model presented in this study could serve as a testing platform for compound 
screening or RNAi screening. Both identified regulators, PTEN and ATM could be addressed in the 
nematode as there are orthologues daf-18 for PTEN and atm-1 for ATM. RNAi or CRISPR-based 


















Conclusion and Outlook 
 
 
A novel model to study Alzheimer’s Disease 
 
Taken together, a novel Alzheimer’s Disease model was generated to analyse key features of the Aβ1-42 
pathology that enabled me to identify many characteristic aberrations occurring in AD patients or that 
were observed in experiments with murine neurons. This new model provides insight into amyloid 
aggregation in vivo and in situ in a non-invasive manner. Furthermore, it allowed me to identify the IL2 
neurons as particularly vulnerable to Aβ1-42 aggregation and may further represent an initiation site for 
amyloid spreading or a yet unknown, transcellular signalling cascade, eliciting amyloid formation in 
distant neurons or evoking proteostasis imbalances in distant cells. 
This model can serve for manifold succeeding experiments including analysis of signalling cascades, 
dysregulation of proteostasis or even large-scale screening approaches to identify yet unknown players. 
A few questions arose during this project that could not be answered yet. 
 
What are the mechanisms of amyloid spreading?  I could present evidence, that Aβ1-42 can spread 
to distant tissues, yet without knowing the exact mechanisms behind. One possibility was addressed 
by the analysis of membrane integrity, that was found to be compromised, being a passive Aβ1-42 
migration by passaging directly through membranes. Yet, I cannot exclude any mechanism that works 
in a cell dependent manner. 
Further studies addressing this question should consider analysis of subcellular compartment 
alterations, with special regard to endo/lysosomal vesicle transportation. Furthermore, analysing motor 
proteins (e.g. dynein, kinesin, non-muscle myosin) driving intracellular protein trafficking, as well as, 
regulators of protein transport.  
 
Why are IL2 neurons more vulnerable to Aβ1-42 aggregation?  To address this question, it seems to 
become necessary to generate even more AD model strains that exhibit differential expression (e.g. 
limited to cholinergic/glutamatergic/dopaminergic etc. neurons or limited to smaller subsets of 
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neurons). Expression profiles of IL2 neurons vs. other neurons could be generated to analyse clusters 
of altered gene expression that could induce vulnerability, that could be subsequently tested in other 
neurons. 
 
Is Aβ1-42 spreading from IL2 neurons towards other neurons?  To answer this question, it would be 
the easiest to generate a new model strain expressing Aβ1-42 (and sub-stoichiometric amounts of 
fluorescently tagged Aβ1-42) only in IL2 neurons and observe fluorescence dispersion. Furthermore, if 
labelled with a not-red fluorescent fluorophore and crossed with the initial JKM2 model (to combine 
wrmScarlet derived red fluorescence in all neurons and a different fluorescence in IL2 neurons), 
spreading from IL2 neurons could be correlated with the onset of aggregation in distant neurons. 
 
How are proteostasis mechanisms contributing to pathogenicity or prevention of pathogenicity?  
All aforementioned questions are connected to this fourth question, as the proteostasis regulation is 
vital for proper function of all cellular processes. Chaperones safeguard the proteome on all levels from 
protein biosynthesis to degradation and their functionality is essential to keep protein misfolding and 
aggregation in check. Yet, proteinopathies like AD are overwhelming chaperone capacities by various 
mechanisms. 
To analyse how the presence or absence of certain chaperones are contributing to disease progression 
and spreading, knockdown experiments could be performed to test a set of known chaperones (Hsp-
70s, J-proteins etc.). Furthermore, promising candidates that were alleviating or aggravating the Aβ 
toxicity could be overexpressed to complement the analysis. 
 
A model to study human Drebrin in the context of a living animal 
 
In the presented study, a humanized nematode line was presented that expresses human Drebrin 
pan neuronally that could compensate to a certain extent for the loss of endogenous dbn-1. 
Furthermore, Drebrin is regulated by phosphorylation of Serine-647 residue and can render the 
nematodes more resistant to oxidative stress. 
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How is Drebrin further regulated?  Multiple other phosphorylation sites have been identified or 
predicted to regulate Drebrin (e.g. Serine-142, Threonine-392 etc.) that are controlled by kinases and 
phosphatases of well conserved signalling pathways. Most of them with orthologues in the nematode 
that enable specific manipulation by depletion or overexpression of those regulatory proteins. 
 
How is Drebrin interacting with the actin cytoskeleton?  Drebrin can bind F-actin and bundle single 
strands to compact fibres, a pivotal mechanism of dendritic spine maturation and plasticity. Yet, the 
postsynaptic structures in nematode neurons do not exhibit dendritic spines, but patches that cluster 
proteins of the postsynaptic density. F-actin organization and regulation by Drebrin should be analysed 
in the nematode to understand, if they are comparable and follow conserved mechanisms for increasing 
and decreasing synaptic strength and therefore be a suitable tool to analyse synaptic plasticity and 
memory consolidation in the nematodes. 
 
A model to study the interaction of Drebrin and Amyloid-β 
 
A conjoined analysis of Drebrin and Aβ1-42 was carried out in the nematode model system. Yet, Drebrin 
overexpression could ameliorate Aβ1-42 toxicity with pSerine-647 dependent efficacy. A direct 
interaction between Drebrin and Aβ1-42 was observed as foci wise colocalization, but the majority of 
Drebrin was detected to not interact with Aβ1-42 aggregates. 
Yet, this study sets a starting point for future analyses of the Drebrin - Aβ1-42 interaction to address many 
more questions. 
 
Most of the questions that arose during the analysis of Aβ1-42 alone, as well as Drebrin alone, could be 
subject for further studies in conjunction with the respective other protein. Yet, most interestingly would 
be the question, how Aβ1-42 expression alters the neuronal proteome and gene expression profile and if 
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Coomassie Brilliant Blue R-250 Carl Roth, Karlsruhe, Germany 
DAPI Carl Roth, Karlsruhe, Germany 
Diacetyl Sigma Aldrich, St. Louis, USA 
Digitonin Sigma Aldrich, St. Louis, USA 
DMSO Carl Roth, Karlsruhe, Germany 
dNTP Mix 100 mM Thermo Fisher Scientific, Waltham, USA 
DTT Carl Roth, Karlsruhe, Germany 
Formaldehyde (37%) Carl Roth, Karlsruhe, Germany 
Gold powder 0.3-3 micron / 99.9% Chempur, Karlsruhe, Germany 
IPTG Thermo Fisher Scientific, Waltham, USA 
Isoamyl alcohol Carl Roth, Karlsruhe, Germany 
Kanamycin  Carl Roth, Karlsruhe, Germany 
KU-55933 (ATM kinase inhibitor) Sigma Aldrich, St. Louis, USA 
LB agar Serva, Heidelberg, Germany 
LB medium Carl Roth, Karlsruhe, Germany 
Levamisole AppliChem GmbH, Darmstadt, Germany 
Methanol Fisher Scientific, Schwerte, Germany 
Methyl viologen dichloride hydrate (Paraquat) Sigma Aldrich, St. Louis, USA 
Milk powder Carl Roth, Karlsruhe, Germany 
Nuclease free water Carl Roth, Karlsruhe, Germany 
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PMSF Sigma Aldrich, St. Louis, USA 
Polyvinylpyrrolidone Sigma Aldrich, St. Louis, USA 
RedSafe™ nucleic acid staining solution iNtRON Biotechnology, Freiburg, Germany 
Rotiphorese® Gel 30 (Acrylamid/Bisacrylamid Mix) Carl Roth, Karlsruhe, Germany 
Sodium azide Sigma Aldrich, St. Louis, USA 
Sodium hypochloride solution Fisher Scientific, Schwerte, Germany 
Spermidine Sigma Aldrich, St. Louis, USA 
Streptomycin Carl Roth, Karlsruhe, Germany 
TEMED Carl Roth, Karlsruhe, Germany 
Tetracycline Carl Roth, Karlsruhe, Germany 
Thioflavin T Sigma Aldrich, St. Louis, USA 
Triton X-100 Carl Roth, Karlsruhe, Germany 
Tween 20 Carl Roth, Karlsruhe, Germany 
VECTASHIELD® mounting medium with DAPI Vector Laboratories, Inc., Burlingame, USA 
 
Markers and loading dyes 
Product Company 
DNA loading dye (6x) Thermo Fisher Scientific, Waltham, USA 
GeneRuler™ 1kb Thermo Fisher Scientific, Waltham, USA 
GeneRuler™ 50bp Thermo Fisher Scientific, Waltham, USA 
PageRuler™ Plus Prestained Protein Ladder Thermo Fisher Scientific, Waltham, USA 
 
Enzymes 
Restriction Enzyme Company 
AgeI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 
BamHI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 
ClaI-HF  (+CutSmart buffer)  New England Biolabs, Ipswich, USA 
EcoRI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 
KpnI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 
NheI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 
SpeI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 
SphI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 
XhoI-HF  (+CutSmart buffer) New England Biolabs, Ipswich, USA 








Collagenase (Type IV) Sigma-Aldrich, St. Louis, USA 
FastAP Alkaline Phosphatase Thermo Fisher Scientific, Waltham, USA 
Phusion Polymerase Kirstein Lab 
Proteinase K Roche Diagnostics GmbH, Mannheim, Germany 





Antibody Origin Dilution Source !-Abeta (4G8)	 Mouse 1:1000 (WB), 1:100 (IHC) BioLegend, San Diego, USA !-Abeta (6E10) Mouse 1:1000 (WB), 1:100 (IHC) BioLegend, San Diego, USA !-DBN-1 	 Rabbit 1:1000 (WB) Klopfenstein Lab !-Drebrin (M2F6) Mouse 1:2000 (WB) Enzo Life Sciences, Farmingdale, USA !-GFP (B34) Mouse 1:2000 (WB) Enzo Life Sciences, Farmingdale, USA !-alpha-Tubulin Mouse 1:2500 (WB) Sigma Aldrich, St. Louis, USA !-LGG-1	 Rabbit 1:1000 (WB) Kirstein Lab (Pineda Antikörper-Service, 




Antibody Origin Dilution Source 
Goat-Anti-Mouse IR 680 Goat 1:1000 (IHC) LI-COR, Lincoln, USA 
Pierce®-Goat-Anti-Mouse 
IgG + IgM (H+L) Peroxidase 
Conjugated 
Goat 1:2000 – 1:5000 (WB) Thermo Fisher Scientific, 
Waltham, USA 
Pierce®-Goat-Anti-Rabbit 
IgG (H+L) Peroxidase 
Conjugated  







Product Name Company 
ECL Detection Kit Pierce ECL Western Blot Substrate Thermo Fisher Scientific, Waltham, 
USA 
Gel extraction Qiaquick Qiagen, Hilden, Germany 
Gibson cloning Gibson Assembly®  New England Biolabs, Ipswich, 
USA 
Plasmid isolation for 
cloning and 
sequencing 
NuceloSpin Plasmid Mini Macherey-Nagel, Düren, Germany 
Plasmid isolation for 
micro injections 
ZR Plasmid Miniprep™-Classic Zymo Research Europe GmbH, 
Freiburg, Germany 
Western blot Trans-Blot® Turbo™ Mini PVDF Transfer Packs BioRad, Hercules, USA 
 
Primer 
All sequences are given in 5’-end --> 3’-end direction. 
 
Primer for cloning 
Primer working concentration stocks were 10 mM; 200 - 400 nM were used for PCRs. 
Primer name Sequence 
k_ceDBNProm - f CTCAAGTCTAGAACGCTGTGAGCACTGGTGAC 
k_ceDBNProm - r CTCAGGATCGATCTGGAACACATACAATATAGGGTTC 
k_ClaI-DBN-YFP - f CTCAAATCGATATGGCCGGCGTCAGCTTC 
k_NheI-DBN-YFP - f CTAAGCTAGCATGGCCGGCGTCAGCTTC 
k_DBN-YFP-EcoRI - r CTCCAGAATTCTTACTTGTACAGCTCGTCCATGC 
k_hDrebrin-AgeI--rev CTCACCGGTATCACCACCCTCGAAGCCCTC 
k_SphI-B3.3Pr long - f CTCAAGGCATGCCGTTTCCGATACCCCCTTATATC 






k_AgeI/NheI-Abeta - f cagtcaaccggtcagtcagctagcGATGCAGAATTCCGACATGAC 
k_Abeta-XhoI - r ataagaatctcgagctaCGCTATGACAACACCGCCCACC 
k_AgeI/XbaI-wrmScarlet -f cagtcaaccggtcagtcatctagaATGGTCAGCAAGGGAGAGGC 
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k_NheI-wrmScarlet - r ataagaatgctagcCTTGTAGAGCTCGTCCATTCC 
k_SphI-rgef1p -f cagtcagcatgcCAAGACTAATTTTCGATTAACC 
k_rgef1p-ClaI/AgeI -r ataagaatatcgatataagaataccggtCGTCGTCGTCGTCGATGCCGTC 
O_SigPep-DA for gttttgctggcactgttctttatctttctggcaccagcaggtaccGACGCG 
O_SigPep-DA rev CGCGTCggtacctgctggtgccagaaagataaagaacagtgccagcaaaac 
k_Fusion SigAb rev CATGTCGGAATTCTGCATCCGCGTCGGTACCTGCTGG 
k_Fusion SigAb for CCAGCAGGTACCGACGCGGATGCAGAATTCCGACATG 
k_ClaI-SigPep for CTATAGATCGATGCATAAGGTTTTGCTGGCACTGTTC 
k_Abeta-AgeI rev TCATCGACCGGTTTACGCTATGACAACACCGCC 
k_AgeI-IRES - f CCTATGACCGGTTGCTCTCCCTTCACCACTCC 
k_IRES-XbaI GGATACTCTAGAGCCCAACAAGAATAAGGTCTTCATA 
k_XmaI-SigPep for CTAACTCCCGGGATGCATAAGGTTTTGCTG 
k_XmaI-IRES rev TGACTGCCCGGGTGAGCCCAACAAGAATAAGGTC 
k_mScarlet_ext - f GATTAGCTAGCATGAAGACCTTATTCTTGTTGG 
k_mScarlet_stop - r GACTAGAATTCCTACTTGTAGAGCTCGTCCATTCC 
k_AgeI-myo-3 - f GCTGAACCGGTAGTGATTATAGTCTCTGTTTTCGTTAAT 
k_myo-3-NheI - r GATTAGCTAGCCATTTCTAGATGGATCTAGTGGTCG 
Gib_f1_myo3p-Sb - r GCAAAACCTTATGCATCCCGGTCGTCATTTCTAGATGGATCTAGTGGTCGTG 
Gib_f1_Sb-myo3p - f CTTGGAAATGAAATAAGCTTGCATGAGTGATTATAGTCTCTGTTTTCGTTA 
Gib_f2_myo3p-Sb - f CACGACCACTAGATCCATCTAGAAATGACGACCGGGATGCATAAGGTTTTGC 
Gib_f2_Sb-myo3p - r TAACGAAAACAGAGACTATAATCACTCATGCAAGCTTATTTCATTTCCAAG 
k_AgeI-myo-3p - f GCTGAACCGGTAGTGATTATAGTCTCTGTTTTCGTTAAT 
k_myo-3p-NheI - r GATTAGCTAGCCATTTCTAGATGGATCTAGTGGTCG 
Gib_SigP-mTrq --f CTTTCTGGCACCAGCAGGTACCATGGTGAGCAAGGGCGAGGAGC 
Gib_mTrq-IRES --r GTGGTGAGGGAGAGCAACCGGTTACTTGTACAGCTCGTCCATGCCG 
Gib_mTrq-IRES --f CGGCATGGACGAGCTGTACAAGTAACCGGTTGCTCTCCCTCACCAC 





















Primer for genotyping 
Primer name Sequence Expected fragments 
GT_dbn-1ko 3 f GCCGCTCAACTACCGTAACT wt-band: 3315 bp 
ko-band: 800 – 1000 bp GT_dbn-1ko 3 r CAGGAAGTGGGAGAATGGGAG 
   
 
Primer for mutagenesis 
The modified base pairs are underlined and highlighted in green. 
Primer name Sequence 
m_DBN(S647A)_1938 - F GGTACTTCAGTCAAGCACAGGAGGAGGAG 
m_DBN(S647A)_1938 - R CTCCTCCTCCTGTGCTTGACTGAAGTACC 
m_DBN(S647D)_1938-40 - F GGTACTTCAGTCAAGACCAGGAGGAGGAG 
m_DBN(S647D)_1938-40 - R CTCCTCCTCCTGGTCTTGACTGAAGTACC 
m_DBN-wt f GGTACTTCAGTCAATCACAGGAGGAGGAG 
m_DBN-wt r CTCCTCCTCCTGTGATTGACTGAAGTACC 
mut_AgeI-rgef-SigPep - F GACGACGACGACCGGTATGCATAAGG 
mut_AgeI-rgef-SigPep - R CCTTATGCATACCGGTCGTCGTCGTC 
 
 
Primer for sequencing 
Primer name Sequence 
Seq_Scarlet-1-rev GGATGTCCCAGGAGAATGG 
Seq_Scarlet-2-rev TCGTGTCCGTTCATGGATC 
Seq_DBN - 1 -- r GCTTGAGGTCATCGGAGCC 
Seq_DBN - 2 --f GAGGCGGTTGAAGGAGCAG 
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Seq_DBN - 3 -- r GGGTTGTCAGGCCGCTGG 
Seq_DBN - 4 --f GCCGCCACCAGCCTCATTG 
Seq_YFP - 1 --f GCGCACCATCTTCTTCAAG 





Seq_wrmScarlett - f (NheI) GATTAGCTAGCATGGTCAGCAAGGGAGAGG 
 
 
Oligonucleotides for CRISPR/Cas9 
Oligonucleotide name Sequence 
o_sgRNA1 - f tcttgCAACTATCATGCACACGGCA 
o_sgRNA1 - r aaacTGCCGTGTGCATGATAGTTGc 
o_sgRNA4 - f tcttgTAGCGGGAAAAAGGCCTACG 
o_sgRNA4 - r aaacCGTAGGCCTTTTTCCCGCTAc 
o_sgRNA5 - f tcttgGATGGCTCTCTGGGACTACC 
o_sgRNA5 - r aaacGGTAGTCCCAGAGAGCCATCc 
o_sgRNA7 - f tcttgAGGAGATTGAAGCGTCGTAT 




Name Insert Resistance Origin 
pPD95_77 GFP Amp Fire Lab 
L4440 2x T7-promoter Amp Fire Lab 
pCFJ104 myo-3p::mCherry Amp Jorgensen Lab 
pJJR50 sgRNA-empty Amp Boxem Lab 
pMB67 hsp-16.48p::Cas9 Amp Boxem Lab 
IR98 rps-0p::hygR CeOpt Cam Chin Lab 
pEYFP-N1-DBNA(WT) DBN1A-YFP Kan/Neo Eickholt Lab 
pSEM87 wrmScarlet–twk-18 Amp Boulin Lab 
pEY54 klp-6p::mNeptune2.5 Amp Hobert Lab 
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pJB253 tol-1p::GFP Amp Ringstad Lab 
pCR-flp-22 flp-22p::GFP Amp Li Lab 
XW08 unc-4p::QF::SL2::mCherry Amp Shen Lab 
pPD_DBN1A(wt) rgef-1p::DBN1Awt-YFP Amp this work 
pPD_DBN1A(S647A) rgef-1p::DBN1AS647A-YFP Amp this work 
pPD_DBN1A(S647D) rgef-1p::DBN1AS647D-YFP Amp this work 
pPD_DBN-Dendra (wt) rgef-1p::DBN1Awt-Dendra2 Amp this work 
pPD_DBN-Dendra (S647A) rgef-1p::DBN1AS647A-Dendra2 Amp this work 
pPD_DBN-Dendra (S647D) rgef-1p::DBN1AS647D-Dendra2 Amp this work 
pJJR_sgRNA1 U6prom::guideSeq-1 Amp this work 
pJJR_sgRNA4 U6prom::guideSeq-4 Amp this work 
pJJR_sgRNA5 U6prom::guideSeq-5 Amp this work 
pJJR_sgRNA7 U6prom::guideSeq-7 Amp this work 
pPD_nScabeta rgef-1p::SigPep-Abeta1-42::               
hsp-3IRES::wrmScarlet-Abeta1-42 
Amp this work 
pPD_mScabeta myo-3p::SigPep-Abeta1-42::              
hsp-3IRES::wrmScarlet-Abeta1-42 
Amp this work 
pPD_StopAbeta rgef-1p::ProxyStop::hsp-3IRES:: 
wrmScarlet-Abeta1-42 
Amp this work 
pPD_nSca-ext rgef-1p::wrmScarlet_ext Amp this work 
pPD_mSca-ext myo-3p::wrmScarlet_ext Amp this work 
pPD_nTrq2_Scabeta rgef-1p::SigPep-Trq2::                     
hsp-3IRES::wrmScarlet-Abeta1-42 
Amp this work 
pPD_shAbeta(URY) tol-1p::shAbeta::SL2::GFP Amp this work 
pPD_shAbeta(IL2) klp-6p::shAbeta::SL2::scramble Amp Kirstein Lab 
pPD_klp-6::GFP klp-6p::GFP Amp Kirstein Lab 
pSUMO-Abeta42 T7prom::SUMO-Abeta Amp Kirstein Lab 




Device Name Company 
Agarose gel electrophoresis 
system 
 Carl Roth, Karlsruhe, Germany 
Centrifuge (1,5ml / 2ml) Heraeus Fresco 17 Thermo Fisher Scientific, Waltham, USA 
Centrifuge (15ml / 50ml) 3K12 SIGMA, Osterode am Harz, Germany 
Table-top Centrifuge (PCR-tubes) Ministar VWR, Radnor, USA 
Centrifuge (6x 1L) Sorvall LYNX 6000, 
Rotor: F9-6x1000 LEX 
Thermo Fisher Scientific, Waltham USA 
Centrifuge 5417C, Rotor: F45-30-
11 015999 
Eppendorf, Hamburg, Germany 
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Confocal laser scanning 
microscope 
ZEISS LSM-780 Carl Zeiss Microscopy GmbH, Jena, 
Germany 
Confocal laser scanning 
microscope (for FLIM) 
Leica SP5 Leica, Wetzlar, Germany 
Confocal laser scanning 
microscope (for STED) 
Leica SP8 Leica, Wetzlar, Germany 
Fluorescence lifetime 
measurement microscopy 
PicoHarp 300 PicoQuant, Berlin, Germany 
Fluorescence microscope M165FC Leica, Wetzlar, Germany 
Freezer (-80°C) KM-DU73Y1E Panasonic, Kadoma, Japan 
Gamma irradiator OB29 STS, Braunschweig, Germany 
GeneGun  FMP work shop facility 
Heating block incubator HLC Ditabis, Pforzheim, Germany 
Homogenizer PrecellysⓇ   24 Bertin instruments, Montigny-le-Bretonneux, 
France 
Incubator (30°C and 37°C) Heraeus Kelvitron Thermo Fisher Scientific, Waltham USA 
Incubator (15°C) TC255 Lovibond Tintometer GmbH, Dortmund, 
Germany  
Incubator (20°C) TC255L Lovibond Tintometer GmbH, Dortmund, 
Germany  
Magnetic stirrer RET basic IKA, Staufen, Germany 
Mass spectrometer NanoLC-Esi-MSMS 
(Orbitrap Elite) 
Thermo Fisher Scientific, Waltham, USA 
Nanodrop NanoVue Plus GE Healthcare, Buckinghamshire, UK 
pH meter  Mettler Toledo, Ohio, USA 
Pipettes TransferpetteⓇ Brand, Wertheim, Germany 
Pipettor Pipetboy Integra Bioscience, Bibertal, Germany 
Plate reader F200 Pro Tecan, Männedorf, Switzerland  
Power supply PowerPac HC / Basic Bio-Rad, Hercules, USA 
SDS PAGE system Mini-PROTEAN cell 
chambers 
Bio-Rad, Hercules, USA 
Shaker (4°C) SM-30 control Edmund Bühler GmbH, Hechingen, 
Germany 
Shaker/Incubator Innova 4230 New Brunswick Scientific / Eppendorf, 
Hamburg, Germany 
Shaker/Incubator Multitron Pro Infors HT, Bottmingen, Switzerland 
Sonication water bath XUBA Grant Scientific, Royston, UK 
Stereo microscope M165 FC Leica, Wetzlar, Germany 
Stereo microscope SMZ 745 Nikon, Tokio, Japan  
Thermocycler Mastercyler Gradient Eppendorf, Hamburg, Germany 
Thermocycler C1000 Touch Bio-Rad, Hercules, USA 
Tube roller RS-TR-5 Phoenix Instrument, Garbsen, Germany 
Vacuum pump  KNF Lab, New Jersey, USA 
Vortex Vortex-GenieⓇ 2 Scientific Industries, Bohemia, USA 
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Westernblot detection system Lumi-Imager F1 Boehringer Mannheim GmbH, Mannheim, 
Germany 
Westernblot system (semi-dry) Trans-Blot Turbo 
Transfer System 
Bio-Rad, Hercules, USA 





Culture plates (35/60/100 mm) Sarstedt, Nümbrecht, Germany 
Falcon tubes (15 ml and 50 ml) Sarstedt, Nümbrecht, Germany 
Filter tips Sarstedt, Nümbrecht, Germany 
Glass vial / lid Carl Roth, Karlsruhe, Germany 
Glass cover slips (18 x 18 mm) Carl Roth, Karsruhe, Germany 
Glass slides (76 x 26 mm) Carl Roth, Karsruhe, Germany 
Kwik-Fil™ borosilicate glass capillaries World Precision Instruments, Sarasota, USA 
Lysing Kit tubes (0.5 and 2 ml) Bertin instruments, Montigny-le-Bretonneux, France 
MicroAmp ™ Fast optical 96-well reaction plate Applied Biosystem by life technologies, Foster City, 
USA 
MicroAmp ™ Fast optical adhesive film Applied Biosystem by life technologies, Foster City, 
USA 
Parafilm Bemis, Neenah, USA 
Pasteur pipettes (glass) Carl Roth, Karsruhe, Germany 
PCR tubes (single) Sarstedt, Nümbrecht, Germany 
PCR tubes (stripes) Kisker Biotech GmbH & Co. KG, Steinfurt, Germany 
Plates (96-well) Sarstedt, Nümbrecht, Germany 
Platinum wire (0.3 mm) Carl Roth, Karlsruhe, Germany 
Reaction tubes (1.5 ml and 2.0 ml) Sarstedt, Nümbrecht, Germany 
Roti®-Fluoro PVDF Carl Roth, Karlsruhe, Germany 
Scalpel Carl Roth, Karlsruhe, Germany 
Serological pipettes Sarstedt, Nümbrecht, Germany 
Table waste bags Sarstedt, Nümbrecht, Germany 






C. elegans strains 
Strain name Genotype / description / state of integration Source 
BIJ34 jaaIs4 (hyp7p::sfGFP-LGALS3) Is Jäättelä Lab 
BZ555 egIs1 (dat-1p::GFP) Is CGC 
CS628 qcIs55 [vha-7p::GFP::sma-3 + rol-6(su1006)] Is CGC 
IG10 tol-1 (nr2033) I ko CGC 
JKM1 ∆dbn-1 (Exon 1 – 6) III           (CRISPR/Cas9-total knockout) ko this work 
JKM2 (nAβ) rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt 
Is this work 
JKM2-∆ (nAβ-∆) [∆dbn-1 (Exon 1 – 6) III]; [rgef-1p::SigPep-
Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + rps-0p::hygR CeOpt] 
Is this work 
JKM2-∆-nDBN 
(nDBNwt) 
[∆dbn-1 (Exon 1 – 6) III]; [rgef-1p::SigPep-
Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + rps-0p::hygR CeOpt]; 
[rgef-1p::hDBN1Awt-Dendra2] 
Is this work 
JKM2-∆-nDBNS647A 
(nDBNS647A) 
[∆dbn-1 (Exon 1 – 6) III]; [rgef-1p::SigPep-
Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + rps-0p::hygR CeOpt]; 
[rgef-1p::hDBN1AS647A-Dendra2] 
Is this work 
JKM2-∆-nDBNS647D 
(nDBNS647D) 
[∆dbn-1 (Exon 1 – 6) III]; [rgef-1p::SigPep-
Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + rps-0p::hygR CeOpt]; 
[rgef-1p::hDBN1AS647D-Dendra2] 
Is this work 
JKM2-BIJ34 [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt]; jaaIs4 [hyp7p::GFP-LGALS3] 
Is this work 
JKM2-CS628 [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt];           
qcIs55 [vha-7p::GFP::sma-3 + rol-6(su1006)] 
Is this work 
JKM2-JKM10 [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 




JKM2-LX929 [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt]; vsIs48 [unc-17p::GFP] 
Is this work 
JKM2-OH10972 [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt];                    
otIs376 [eat-4(prom4)::GFP + rol-6(su1006)] 
Is this work 
JKM2-shAbeta(IL2) [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt];           
[klp-6p::shAbeta::SL2::Scramble + myo-2p::GFP]ex 
Is/Ex this work 
JKM2-shAbeta(URY) [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt]; [tol-1p::shAbeta::SL2::GFP]ex 
Is/Ex this work 
JKM2-ZIM1048 [rgef-1p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt]; mzmIs4 (unc-31p::NLS-GCaMP5Kf + 
unc-122p::GFP); lite-1 (ce314) X 
Is this work 
JKM3 rgef-1p::wrmScarlet_ext + rps-0p::hygR CeOpt Is this work 
JKM3-CS628 [rgef-1p::wrmScarlet_ext + rps-0p::hygR CeOpt];    
qcIs55 [vha-7p::GFP::sma-3 + rol-6(su1006)] 
Is this work 
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JKM3-ZIM1048 [rgef-1p::wrmScarlet_Ext + rps-0p::hygR CeOpt];       
mzmIs4 (unc-31p::NLS-GCaMP5Kf + unc-122p::GFP);    
lite-1 (ce314) X 
Is this work 
JKM5
  
rgef-1p::ProxyStop::hsp-3IRES::wrmScarlet-Aβ1-42                     
+ rps-0p::hygR CeOpt 
Ex this work 
JKM6 rgef-1p::SigPep-mTurquois2::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt 
Ex this work 
JKM7 (mAβ) myo-3p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt 
Is this work 
JKM7-CS628 [myo-3p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt];                                                                       
qcIs55 [vha-7p::GFP::sma-3 + rol-6(su1006)] 
Is this work 
JKM7-jaaIs4 [myo-3p::SigPep-Aβ1-42::hsp-3IRES::wrmScarlet-Aβ1-42 + 
rps-0p::hygR CeOpt]; jaaIs4 [hyp7p::GFP-LGALS3] 
Is this work 
JKM8 myo-3p::wrmScarlet_ext + rps-0p::hygR CeOpt Ex this work 
JKM8-CS628 [myo-3p::wrmScarlet_ext + rps-0p::hygR CeOpt]ex;    
qcIs55 [vha-7p::GFP::sma-3 + rol-6(su1006)] 
Ex/Is this work 
JKM10 tol-1p::GFP Is this work 
LX929 vsIs48 [unc-17p::GFP] Is CGC 
N2 wild type  (C. elegans var Bristol) -- CGC 
nDBNS647A ok925; rgef-1p::hDBN1AS647A-YFP + myo-2p::RFP Is this work 
nDBNS647A-Dendra ∆dbn-1 (Exon 1 – 6) III; rgef-1p::hDBN1AS647A-Dendra2 Is this work 
nDBNS647D ok925; rgef-1p::hDBN1AS647D-YFP + myo-2p::RFP Is this work 
nDBNS647D-Dendra ∆dbn-1 (Exon 1 – 6) III; rgef-1p::hDBN1AS647D-Dendra2 Is this work 
nDBNwt ∆dbn-1 (Exon 1 – 6) III; rgef-1p::hDBN1Awt-YFP Is this work 
nDBNwt-Dendra ∆dbn-1 (Exon 1 – 6) III; rgef-1p::hDBN1Awt-Dendra2 Is this work 
OH10972 otIs376 [eat-4(prom4)::GFP + rol-6(su1006)] Is CGC 
RB1004 ok925 (∆dbn-1 Exon 5 – Exon 6) ko CGC 
shAbeta(IL2) klp-6p::shAbeta::SL2::Scramble + myo-2p::GFP Ex Kirstein Lab 
shAbeta(URY) tol-1p::shAbeta::SL2::GFP Ex this work 
ZIM1048 mzmIs4 (unc-31p::NLS-GCaMP5Kf + unc-122p::GFP);    
lite-1 (ce314) X 









Bacterial strains and RNAi clones 
Baterial strain – application Genotype 
E. coli DH5!Z1 – cloning	 laciq, PN25-tetR, SpR, deoR, supE44, Delta(lacZYA-argFv169), Phi80 
lacZDeltaM15, hsdR17(rK- mK+), recA1, endA1, gyrA96, thi-1, relA1 
E. coli HT115(DE3) – RNAi F-, mcrA, mcrB, IN(rrnD-rrnE)1, rnc14::Tn10(DE3) lysogen: lavUV5 
promoter -T6 polymerase 
E. coli OP50 – food source uracil auxotroph 
S. marcescens Db11 – Pathogen 
Avoidance Assay 
KanR, TetR, StrepR 
S. marcescens Db1140 – Pathogen 
Avoidance Assay 
KanR, TetR, StrepR, Protease 1 deficient, phage ΦJR 
 
HT115 RNAi clones Source 
L4440–dbn-1 Ahringer Library  
L4440–empty Fire Lab 
 
Software and online tools 
Software Name Source 
Confocal Microscopy Zen 2010B SP1 v6.0 Zeiss, Oberkochen, Germany 
Data analysis Prism 8 for macOS GraphPad Software Inc. 
Documents Word 2016 Microsoft 
Figure composition Adobe Illustrator Adobe Systems Inc. 
FLIM image analysis FLIMfit (v4.12 and v5.1.1) Warren et al.300 
FLIM / STED Microscopy 
(microscopy setup)  
Leica Application Suite     
Advanced Fluorescence 
2.7.3.9723 
Leica Microsystems CMS GmbH, 
Mannheim, Germany 
FLIM Microscopy (TCSPC) SymPhoTime 64 PicoQuant, Berlin, Germany 
Image adjustment  Adobe Photoshop Adobe Systems Inc. 
Image analysis Fiji v2.0 Schindelin et al.301 
Image colocalization analysis Fiji-plugin: EzColocalization Stauffer et al.302 
Nematode swimming analysis Fiji-plugin: WrmTrck Pedersen et al.303 
Presentations Keynote 9.1 Apple Inc. 
Primer design Primer3 v3 Untergasser et al. 
Primer specificity PrimerBLAST NCBI, Bethesda, USA 
sgRNA design crispr.mit.edu Zhang Lab 
Spreadsheets Excel 2016 Microsoft 






Molecular biological and biochemical methods 
 
Polymerase chain reaction 
For sequence specific amplification of DNA, polymerase chain reactions (PCR) were employed. In brief, 
a thermostable, engineered DNA polymerase amplifies a defined stretch of DNA in cycles, while the 
amplicon size is delimited by the binding of two primers defining the 5’- and 3’-end. Primers were 
designed to bind specifically to the gene of interest (GOI) and melting temperatures were arranged to 
be between 58°C and 67°C. For genomic DNA templates Primer3 was used to find specific primers 
(excluding off-targets in C. elegans and E. coli). All reactions were performed with Phusion polymerase.  
The reactions consisted of an initial denaturation step of 98°C for 3 min, followed by 30 to 36 cycles of 
denaturation (at 95-98°C for 30-45 sec), annealing (calculated annealing temperature of the primer pair 
for 30-45 sec) and elongation (at 72°C for 30 sec per kilo base for sequences up to 3 kb, additional 30 
sec per kb after 3rd kb for templates longer than 3 kb). After cycling, a final elongation step is performed 
for 5 min per kb up to 30 min at 72°C. 
To increase specific primer binding, a touch-down approach was employed. In brief, the annealing step 
temperature is gradually decreased every reaction cycle by 0.5 to 1 K, starting from a higher melting 
temperature to reach the calculated temperature by the 10th to 12th cycle. Afterwards, 20 to 24 reaction 
cycles are done with the calculated annealing temperature. 
To increase specificity and yield of difficult-to-amplify sequences, nested PCR was employed. An 
additional primer pair was designed binding approx. 150 – 300 base pairs up- and downstream of the 
GOI. A second PCR amplifying the actual GOI is performed using the amplificate from the preceding 
PCR as template. 
For restriction cloning, recognition sites of Type II restriction enzymes were added at the primers 5’-
ends plus five to six random bases. 
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For Gibson Assembly, primers were designed to be complementary to the two sequences to ligate, 
therefore the designed primer’s 5’ends are homologous to the 3’end of the respective upstream 
fragment. 
For fusion PCR, two primer pairs are designed: two outer primers on different genes and two 
homologous primers, which are complementary to each other and bind on both genes to fuse on their 
respective 3’- and 5’-end. In total three PCRs are performed: two to amplify the two GOIs using their 
respective outer and homology primer. Following, the amplificates from the two preceding PCRs are 
used as templates and the outer primers are used to amplify and fuse the two GOIs. 
 
Single worm PCR 
For genotyping or to get fragments from the nematodes’ genomic DNA a single worm PCR was 
performed. The PCR itself is performed as described before but 10 µl of proteinase K (ProtK) digested 
nematodes are used as template. 
One to ten nematodes (best results with day 4 – day 6 old, gravid adults) are picked into 10 µl of ProtK 
lysis buffer and digested for 90 min at 65°C. ProtK enzymes are inactivated at 95°C for 30 min. The 
ProtK digested material can be stored at 4°C for up to a week.  
For the PCR the 10 µl are topped-up with 15 µl Mastermix containing Phusion, Primers, dNTPs and 
additives in 1x PCR-Buffer I. 
 
Mutagenesis 
Mutagenesis is used to introduce defined point mutations in plasmid DNA. In brief, forward and reverse 
primers are designed to bind the sequence to mutate. The mutation is caused by mismatched bases. 
The mismatched bases are in the middle of the primers and the homologous flanking regions are at 
least 10 bp long. 
The reaction is performed as following: Initial denaturation at 98°C. 18 cycles of denaturation (98°C for 
45 sec), primer annealing (at 55°C for 1 min) and elongation (at 68°C for 1 min per kilo base). Final 
elongation at 68°C for 20 min.  
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After the PCR reaction is completed 20 U DpnI per 25 µl reaction volume are added and template vector 
is cleaved for 3 h at 37°C. DpnI enzymes are inactivated at 80°C for 30 min. 10 – 20 µl of the reaction 
are directly used to transform DH5!	bacteria (see transformation). Finally, the mutation is verified by 
sequencing. 
The plasmids pPD_DBN1A(S647A) and pPD_DBN1A(S647D) have been generated by mutagenesis 
from pPD_DBN1A(wt) employing the listed mutagenesis primers. Further, the plasmids pPD_DBN-
Dendra(S647D) and pPD_DBN-Dendra(wt) have been generated by mutagenesis from pPD_DBN-
Dendra(S647A). 
The plasmid pPD_nScabeta was used as template for mutagenesis to restore the AgeI restriction site 




The backbone for all nematode expression plasmids was pPD95_77. All restriction reactions were 
performed with 10 U High Fidelity® enzymes in 1x CutSmart® buffer (NEB). The reaction volume was 20 
µl. 800 ng - 1.2 µg DNA were cleaved for 30 - 45 min at 37°C (if any enzyme required a different 
temperature, temperature was selected following the manufacturer’s instructions). Vector backbones 
were treated with 1 U FastAP (Thermo Scientific) simultaneously. The reactions were stopped by heat 
inactivating the enzymes at 65°C - 80°C for 15 min. Products were purified using a spin column only, 
or if necessary using extraction from an agarose gel (QIAquick Gel Extraction Kit, Qiagen). 
Ligation reactions were performed in 10 µl reaction volume using 5 U T4 DNA Ligase (Thermo Scientific). 
50 ng vector backbone and 20 – 100 ng insert were ligated for 2 h at RT. If colony yield was low, ligation 
was repeated at 16°C over night. 5 – 10 µl of the reaction volume were used for transformation of DH5!.	
 
Drebrin-YFP containing plasmids. GFP was removed from pPD95_77 by SphI + EcoRI cleavage. 
Promoter region of rgef-1 was amplified by PCR including SphI and NheI recognition sites (k_SphI-
B3.3Pr long – f + k_ceF25B3.3Prom-NheI – r). DBN-YFP was amplified by PCR with NheI and EcoRI 




Drebrin-Dendra containing plasmids. GFP was excised from pPD95 by AgeI + EcoRI treatment. Dendra2 
was amplified by PCR from YD3 nematodes (Dendra-EcoRI-rev + AgeI-Dendra-for) and inserted to 
obtain pPD95_Dendra2. DBN1A(S647A) was amplified by PCR (k_NheI-DBN-YFP - f + k_hDrebrin-
AgeI--rev) and inserted upstream of Dendra2 by using NheI + AgeI to obtain pPD95_DBN1A(S647A)-
Dendra2. The promoter region of rgef-1 was amplified (k_SphI-B3.3Pr long – f + k_ceF25B3.3Prom-
NheI – r) and sub-cloned by using SphI + NheI to obtain pPD95_rgef-1p::DBN1A(S647A)-Dendra2 (listed 
as pPD_DBN-Dendra(S647A) ). 
guideRNA containing plasmids. The backbone pJJR50 was used. pJJR50 was cleaved with BbsI-HF. 
Forward and reverse oligonucleotides (see Oligonucleotides for CRISPR/Cas9) were annealed 
according to the Zhang Labs recommendations 304 and ligated into the cleaved pJJR50 vector to obtain 
the plasmids pJJR_sgRNA1/4/5/7. 
Bicistronic operon for sub-stoichiometric expression of mScarlet-Aβ1-42 and Aβ1-42. Aβ1-42 was amplified 
from pSUMO-Abeta42 (k_AgeI/NheI-Abeta - f + k_Abeta-XhoI - r) and replaced GFP in pPD95_77 (AgeI 
and XhoI). wrmScarlet, was amplified from pSEM87 (k_AgeI/XbaI-wrmScarlet -f + k_NheI-wrmScarlet - 
r) and inserted upstream of Aβ1-42 (AgeI and NheI). The promoter sequence of rgef-1 was amplified from 
pPD95_DBN1A(wt) (k_SphI-rgef1p -f + k_rgef1p-ClaI/AgeI -r) and inserted upstream of wrmScarlet 
(SphI and AgeI). Signalpeptide- Aβ1-42 (SigPep-Abeta) was created by Fusion-PCR using a synthetic 
50mer (O_SigPep-DA for + O_SigPep-DA rev) as first PCR template and k_ClaI-SigPep for plus 
k_Fusion SigAb rev as primers; second PCR template was pSUMO-Abeta42 and k_Fusion SigAb for 
plus k_Abeta-AgeI rev as primers. The subsequent Fusion-PCR was carried out with the products of 
the first and second PCR as templates (k_ClaI-SigPep for + k_Abeta-AgeI rev). Insertion between rgef-
1p and wrmScarlet (ClaI and AgeI) resulted in a loss of 400 bp promoter sequence. The hsp-3 IRES 
element was amplified from genomic DNA (k_AgeI-IRES – f + k_IRES-XbaI) and inserted between 
SigPep-Aβ1-42 and wrmScarlet-Aβ1-42 (AgeI and XbaI). The Signalpeptide-Aβ1-42-IRES sequence was 
amplified (k_XmaI-SigPep for + k_XmaI-IRES rev) and inserted (XmaI and AgeI) into the intermediate 
plasmid pPD_rgef-1p::wrmScarlet-Aβ1-42 to obtain the final pPD_nScabeta plasmid (rgef-1p::SigPep- 
Aβ1-42::hsp-3IRES::wrmScarlet- Aβ1-42). 
Control construct for neuronal expression of wrmScarlet. pPD95_77 was cleaved with SphI and EcoRI 
to remove GFP. The promoter sequence of rgef-1 was amplified (k_SphI-rgef1p -f + k_rgef1p-ClaI/AgeI 
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-r) and cleaved with SphI + NheI. wrmScarlet_ext was amplified (k_mScarlet_ext - f + k_mScarlet_stop 
– r) and cleaved with NheI and EcoRI. All three fragments were ligated in one reaction to obtain 
pPD_nSca-ext 
Bicistronic operon for body wall muscle expression. Because of the limitations of available restriction 
sites a restriction enzyme independent method was used: Gibson Assembly (NEB). The promoter 
sequence of myo-3 was amplified from pCFJ104 with homologous overlaps to ‘Scabeta’ 
(Gib_f1_myo3p-Sb - r + Gib_f1_Sb-myo3p - f). The plasmid pPD_nScabeta was amplified by PCR to 
remove rgef-1p and to insert overlaps homologous to myo-3p (Gib_f2_myo3p-Sb – f + Gib_f2_Sb-
myo3p - r). The Gibson Assembly was performed following the manufacturer’s instructions. In brief, 2 µl 
of the unpurified PCR products were mixed, 6 µl water was added as well as 10 µl Gibson-Mastermix. 
The reaction was performed for 60 min at 50°C. 4 µl of the reaction mix were used to transform NEB5! 
cells provided with the Gibson Assembly kit. 
Control construct for muscle expression of wrmScarlet. The promoter region of myo-3 was amplified 
(k_AgeI-myo-3 – f + k_myo-3-NheI – r) and inserted into pPD_nSca-ext to replace rgef-1p using AgeI 
and NheI. 
Signalpeptide-mTurqouis2 + wrmScarlet- Aβ1-42. Because of the limitations of available restriction sites 
a restriction enzyme independent method was used: Gibson Assembly (NEB). Trq2 was amplified from 
pN1-Trq2 (Gib_SigP-mTrq --f + Gib_mTrq-IRES --r). pPD_nScabeta was amplified removing the first 
Aβ1-42 and introducing homology arms (Gib_mTrq-IRES --f + Gib_SigP-mTrq --r). Gibson Assembly was 
performed following the manufacturer’s instructions. 
Proxystop construct for expression of wrmScarlet-Aβ1-42 only. SigPep-Aβ1-42 was removed from 
pPD_nScabeta(AgeI) using AgeI. 100 pmol of two oligonucleotides (o_ProxyStop-in-AgeI-top + 
o_ProxyStop-in-AgeI-bot) were phosphorylated using 5 U T4-polynucleotide kinase and gradually 
annealed, starting with an initial denaturation for 5 min at 95°C followed by subsequent lowering of the 
temperature over 15 min to 25°C. The annealed oligonucleotide was ligated into the AgeI site of 
pPD_nScabeta(AgeI), replacing SigPep-Aβ1-42 and giving pPD_StopAbeta. 
Short-hairpin construct against Aβ1-42 in URY neurons. Aβ1-42 was amplified (k_Abeta-SphI-rev + k_SphI-
Abeta-for) and inserted into pPD95_77 using SphI to obtain pPD_AbetaFOR. By sequencing a plasmid 
containing forward Aβ1-42 was selected for further cloning. Two fragments were cloned, reversed Aβ1-42 
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(k_BamHI-Abeta-for + k_Abeta-NheI-rev) and the splice leader 2 sequence from gdp-2 (k_NheI-SL2-for 
+ k_SL2-AgeI-rev). These fragments were cleaved (BamHI, NheI and AgeI) and inserted into 
pPD_AbetaFOR using BamHI and AgeI restriction sites to obtain pPD_AbetaFOR-REV::SL2. The 
obtained AbetaFOR-REV::SL2 sequence was amplified (k_Abeta-KpnI/SphI-f + k_SL2-AgeI/KpnI-r) and 
inserted into KpnI site of pPD_tol-1p::GFP to obtain pPD_shAbeta(URY). 
 
Agarose gel electrophorese 
To check the size of DNA fragments agarose gel electrophoresis was employed. 0.7 – 2.0 % (w/v) 
agarose were solved in 1x TAE buffer and boiled, 1x SafeRed™ was added and a gel was cast in a 
horizontal chamber. After solidifying, 5 – 10 µl DNA samples were mixed with loading dye (to 1x final 
concentration) and loaded onto the gel. Electrophoresis was performed for 30 - 60 min at 85 - 100 V. 
DNA was visualized using a G:Box Syngene System. 
 
Transformation 
For DNA synthesis E. coli strain DH5! was used, for RNAi by feeding E. coli strain HT115 was used. A 
fresh aliquot of chemo competent bacteria was thawed on ice and DNA was added (maximum 10% 
(v/v)). After 25 min incubation on ice bacteria were heat shocked for 45 s at 42°C (HT115 bacteria were 
heat shocked at 37°C). After heat shock they were put on ice for 2 min immediately. 1 ml LB-medium 
(without antibiotics) was added and bacteria were incubated for 1 h at 37°C, shaking at 450 rpm. 
Afterwards, bacteria were pelleted and pellet was resuspended in 100 µl LB-medium. 50 µl resuspended 
bacteria were plated on LB-agar plates (containing appropriate antibiotics). 
  
Nematode lysis 
Nematodes were grown under desired conditions to the desired age and harvested by rinsing the plates 
with M9 medium and collecting the nematodes in solution into 15 ml tubes. Nematodes were allowed 
to settle by gravity and supernatant was removed. Nematodes were washed three times this way. 
Afterwards, the nematodes were washed with HMK-buffer once and pelleted again. The pellet was 
resuspended in 100 - 500 µl HMK-buffer + inhibitors and transferred to lysis tubes with ceramic beads 
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(Precellys® Lysing Kit). Lysis was performed in a homogenizer (Precellys®24) using the following 
program: (1) homogenize for 30 sec at 6000 rpm, (2) 10 sec break, (3) homogenize for 30 sec at 
6000 rpm, (4) remove from homogenizer and cool on ice for 60 sec, (5) homogenize for 30 sec at 
6000 rpm, (6) 10 sec break and (7) homogenize for 30 sec at 6000 rpm.  
The homogenate was transferred to low binding tubes and centrifuged for 15 min at 4°C and 12000 rpm. 
The supernatant was transferred to fresh low binding tubes and used for further experiments. 
 
Bradford-Assay 
To quantify the protein concentration of nematode lysates, Bradford-Assay was employed. In brief, 
Bradford reagent (Roti-Quant) was prepared following the manufacturer’s instructions and 200 µl were 
filled in wells of a clear 96-well plate. A calibration curve was prepared from BSA (covering a range from 
0 to 10 mg/ml). For each sample, 1 µl was pipetted into the prepared reagent employing triplicates. 
After mixing, samples were incubated for 5 min at RT. Afterwards, absorption was measured at 595 nm 
in a plate reader (Tecan). Protein concentration was calculated using the calibration curve. 
 
Immunoprecipitation 
To precipitate proteins of interest (POI) and interacting proteins, immunoprecipitation was performed. 
25 µl Protein A/G coated, magnetic beads (Pierce) were resuspended with 125 µl 1x TBST. A magnetic 
rack was employed to pellet the beads and the supernatant was removed. 1 ml TBST was added to 
wash and pellet the beads twice. 10 µl monoclonal antibody (anti-GFP or anti-Aβ) + 1 ml TBST were 
added to the beads. The bead and antibody solution was rotated (20 rpm) for 2 h at 4°C. After bead-
antibody-binding, the beads were washed with TBST once, followed by two washing steps with 1 ml 
HMK-buffer.  
500 µl nematode lysate of the strains JKM2 or JKM7 was used to identify proteome alterations upon 
Aβ1-42 overexpression. As control lysates of JKM3 or JKM8 were employed. These experiments have 
been conducted as biological triplicates. 
To analyse alterations upon overexpression of DBN1A-YFP nematode strain nDBN was used for the 
co-IP experiment. 500 µl of nDBN lysate were used. 
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The lysates were mixed with the antibody-coated beads (anti-Aβ for JKM2, JKM3, JKM7 and JKM8; 
and anti-DBN1 for nDBN) and rotated (20 rpm) for 3 h at 4°C. After binding, the beads were washed 
three times with TBST and the supernatant was removed completely. The beads were resuspended in 
2x SDS sample buffer and proteins were eluted by boiling for 10 min at 95°C.  
Following this, the samples were incubated with 15 mM chloroacetamide for 30 min at 55°C as 
preparation for mass spectrometry. For simple analysis by SDS-PAGE, samples were not further 
treated. 
For western blotting to identify Aβ and wrmScarlet-Aβ , nematodes were lysed in RIPA buffer and anti-
GFP antibody was used for detection. 
 
SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gels were cast in a commercial system (BioRad) in two succeeding steps, first a 
separation gel was cast (12.5 % acrylamide or gradient of 5 to 20 % acrylamide following the method 
of Tal Lorberbaum, Columbia University) and overlaid with isopropanol. After solidifying the isopropanol 
was removed and the stacking gel was cast. Recipe for two 0.75 mm gels or one 1.5 mm gel: 
 
Table 4.1: SDS-PAGE recipe 
Components Separation gel (12.5%) Stacking gel (4%) 
Rotiphorese® Gel 30 (37.4:1) 
Separation gel buffer 

















Samples were mixed in 1:1 ratio with 2x SDS sample loading buffer and denatured for 10 min at 95°C. 
The cast gel was placed in a vertical electrophoresis chamber (Mini-Protean Tetra) and running buffer 
was added to cathode and anode reservoirs. Samples were loaded and gel run was performed at a 
constant current of 25-35 mA per gel. 
Afterwards, the gel was stained using Coomassie staining solution for 30 min at RT. Coomassie was 
removed and gel washed with water. Destaining was conducted with destaining buffer until protein 
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bands were clearly visible and background was transparent. For all staining and destaining steps, the 
added volume of solution was chosen so that the gel was able to float in liquid.  
 
Western blot 
To identify proteins and analyse their abundance semi quantitatively, western blots were employed. For 
small proteins (< 65 kDa) a semi dry blot approach (Trans-Blot® Turbo™) was employed preferably, for 
larger proteins (> 65 kDa) a wet blot system (Mini Trans-Blot® Cell) was employed. 
In brief, an SDS-PAGE was performed and the gel was equilibrated in transfer buffer for 5 min. A PVDF-
membrane was activated in methanol for 1 min and also equilibrated in transfer buffer. Whatman® paper 
were soaked with transfer buffer and a Whatman-gel-membrane-Whatman sandwich was assembled 
together with the wet blot systems components (two meshes and a cassette). Blotting was performed 
at 90 V for 90 min cooled by ice or overnight at 4°C using 45 V. For blotting Aβ1-42 transfer was limited 
to 60 min. 
After blotting, the membrane was blocked for 60 min at RT in 5% (w/v) milk powder TBST. For detection 
of endogenous DBN-1, 10% (w/v) milk powder TBST was used instead. For detection of Aβ1-42 
4% (w/v) BSA was used instead. Blocking solution was removed and primary antibody (dilution is 
indicated in ‘Material’ section) was added in 3% (w/v) milk powder TBST or 1x Roti Block (anti-Aβ 
antibody) for incubation over night at 4°C. 
The membrane was washed four times with TBST for 10 min. Afterwards, secondary antibody (dilution 
as indicated) was added in 3% (w/v) milk powder TBST or 1x Roti Block (anti-Aβ antibody) for 60 min 
incubation at RT. The membrane was washed three times with TBST for 10 min and once with TBS for 
15 min. Imaging was performed using ECL-reagent (Pierce) according to the manufacturer’s 
instructions and a Lumi-Imager to measure chemiluminescence.  
 
AMC-Assay / Proteasome activity assay 
To measure the chymotrypsin-like activity of proteasomes in nematode lysate, an AMC-Assay was 
performed as previously described 305,306. In brief, nematodes of defined age (days 3, 4, 6 and 8 old) 
were lysed and protein concentration of the cleared lysates was determined by Bradford assay. 25 µg 
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of total protein was incubated with 100 µM Suc-LLVY-AMC substrate (Enzo) in a clear 96-well plate. As 
inhibition control, one sample was pre-incubated with 50 µM MG-132 (Sigma), a potent proteasome 
inhibitor, for 30 min on ice. Fluorescence was measured in a plate reader (Tecan Safire) at 380 nm 
excitation and 460 nm emission every two minutes for 30 min at 25°C. Lysates were prepared as 
biological triplicates, measurements were performed using technical duplicates. 
For analysis, the slope of the linear component of the curve was used to calculate relative activities. 
 
Plasmid DNA preparation 
Plasmid DNA was isolated from DH5! bacteria growing in their exponential phase using the kits 
‘NucleoSpin MiniPrep’ (Machery-Nagel) for molecular cloning and sequencing, or using ‘ZR Plasmid 
Miniprep’ (Zymo) for microinjection. Preparation was performed following the manufacturer’s 
instructions. In brief, plasmid containing bacteria were cultured in LB-medium containing appropriate 
antibiotics at 37°C and 165 rpm shaking for 15 - 18 h. Bacteria were pelleted by centrifugation for 3 min 
at 15000 g. Resuspension, lysis and extraction of DNA over a silica column was performed following 
manufacturer’s instructions. Finally, DNA was eluted in ddH2O and concentration was measured using 
a nanodrop reader (NanoVue Plus). 
 
Gel extraction 
To retrieve DNA fragments of a desired size after restriction digestion, DNA was used for agarose gel 
electrophoresis. Bands were checked using 354 nm UV light (low power settings) and exposure time 
was minimized to a few seconds. Bands were cut out using a scalpel and collected in tubes. 
Extraction was performed using ‘QIAquick Gel Extraction Kit’ (Qiagen). In brief, Agarose blocks were 
resolved using 3x volume of chaotropic buffer, incubating for 15 - 30 min at 50°C, inverting every 5 min. 
After lysis, 1x volume isopropanol was added and the DNA agarose solution was cast over a silica 
column (following the manufacturer’s instructions) and column was washed with 500 µl wash buffer. 
Final elution was carried out in 15 - 30 µl ddH2O and concentration was determined using a nanodrop 




Bacterial culture  
OP50 food source 
400 ml sterile LB-medium was inoculated with 10 µl E. coli OP50 from a frozen glycerol stock and grown 
over night at 37°C and 165 rpm shaking. Afterwards, the bacteria solution was aliquoted in 40 ml 
aliquots and stored at 4°C. Few drops of OP50 (about 2 cm2) were plated on NGM-plates as food source 
of C. elegans and incubated at RT (seeded plates remained stable for up to two weeks). 
 
DH5! for plasmid extraction 
5 ml sterile LB-medium was mixed with the appropriate antibiotics and inoculated with plasmid bearing 
bacteria (by picking a single colony from a plate or by using 5 µl from a frozen glycerol stock). The 
bacteria were incubated for 12 – 16 h at 37°C shaking at 165 rpm. 
 
Serratia marcescens for pathogen avoidance assay 
Serratia marcescens bacteria were kept on LB-agar plates for up to three weeks at 4°C. To start a 
culture a fresh LB-agar plate was supplemented with Kanamycin, Tetracycline and Streptomycin and 
bacteria were streaked out from the old storage plate. The fresh plate was allowed to grow for 36 h at 
RT. Multiple colonies were used to inoculate 15 ml LB-medium supplemented with 
50 µg/ml Kanamycin, 7.5 µg/ml Tetracycline and 25 µg/ml Streptomycin and incubated for 12 – 16 h at 
25°C, shaking at 165 rpm. 
 
HT115 bacteria for RNAi 
5 – 10 ml LB-medium was supplemented with 100 µg/ml Ampicillin and 15 µg/ml Tetracycline and 
inoculated with 5 µl HT115 bacteria containing L4440-plasmid for RNAi from a frozen glycerol stock. 
Bacteria were grown over night at 37°C, shaking at 165 rpm. The next morning, IPTG (1 M stock) was 
added to a final concentration of 1 mM to induce siRNA expression and the culture was incubated for 
additional 2 h at 37°C, shaking at 165 rpm. Bacteria were directly used to seed plates or stored for up 





Mass spectrometry  
Samples from IP experiments were subjected to SDS-PAGEs until they migrated approx. 2 cm into the 
separation gel. The individual lanes were excised, removing stacking gel and loading dye. A tryptic 
digestion was carried out as previously described 307. LC-MS/MS was performed by the group of 
Dr. Fan Liu using an ‘UltiMate 3000 RSLC nano LC system’ coupled on-line to an ‘Orbitrap Elite mass 
spectrometer’ (Thermo Fisher Scientific). For reversed-phase separation an analytical column (self-
packed Poroshell 120 EC.C18, 2.7 µm, Agilent Technologies) with a 120 min gradient was employed. 
First scan (MS1) was performed in the orbitrap using 60000 resolution, second scan (MS2) was 
recorded in the ion trap using an AGC target of 5E3 and a maximum injection time of 50 ms, 
The label-free quantification was performed as previously reported 308. Data were analysed with 
MaxQuant (v 1.6.1.0) software using following listed parameters. Results were reported at 1% false 
discovery rate at the protein level. 
 
 Type of search:  MS/MS Ion Search 
 Enzyme:   Trypsin/P 
 Variable modifications: Oxidation (Met), Propionamide (Cys) 
 MS1 ion mass tolerance: ± 4.5 ppm 
 MS2 ion mass tolerance: ± 0.5 Da 
 Max. missed cleavages: 2 










C. elegans methods 
Maintenance 
Nematodes were cultured on nematode growth medium (NGM) using established protocols 183,185. 
Culture dish size was 60 mm, filled with 8 to 10 ml NGM. Temperature while culturing and during 
experiments was 20°C. Five to ten nematodes per strain were passaged to fresh plates every four days 
to preserve well fed and clean populations. 
 
RNAi treatment 
For selective gene knockdown, RNA interference (RNAi) was performed by feeding. HT115 bacteria 
containing L4440-target plasmids were used as food source, producing double stranded RNA (dsRNA). 
The uptake of these dsRNAs and subsequent processing to active siRNAs by the nematodes induces 
systemic RNAi. To induce siRNA synthesis in HT115 bacteria NGM-plates were supplemented with 
Ampicillin and IPTG. To cast RNAi-plates 100 µg/ml Ampicillin and 1 mM IPTG were added to NGM 
after cooling down just prior pouring the plates. The used bacterial strains were taken from the Ahringer 
library (Dr. Julie Ahringer, University of Cambridge). 
 
Oxidative stress treatment 
To induce oxidative stress, nematodes were cultured on NGM-plates supplemented with 0.1 - 2.0 mM 
1,1’-Dimethyl-4,4’-bipyridinium (Paraquat). For Lifespan-Assays under oxidative stress, nematodes 
were grown to L4 stage and transferred to 2 mM Paraquat containing plates. For Development-Assays 
under oxidative stress, eggs were prepared by bleaching and transferred onto Paraquat plates with 
concentrations ranging from 0.1 to 0.5 mM. 
 
Compound treatment / ATM-1 kinase inhibition 
To reduce ATM-1 kinase activity chemically, a selective ATM-1 kinase inhibitor (KU-55933) was 
employed. nDBN (S647A / S647D / wt) nematodes were synchronized by bleaching and grown to L4 
stage. The L4 larvae were washed off the plates with M9 medium, washed once with S-Basal and 
pelleted on ice. Approx. 150 nematodes were transferred into wells of a 12-well plate and topped up 
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with prepared S-Basal+ to a total volume of 3 ml. Test wells were supplemented with 500 µM KU-55933 
(dissolved in DMSO) and control wells were supplemented with 1% (v/v) DMSO. 
After 22 h incubation at 20°C nematodes were transferred to NGM-plates and used for life span assay 




To generate male nematodes for crossing, up to five NGM-plates were colonized with five L4 to young 
adult stage nematodes. Nematodes were incubated at 30°C for 6 to 8 h and shifted back to 20°C. After 
three to five days, plates were screened for males and those found were transferred to a fresh plate. To 
maintain males, two L4 hermaphrodite nematodes were added to the male plate. 
Alternatively, wild type males (generated using the protocol above) were cultured and crossed with 
other transgenic nematodes to obtain heterozygous males for crossing.  
 
Crossing 
To obtain hybrid nematode strains, two strains bearing different genetic features were crossed. Male 
nematodes of one strain were generated. For crossing, seven adult males were put on a plate and two 
L4 stage hermaphrodites of the other strain were added. After three to five days incubation at 20°C 
nematodes were checked for crosses (identifiable by phenotypic or fluorescent markers). First 
generation crosses (F1; definitely heterozygous for both features) were put on a fresh plate and grown 
for four to five days. Six second generation nematodes, positive for both markers (F2; potentially 
homozygous for one or both feature/s ), were singled onto fresh plates. The resulting populations were 
checked for (double-)homozygote. If only one feature was homozygous, nematodes were singled and 
procedure was repeated until both genetic features were homozygous. 
If one genetic feature was not coupled to a phenotypic or fluorescent marker, the genotype was 
controlled by PCR. The crossing strategy was slightly altered: Males were generated from the strain 
bearing a phenotypic/fluorescent marker. The crossing was set up as 7 male adults + 2 L4 
hermaphrodites of the second strain (no marker). After crossing, young male nematodes bearing the 
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phenotypic/fluorescent marker were used to set up a second crossing: 7 males + 2 L4 hermaphrodites 
of the second strain (no marker). The resulting hybrid generation has a 50% chance to be homozygous 
for the second genetic feature (with no marker). F2 generation is cultured and genotyped. After the 




For age synchronisation, three different methods were employed: bleaching, egg-laying or L4-picking. 
For bleaching, mixed populations of adult nematodes were harvested by washing them off the plates 
with M9 buffer. Nematodes were collected in a 15 ml tube and volume was topped up to 7.5 ml with 
H2O. 500 µl NaOH (10 M) + 2 ml hypochlorite solution (20%) were added and nematodes were harshly 
mixed on a vortex mixer for 1 min. Afterwards, tubes were inverted until nematodes started to dissolve 
completely. To stop the reaction, nematodes were pelleted by centrifugation (1 min at 2500 rpm) and 
the supernatant was removed. The pellet was washed with H2O, twice, and once with M9. The 
supernatant was removed a final time and pellet was resuspended in 500 µl M9. The eggs were 
incubated for 22 h at 20°C and L1-arrest was exploited to generate age synchronous L1 ( = day 1) 
populations. Bleaching was not applicable for nematodes carrying Aβ1-42 transgene. 
For egg-laying, ten to twenty day 5/6 old nematodes were put on a fresh plate and allowed to lay eggs 
for 4 h. After egg laying the adults were removed and the plates incubated at 20 °C ( = day 0). Egg-
laying was not applicable for nematodes carrying Aβ1-42 transgene as they tend to arrest in larval stages 
or develop at different speeds. 
For L4-picking, a mixed population of nematodes was started approx. five days before picking. L4 
nematodes were picked from the population and transferred to a fresh plate ( = day 3). L4-picking was 
used for nematodes carrying Aβ1-42 transgene; the preparation of a mixed population five days before 








To assess the lifespan of the different nematode strains 100 to 150 nematodes were age synchronized. 
Nematodes were transferred to fresh plates daily until the end of their fertile period, afterwards they 
were transferred every three days to fresh plates. Surviving and dead nematodes were scored every 
day and corpses were removed. If a nematode was not moving, survival was checked by first, tapping 
the agar beside the nematode to provoke a reaction. If tapping failed, the nematode was gently prodded 
with a platinum wire at head, tail and mid body region. If there was no reaction the nematode was 
removed and counted as dead. Nematodes that disappeared or died while transfer to a fresh plate were 
censored and removed from the analysis. To increase statistical significance, up to three independent 
cohorts were recorded. Lifespan was evaluated as cumulative survival probability. The fraction of 
survivors (qi) was calculated as: ,- = /012	3	40/012   (equation 1.1) 
ni …   count of living individuals at day i 
di …   dead individuals at day i 
 
And the cumulative survival probability was calculated as:  567898:;- = ,< ⋅ ,> ⋅ …	⋅ ,-   (equation 1.2) 
qi …   fraction of survivors at day i 
 




Nematodes were age synchronized and grown to day 4, day 7 and day 10 of life. Nematodes were 
transferred to a fresh plate and allowed to crawl onto the bacterial lawn. Pharynx pumping was counted 







10 to 15 L4 stage nematodes were singled per strain and analysed. Each nematode was transferred to 
a fresh plate every day and laid eggs / L1 larvae were counted. Transferring the elder nematodes was 
done until no more eggs were laid (usually on day 9). To ease counting, assay plates were seeded with 
a drop of 50 µl OP50 and were put to 4°C immediately after drying. Before placing the nematodes on 
the plates, the plates were incubated at RT for 30 min. 
 
Thrashing-Assay 
To analyse the thrashing / swimming of nematodes in M9 medium, nematodes were synchronized and 
grown to day 4 or day 7. Nematodes were picked from plates and transferred to fresh M9 medium in 
35 mm plates (liquid column 3 – 4 mm). Nematodes were moved with an eye leash to remove residual 
bacteria clumps and to disperse them evenly in the liquid. Nematodes were allowed to swim for 3 min 
before video acquisition. 
Videos were recorded at 7.3x magnification, 5 frames per second, for three times 10 - 20 seconds per 
group of nematodes (5 to 10 nematodes) in triplicates. If nematodes touched each other, they were 
separated with an eye leash and video acquisition was repeated. 
The videos were analysed using Fiji + Fiji-plugin: wrMTrck. First, they were converted into 8-bit grey 
scale images. The background was removed, AutoThreshold was applied and wrMTrck was run (script 
for automation and settings can be found in the appendix). The analysed data were saved as Excel files 
and further processed. Analysed objects with a size smaller than 0.04 mm2 (area) were omitted, objects 
that were not present in all 100 frames (#frames) were omitted. The table was sorted by body bends 
per seconds (BBPS) and objects with more than 2 BBPS plus a moved distance less than 0.1 mm were 
re-checked in the videos if they were truly moving nematodes or just artefacts.  
 
Swim-Exhaustion-Assay 
Nematodes were synchronized and grown to day 4 or day 7. 20 – 50 nematodes were picked and 
transferred to M9 medium (3 – 4 mm liquid column in 3.5 mm plate). Nematodes were separated with 
an eye leash and non-moving nematodes were removed. Nematodes were incubated for 30 min at RT. 
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Moving and non-moving nematodes were counted. Non-moving nematodes were touched with an eye 
leash and reacting nematodes were counted. Fraction of paralyzed nematodes was calculated as 
number of non-moving divided by total count. 
 
Chemotaxis-Assay 
To assess the nematodes’ behaviour towards volatile odorants, a four quadrant chemotaxis assay was 
employed 309. In brief, unseeded NGM plates were divided into four quadrants by two perpendicular 
lines. The centre of the plate was marked with a circle (diameter » 1 cm). 2 µl test substance was applied 
in two opposing quadrants, 2 cm from the central intersection. 2 µl of control substance was applied 
the same way to the remaining two quadrants. This preparation had been done approx. 5 min before 
starting the assay. 
To prepare the test substances, NaN3 (500 mM) was mixed in a 1:1 ratio with (a) pure benzaldehyde 
and (b) with prediluted benzaldehyde (2% v/v in water). To prepare the control substances, NaN3 
(500 mM) was mixed in a 1:1 ratio with the used solvent (water). 
Nematodes were washed three times with M9 medium and collected in a 15 ml tube. Afterwards, the 
nematodes were incubated for 5 min in M9 and washed again, this was repeated once. Subsequently, 
the supernatant was removed again and 1 ml fresh M9 medium was applied. The nematodes were 
incubated for 30 min at RT to starve. 
The assay was started by pipetting 4 µl nematodes (directly from the pellet) to the intersection of the 
prepared plates (there should be 80 to 120 nematodes per plate, if the count was too low, more 
nematodes were pipetted). The nematodes were allowed to crawl on the plates for 2 h, being incubated 
at 20°C in a dark environment. Afterwards, nematodes in test and control quadrants were counted and 
the chemotactic index (ci) was calculated as: 







Pathogen avoidance assay was adopted after Pujol et al. 237. The nematode’s reaction to pathogenic 
Serratia marcescens bacteria was tested. S. marcescens was cultured as described above. Assay 
plates were seeded with exactly 150 µl bacteria five to seven days prior starting the experiment. The 
bacteria were spotted slowly to ensure a circular lawn. E. coli OP50 were used as control. An attenuated 
S. marcescens strain (Db1140) was used as negative control. 
Nematodes were synchronized by L4-picking and grown for 16 h at 20°C to reach day 4 of life. Day 4 
old nematodes were transferred to the prepared assay plates (approx. 50 - 75 nematodes per strain 
and bacteria tested). After 24 h incubation at 20°C nematodes were transferred to fresh assay plates 
(with the same bacteria they were exposed to) in groups of 10 to 15 nematodes, resulting in 4 - 5 groups 
per nematode strain and bacteria strain. After 24 h further incubation at 20°C nematodes were scored 
for dwelling on the bacterial lawn or staying away. Every group was counted four times, with at least 
5 min intervals between counting. An avoidance index (ai) was calculated as: 
 :9 = QRS(PMH/EC4	/COIEM4CD	MTT	NIU/)QRS(PMH/EC4	/COIEM4CD	MTT	NIU/	K	PMH/EC4	/COIEM4CD	M/	NIU/)   (equation 3) 
 




To analyse membrane rupture and calcium influx into cytoplasm in hypodermal cells, the galectin 
punctae assay was employed after Aits et al.310. In brief, nematodes were crossed with the reporter 
strain BIJ34, carrying the integrated array jaaIs4 (hyp7p::sfGFP-Gal3). 
Nematodes carrying jaaIs4 were grown to day 4 of life and used for confocal laser scanning microscopy. 
10 - 20 individual nematodes were used and three images of different, randomly selected parts of the 
hypodermis were recorded. Three independent cohorts per strain were imaged. 
Fluorescent foci with an area ≥ 1.0 µm2 were counted per nematode and nematodes were categorized 




Colocalization of fluorophores 
To assess subcellular colocalization of fluorescent molecules, images were acquired at a confocal laser 
scanning microscope in line mode, using a multi-pass dichroic to image two different fluorophores 
(mScarlet and IR-680) simultaneously. Analysis was performed in Fiji using the plug-in 
EzColocalization 302. Colocalization was evaluated using Pearson’s correlation coefficient. Approx. 20 
individual nematodes were analysed per condition. 
 
CRISPR/Cas9 for total knockout generation 
To generate a full knockout of endogenous dbn-1 CRISPR/Cas9 was employed. Four guide RNAs were 
designed using the web tool crispr.edu.mit. Guides were selected to be located within the first 50 base 
pairs of exon 1 and the last 50 base pairs of exon 6. Guide_1 exhibited 2 predicted off targets (score = 
100%), Guide_4 exhibited 2 predicted off targets (score = 100%), Guide_5 exhibited 1 predicted off 
target (score = 100%), Guide_7 exhibited 0 predicted off targets (score = 100%). Guide_1 and Guide_7 
were located in Exon 1, Guide_4 and Guide_5 were located in Exon 6. Guide sequences were ordered 
as oligo nucleotides and inserted into BbsI-cleaved pJJR50 after Cong et al. 304. 
N2, wild type, nematodes were injected with an injection mix containing:  
  50 ng/µl pJJR50_sgRNA-1 (germ line expressed Guide_1+tracerRNA) 
  50 ng/µl pJJR50_sgRNA-4 (germ line expressed Guide_4+tracerRNA) 
  50 ng/µl pJJR50_sgRNA-5 (germ line expressed Guide_5+tracerRNA) 
  50 ng/µl pJJR50_sgRNA-7 (germ line expressed Guide_7+tracerRNA) 
  50 ng/µl pMB67 (heat shock inducible Cas9) 
  3 ng/µl Pmyo-2::mCherry (co-injection marker, pharyngeal red fluorescence) 
  5 ng/µl pCFJ104 (co-injection marker, body wall muscle red fluorescence) 
  1,5 ng/µl pIR98 (co-injection marker, hygromycin resistance) 
 
A strain expressing all markers was selected and cultured in presence of hygromycin. 20 L4 stage to 
young adult stage nematodes were heat shocked at 34°C for 2 h. After 12 h recovery time nematodes 
were allowed to lay eggs for 6 h on a fresh NGM plate supplemented with hygromycin. Offspring was 
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grown to L4/young adult stage and treated the same way. This procedure was repeated a third time. 
20 nematodes of the F3 generation were singled onto separate plates. Populations were tested for 
knockout using PCR (primer pair GT_dbn-1 ko 3 f + GT_dbn-1 ko 3 r) and populations with wild type 
bands of 3.3 kb were omitted. One population was found to exhibit a 900 bp band (“green 7”). 10 
nematodes of this population were singled out and genotyped again to ensure homozygous appearance 
of the knock-out band (“green 7.4” = JKM1). PCR products were sequenced using the separate 
genotyping primer as sequencing primers. 
 
Transgenic strain generation 
Microinjection 
One method to generate transgenic nematode strains with complex extra-chromosomal arrays is 
microinjection. GOIs are cloned together with promoter sequences into the nematode expression vector 
pPD95. Plasmids for microinjection were purified using ZR Plasmid Miniprep™-Classic (Zymo). 
Injection mixes were prepared in 15 µl total volume. GOI were added for final concentrations of 10 - 
30 ng/µl in desired combination and amount. Co-injection markers were added if necessary in following 
concentrations: 1.5 ng/µl pIR98 (hygromycin resistance), 3 ng/µl Pmyo-2::mCherry (red pharynx 
marker), 3 ng/µl Pmyo-2::GFP (green pharynx marker), 5 ng/µl pCFJ104 (red body wall muscle marker). 
If the combined DNA of GOI and Marker were below 100 ng/µl, filler DNA was added (100 – 150 ng/µl, 
50bp-Ladder, Thermo). 
Injection mixes were centrifuged 11 min at 13000 rpm in a benchtop centrifuge prior to injection. Glass 
needles were drawn using a needle puller model P-97 (Sutter Instruments Co., with settings heat = 600, 
pull = 45, vel = 75, del = 90) and loaded with 1.8 µl injection mix. Agar pads for mounting the nematodes 
were prepared in advance, in brief, 2% agarose (w/v) was dissolved in water, boiled and one drop of 
liquid agarose was put on a coverslip. A second coverslip was placed on top to get an even texture and 
a diameter of < 1 mm. Agar pads were allowed to solidify and the top coverslip was removed. The agar 
pad sticking to the first coverslip was baked for 120 min on an 80°C heat block. 
For injection, one to five nematodes (day 4 adults) were picked using halocarbon oil (type 700) and put 
onto a dried agar pad. The nematodes were arranged to expose their gonads to the sides using an eye 
leash. Few picolitres of injection mix were injected into both gonads using an FemtoJet (Eppendorf, 
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settings: pi = 1905 hPa, ti = 0.5, pc = 51 hPa). The nematodes were recovered in M9 solution and placed 
in groups of 3 - 5 on fresh NGM plates. The nematodes were incubated at 20°C and positive 
transformants among the offspring were screened for every day.  
 
Ballistic transformation – micro particle bombardment 
The second employed method to generate transgenic nematode strains was micro particle 
bombardment. A gene gun was built by the FMP workshop following the documentation of the Schnabel 
lab 311.  
Wild type nematodes were synchronized by bleaching and grown to day 4 of life. For the bombardment, 
gold particles (0.3 - 3 microns) were coated in a stepwise protocol with DNA.  
1 mg particles were resuspended in 100 µl spermidine solution (50 µM) by sonication in a water bath 
sonicator. After 10 min incubation at RT and resuspending by flicking every 2 min, 10 µg of one plasmid 
were added (one additional marker could be added as 1 µg). After 10 min incubation at RT and 
resuspending by flicking every 2 min, H2O was added to a total volume of 360 µl. After 10 min incubation 
at RT and resuspending by flicking every 2 min, 100 µl CaCl2 (1 M) was added dropwise and the resulting 
solution was mixed on a vortex mixer for 30 sec. After 10 min incubation at RT and resuspending by 
flicking every 2 min, the particles were pelleted by centrifugation for 30 sec at 13000 rpm in a benchtop 
centrifuge. The supernatant was removed and the pellet was resuspended in 500 µl ethanol (absolute). 
This procedure was repeated twice. Afterwards, the supernatant was removed completely and the pellet 
was resuspended in 200 µl PVP-solution.  
In between, nematodes were harvested in M9. Five shooter plates (unseeded 35 mm NGM plates) were 
seeded with 12 µl OP50 and let allowed to dry. The seeded shooter plates and nematodes were cooled 
on ice. 20 µl nematodes (directly taken from the pellet) were put on the shooter plates as one pile, 
directly in the centre.  
22 µl coated particle PVP solution was loaded to the gene gun. One shooter plate was positioned in the 
shooting chamber and the chamber pressure was reduced by 0.4 bar. The shot was released with 8 bar 
pressure (using He gas) within < 150 ms. The nematodes of one shooter plate were recovered in M9, 
spread on two seeded 100 mm NGM plates and incubated at 15°C overnight. Afterwards, the 






To integrate extra-chromosomal DNA stably into genomic DNA, UV-integration was employed. In brief, 
200 transgenic nematodes (day 4 old adults) were picked and washed five times with M9 to remove 
residual bacteria. The nematodes were placed on a not seeded NGM plates and irradiated with 30 mJ 
UV light of 251 nm (Stratalinker® 2400). The nematodes were transferred to 20 - 30 fresh NGM plates 
(seeded with OP50) in groups of five and incubated at 20°C for 6 - 8 days. Afterwards, nematodes have 
been starved and were chunked to fresh plates. Chunked nematodes were allowed to crawl off their 
former agar for 10 min. Positive L1/L2 larvae were singled to seeded 35 mm NGM plates, until approx. 
300 nematodes per strain were singled. 
The populations were grown at 20°C for up to a week and screened for successful integration (all 
progeny is positive for the transgene / the co-transformation marker). 
 
Gamma-irradiation integration 
Same procedure as above, but nematodes did not need to be washed. DNA double strand breaks and 
DNA damage repair are achieved by irradiation with 4000 rad of gamma rays instead of UV treatment. 
 
Selection on Hygromycin 
To enrich transgenic nematodes that carry the pIR98 cassette, 15 µl hygromycin (50 mg/ml stock) were 
resuspended in 150 µl H2O and spread on one 60 mm NGM-plate (to get a final concentration of 0.08 
– 0.1 mg/ml). If nematodes were placed onto these plates, only offspring carrying the hygromycin 
resistance would survive. If the hygromycin was applied to a mixed population, adult nematodes without 
the resistance gene would die within four days, hatched larvae without the resistance would arrest in 








Alive and moving 
To record time series of moving/swimming nematodes, M9 medium was filled into empty 35 mm plates, 
to reach a liquid column of 3 – 4 mm (2.25 ml) and nematodes were picked into the liquid. An eye leash 
was used to arrange them and to remove bacteria clumps. 
  
Alive and anesthetized   
To record images of living nematodes, 2.5% agarose pads were casted and nematodes mounted on 
them. For casting the agar pads, 2.5% (w/v) agarose was dissolved in water and boiled in a micro wave. 
1 cm2 drops of agarose were pipetted onto glass slides and directly sealed with a second slide on top. 
After solidifying, the second slide was removed and the flattened agar pad was used for mounting 
nematodes. 8 - 10 µl of 2 mM levamisole was pipetted onto the agar pad and up to 20 nematodes were 
picked into that drop. An eye leash was used to arrange the nematodes and a coverslip was applied. 
Alternatively, 250 mM NaN3 were used, as a stronger anaesthetic (especially for FLIM). To prevent drying 
out, liquid agarose was used to seal the coverslip on the edges. 
 
PFA fixation and immunostaining 
Mixed populations of nematodes were harvested in M9 and washed three times. Nematodes were 
pelleted and supernatant was removed. 500 µl ice cold formaldehyde solution was added and 
nematodes were inverted every three seconds at 4°C overnight. After fixation, nematodes were washed 
three times with 1 ml PBS. Nematodes were incubated with 500 µl PBS + 2% (v/v) Tween-20 for 30 min 
at RT and washed three times with 1 ml PBST afterwards. 
The nematodes were incubated for 24 h at 37°C in bME-solution. Afterwards, the pellets were washed 
three times with 1 ml PBST. The supernatant was removed and 100 µl Collagenase-solution was added 
followed by incubation at 37°C and violent shaking (> 3000 rpm) for 5 min. After 5 min, 10 µl were taken 
as sample for microscopy and the number of cracked nematodes was evaluated. Incubation at 37°C 
shaking was continued until > 20% of the nematodes were broken. The reaction was stopped by placing 
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the tube on ice and washing two times with 1 ml PBST. The pellet was washed once in 1 ml AbA 
solution. 
For Aβ1-42 detection, nematodes were incubated in 200 µl AbA solution + anti-Aβ (4G8 or 6E10) antibody 
in 1:100 dilution for 18 h at 4°C, rotating at 20 rpm. The supernatant was removed and nematodes were 
washed in 1 ml AbA solution three times for 2 h at RT, rotating at 20 rpm. Supernatant was removed 
and 200 µl AbA solution + 1:200 anti-Mouse-680 antibody was added, incubating over night at 4°C and 
rotating at 20 rpm.  
The pellets were washed with 1 ml AbA solution three times for 2 h at RT, rotating at 20 rpm. The 
supernatant was removed and nematodes were mixed with 10 µl mounting medium + DAPI 
(VectaShield®). Nematodes were mounted on clean glass slides and sealed with cover slips and clear 
nail polish. Imaging was performed immediately or slides were stored at - 20°C until imaging.  
 
PFA fixation and amyloid specific Thioflavin T staining 
Fixation and permeabilization was done as described above, but Collagenase treatment was not 
performed. For specific staining of amyloid aggregates Thioflavin T (ThT) was employed.  
Fixed and permeabilized nematode pellets were incubated with 500 µl 0.125% (w/v) ThT in 50% (v/v) 
ethanol for 2 min at RT. The supernatant was removed and the pellet sequentially washed with 50% / 
75% / 90% (v/v) ethanol for 5 min at RT inverting twice a minute. Afterwards, the pellet was washed 
with water. 5 µl nematodes were mixed with 5 µl mounting medium + DAPI (VectaShield®) and put on 
clean glass slides, sealed with coverslips and clear nail polish. Imaging was performed immediately. 
Every step involving ThT, including transport of the final slides, was done in the dark or by covering the 
agents with aluminium foil. 
 
Confocal laser scanning microscopy 
Standard imaging 
For confocal image acquisition a laser-scanning microscope (LSM-780 or LSM-710, Zeiss) was used. 
Objectives were ‘Plan-apochromat 100x/1.40 Oil DIC M27’, ‘Plan-apochromat 63x/1.40 Oil DIC M27’, 
‘Plan-apochromat 20x/0.8 M27’ and ‘EC Plan-Neofluar 10x/0.3’ used in combination with a 10x 
magnification ocular. Used were Argon, HeNe, DPSS and diode lasers. DAPI was excited at 405 nm, 
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CFP was excited at 458 nm, GFP was excited at 488 nm, YFP was excited at 514 nm, RFP was excited 
at 561 nm, IR680 was excited at 633 nm. Laser power was set to 1 – 20% as required. Photomultiplier 
voltage was set to 550 – 650 V. Digital Gain was set to 1, only for non-quantitative measurements of 
weak signals digital gain was increased up to 2. Pin hole was set between 40 – 100 µm, usually at airy 
disk ratio = 1.0. For recording Z-Stack images, the pin hole was opened up to 200 µm. Emission was 
measured according to the used fluorophores. 
  
Dendra2 conversion for protein turn-over measurements 
To measure protein degradation in vivo the convertible fluorophore Dendra2 was expressed in 
C. elegans. Two to four nematodes were mounted on an agar pad using 0.5 mM Levamisole as 
anaesthetic. Neurons of interest were selected and a region for conversion was defined. GFP and RFP 
signal were recorded before and after conversion. Conversion was performed by scanning the selected 
region with 405 nm laser (set to 60% power) up to 20 times, or until GFP fluorescence was reduced to 
less than 40%. 
The nematodes were immediately recovered in M9 medium and singled to seeded NGM-plates. After 
3, 6 or 24 h the nematodes were imaged again and GFP and RFP signals were recorded applying the 
exact same settings as before. Per timepoint three independent cohorts of 10 nematodes were imaged. 
The fluorescence decay (RFP) was calculated. 
  
Fluorescence lifetime measurement 
To assess the aggregation state of Aβ1-42 in vivo, the fluorescence lifetime was measured by time 
correlated single photon counting (TCSPC) using a confocal SP5 microscope (Leica) and PicoHarp300 
FLIM unit (PicoQuant). mScarlet was excited at 565 nm using a super continuum pulsed laser (80 MHz 
pulse rate) and emission was measured from 575 - 625 nm. Photomultiplier voltage was set to 990 V. 
Five to ten Nematodes were anesthetized with 250 mM NaN3 and mounted on 2.5% agarose pads. 
Imaging was performed within 45 min after mounting. nAβ1-42 (JKM2) was imaged in the head region to 
get images from the anterior to the retrovesicular ganglion. Image recording was performed for up to 
3 min or until 3500 counts on the brightest pixels were accumulated. The laser was set to 1 - 15% 
power and incoming signal rate was kept below 1% laser repetition rate. Magnification was 945fold 
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(63x/1.3 objective, 10x ocular, 1.5 fold zoom), pin hole was set to airy = 1.0 - 1.2. Neuronal control 
(JKM3) was acquired the same way. 
mAβ1-42 (JKM7) was imaged at the body walls to image muscle cells. Image recording was performed 
for up to 3 min or until 2000 counts on the brightest pixels were accumulated. The laser was set to 1 - 
15% power and incoming signal rate was kept below 1% laser repetition rate. Magnification was 
630fold (63x/1.3 objective, 10x ocular), pin hole was set to airy = 1.0 - 1.2. Muscle control (JKM8) was 
recorded as JKM7. 
An IRF was measured as scattering at the glass slide’s surface for every day and at every excitation 
wavelength measurements were performed. 
Data were analysed using FlimFit software. In brief, an integration value of 80 – 150 was defined to 
remove stray light and autofluorescence. The corresponding IRF was imported and aligned. Data points 
for fitting of the mono exponential decay were limited to 1100 ps to 4000 ps. If necessary, segmentation 
was used to remove autofluorescence that was still present. 
 
Stimulated emission depletion 
To generate confocal images with resolutions beyond the diffraction limit, gated stimulated emission 
depletion microscopy (STED) was performed on JKM2 and nDBN nematodes. Nematodes were 
mounted on agar pads and anesthetized. First, a conventional confocal image was acquired at 6000x 
magnification. Afterwards, the same region was imaged using STED. The depletion laser was set to 
60% power at 592 nm. 
 
Spinning disk microscopy 
To record confocal time lapse images or to acquire Z-Stack images with high axial resolution 
(Z-dimension), Spinning disk microscopy was employed.  
For fluorescence intensity quantification, nematodes were anaesthetized and immobilized on agar pads. 
Z-Stack images were acquired of the nematodes’ heads in 1 µm steps at 400-fold magnification. Field 
of view was set such that the head fit from the tip of the mouth to the retrovesicular ganglion. Exposure 
time was set to 75  ms for nDBN-Dendra (all variants) and 30 ms for mScarlet-Aβ (all crosses and 
variants) for every image of the stacks. Laser power and sensor sensitivity were kept constant. 
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Quantification was done using Fiji by performing a ‘max projection’ + density measurement and 
subtracting of background density.  
 
Light microscopy 
To analyse the motility of large cohorts on nematodes, time lapse images of swimming nematodes in 
M9 were recorded using a transmission light microscope at 7.3-fold magnification.  
 
Transmission electron microscopy  
To analyse the ultrastructure of nematode tissues, transmission electron microscopy was performed on 
wild type, mAβ1-42 and nAβ1-42 day ten old nematodes. 
Nematodes were cryofixed by high pressure freezing (in a HPM100 instrument) using bacteria as 
cryoprotectant. The nematodes were embedded in epoxy resin. First, the remaining water was freeze 
substituted by acetone + 1% (w/v) osmium + 0.1% (w/v) uranyl acetate + 0.1% (v/v) glutaraldehyde 
over a time course of 36 h from -90°C to 0°C. After freeze substitution, the nematodes were washed in 
100% acetone and infiltrated by acetone-epoxy resin mix (ratio 2:1, 1:1, 1:2) followed by pure epoxy 
resin and polymerization at 60°C. 
The polymerized blocks were trimmed and ultrathin sectioned onto hexagonal finder grids (Plano). The 
nematode sections were contrasted with uranyl acetate and lead citrate and imaged at a transmission 
electron microscope (Zeiss 900).  
Cryofixation, freeze substitution, sectioning and contrasting was performed by Dmytro Puchkov. Image 
acquisition was performed together with Dmytro Puchkov. 
For image analysis, images of nematode sections were stitched together manually using prominent 
landmarks (e.g. unique shapes, staining artefacts). To assess the volumetric abundance of 
mitochondria, amphisomes and bloated endoplasmic reticulum, a virtual grid was used as overlay 
(mesh size 2 µm x 2 µm squares). Intersections in muscle cells were counted as well as intersections in 








One/Two-way ANOVA + Bonferroni post hoc test were performed using GraphPad Prism 8. P-values 
were selected as following:   ∗  =  p < 0.0334;   ∗∗  =  p < 0.01;   ∗∗∗  =  p < 0.001. 
 
Log-Rank-Test 
Log-rank tests were performed in Excel to test for significant differences of lifespan assays. For LS 
experiments with multiple analysed cohorts all cohorts were tested separately and the lowest 
significance value was displayed. P-values were selected as:  ∗  =  p < 10-2;   ∗∗  =  p < 10-4;   ∗∗∗  =  p < 10-6. 
 
Student’s t-test 
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Fiji-Scripts for Thrashing Assay 
 
(1) Save every open image (after opening a *.lif archive file) 
 //get image IDs of all open images  
  dir = getDirectory("Choose a Directory");  
  ids=newArray(nImages);  
  for (i=0;i<nImages;i++) {  
         selectImage(i+1);  
         title = getTitle;  
         print(title);  
         ids[i]=getImageID;  
 
         saveAs("tiff", dir+title);  
  } 
  close("*") 
 
 
(2) Convert all images in a folder to 8-bit, remove background and apply threshold  
path=getDirectory("Choose a Directory"); 
list=getFileList(path);  
for(i=0;i<list.length;i++){  
 open(path+list[i]);  
 dir = getDirectory("image");  
 name = getTitle; 
 run("8-bit"); 
 run("Subtract Background...", "rolling=50 light stack"); 
 setAutoThreshold("Default"); 
 //run("Threshold..."); 
 setThreshold(0, 196); 
 setOption("BlackBackground", false); 
 run("Convert to Mask", "method=Default background=Light calculate"); 






(3) Run wrMTrck 
//defining scales, according to settings used in this thesis 
run("Set Scale...", "distance=098 known=1 pixel=1 unit=mm global"); 
 





 open(path+list[i]);  
 
 dir = getDirectory("image");  





 setOption("BlackBackground", false); 
 run("Convert to Mask", "method=Default background=Light calculate"); 
 
 run("wrMTrck", "minsize=30 maxsize=4000 maxvelocity=30 maxareachange=40 
mintracklength=20 bendthreshold=2 binsize=0 showpathlengths showlabels showpositions 
showsummary smoothing rawdata=0 benddetect=1 fps=5 backsub=0 threshmode=Otsu fontsize=24"); 
 
 saveAs("results",  dir + name + ".csv");  









Additional Information about JKM7 
 
Figure 7.1: Aβ1-42 and wrmScarlet-Aβ1-42 are forming amyloids in strain JKM7 
(A) Representative confocal image of mAβ fixed with PFA and stained with anti-Aβ (6E10) + anti-mouse-
IR680. Scale bar represents 20 µm. Colocalization of mScarlet fluorescence and IR680 fluorescence was 
analysed and Pearson’s correlation coefficient was determined for all acquired images (n = 14), noted 
as mean ± SD. (B) Representative confocal image of mAβ, fixed and stained with ThT. ThT-positive foci 
are marked with white arrows. Scale bar is 20 µm. 
  
mScarlet-Aβ1-42 anti-Aβ (4G8) bright field merged
A
mScarlet-Aβ1-42 Thioflavin T bright field merged
B
Pearson‘s correlation = 0.77 ± 0.11
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Additional Information about JKM5 
 
Figure 7.2: Characterization of StopAβ (JKM5) 
(A) Schematic depiction of the organisation of the transgene operon. The ‘empty proxy’ is coding for the 
sequence: Met-Gly-Ala-Stop-Ala-Stop. (B) Representative confocal images of StopAβ stained with ThT. 
No ThT fluorescence was detected. Upon increasing the contrast, mScarlet auto fluorescence arises in 
the green channel. Scale bar is 20 µm. (C) Kaplan-Meier plot of the cumulative survival probability of 
nAβ (red), StopAβ (green) and wild type (black). Log-rank test was performed to test for significance (*** 
p < 10-6). (D) Scatter-dot plot of viable offspring per nematode of StopAβ (green) and wild type (N2, 
black) nematodes. Depicted is mean ± SD. Analysed were three cohorts of 8   15 nematodes. (E) Scatter-
dot plot of the avoidance index of StopAβ (green), IG10 (dark green) and wild type (black) nematodes. 
Three independent experiments with 3   5 cohorts of 10   15 individual nematodes were analysed (four 
times counted with 5 min breaks between counting). Depicted is mean ± SD. Pathogen-Avoidance-
Assay was performed together with Manuel Iburg. 
A
wrmScarlet-Aβ1-42hsp-3 IRES 


















































































Aβ spreading to hypodermis 
 
Figure 7.3: Aβ spreads from muscle cells to hypodermis 
Representative confocal image of JKM7×CS628 (hypodermal GFP marker) exhibits wrmScarlet-Aβ1-42 
derived fluorescence (white arrows) in body wall muscle cells (delimited by dashed, white line) as 
expected and wrmScarlet-Aβ1-42 derived fluorescence colocalizing with GFP in hypodermis (blue arrows) 
around one hypodermal nucleus (n). 
 
 
Aβ aggregation is independent of expression levels 
 
Figure 7.4: Aβ aggregates appear independent from strong accumulation 
Representative TCSPC-FLIM image and corresponding intensity map of nAβ. Cyan arrows mark IL2 
neurons with the first aggregates on day 4 alive. Red arrow heads depict other neurons with equivalent 
or higher fluorescence intensity than IL2 neurons but no aggregates. Small yellow arrows depict 


























Short hairpin construct expression leads to cell-type specific knockdown 
 
 
Figure 7.5: shRNA expression in URY neurons rescues pathogen avoidance but not chemotaxis 
(A) Scatter-dot plot of avoidance-index of nAβ (red), nAβ + shRNAURY (pink), ∆tol-1 (green), wild type 
(black) on E. coli OP50 or S. marcescens Db11 bacteria. Depicted is mean ± SD of three independent 
experiments with 3 – 5 cohorts of 10 – 15 nematodes each. Data acquired in cooperation with Manuel 
Iburg. (B) Scatter-dot plot of the Chemotaxis-Index of nAβ, nAβ + shRNAURY and wild type tested against 
1% Benzaldehyde and 100% Benzaldehyde. Two-way ANOVA plus Bonferroni post hoc test was 
employed to test significance (*** p < 0.001). Three independent experiments with 4 – 5 cohorts of 50 – 






























































°C Degree Celsius ⍺7nACh ⍺7 Nicotinic Acetylcholine 
AD Alzheimer’s Disease 
AMC 7-amino-4-methylcoumarin 
AMPA ⍺-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	
APP Amyloid precursor protein 
ATM Ataxia telangiectasia mutated kinase 
Aβ Amyloid beta 
bp Base pairs 
BSA Bovine serum albumin 
C. elegans Caenorhabditis elegans 
CGC Caenorhabditis genetic center 
CLEM Correlative light-electron microscopy 
daf-18 Abnormal dauer formation (gene) 
(human homolog: PTEN) 
DAPI 4’,6-Diamidin-2-phenylindol 
DIC Differential interference contrast 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
Drebrin Developmentally regulated brain protein (also: DBN) 
DTT Dithiothreitol 
E. coli Escherichia coli 
ECL Enhanced chemiluminescence 
EDTA Ethylenediaminetetraacetic acid 
EM Electron microscopy 
ER Endoplasmic reticulum 
Ex Extra-chromosomal array 
FLIM Fluorescence lifetime imaging 
g Gram   or   Gravitational force equivalent (x times 9.8 m/s2) 
GFP Green fluorescent protein 
GOI Gene of interest 
h Hour 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
het Heterozygous 
hsp Heat shock protein (gene), protein: HSP 
Hz Hertz 
IHC Immunohistochemistry 
IL2 Inner labial sensilla 2 (set of six ciliated neurons)  
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IRES Internal ribosome entry site 
Is Integrated strain 
J Joule 
kb Kilobase 
kDa Kilo Dalton 
ko Knockout 
l Litre 
L1 – L4 Nematode larval stages 1 to 4 
LSM Laser scanning microscope 
LTD Long-term depression 
LTP Long-term potentiation 
m Meter 
M Molar 
myo-3 Myosin heavy chain structural gene 
NGM Nematode growth medium 
NMDA N-methyl-D-aspartic acid 
n.s. Not significant 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PMSF Phenylmethylsulphonyl fluoride 
POI Protein of interest 
PTEN Phosphatase and Tensin homolog 
PVDF Polyvinylidene fluoride 
PVP Polyvinylpyrrolidone 
RFP Red fluorescent protein 
rgef-1 Rap Guanine nucleotide Exchange Factor homolog (gene) 
RNA Ribonucleic acid 
RNAi RNA interference 
ROS Reactive oxygen species 
rpm Revolutions per minute 
RT Room temperature (approx. 20°C) 
s / sec Second 
S. marcescens Serratia marcescens 
SDS Sodium dodecyl sulphate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
siRNA Small interfering RNA 
STED Stimulated emission depletion 
TAE Tris-acetate-EDTA 
TBS Tris buffered saline 
TEMED Tetramethyl ethylenediamine 




unc-119 Uncoordinated (gene) 
UPS Ubiquitin-Proteasome System 
URY Subset of sensory head neurons 
UTR Untranslated region 
UV Ultraviolet 
v/v Volume per volume 
WB Western blot 
wt Wild type 
w/v Weight per volume 
 
SI prefixes 
p pico (10-12) m milli (10-3) 
n nano (10-9) k kilo (103) 
µ micro (10-6) M mega (106) 
 
Amino acids – one letter / three letter code 
      
Alanine A Ala Leucine L Leu 
Arginine R Arg Lysine K Lys 
Asparagine N Asn Methionine M Met 
Aspartate D Asp Phenylalanine F Phe 
Cysteine C Cys Proline P Pro 
Glutamine Q Gln Serine S Ser 
Glutamate E Glu Threonine T Thr 
Glycine G Gly Tryptophan W Trp 
Histidine H His Tyrosine Y Tyr 
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